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Colic, the syndrome of abdominal pain, is a frequent condition in horses. Whilst the 
majority of horses with colic resolve spontaneously or with medical treatment alone, 
a proportion require abdominal surgery to address the underlying cause. Any horse 
undergoing abdominal surgery is at risk of developing post-operative ileus (POI). POI 
is the functional inhibition of normal intestinal motility. POI affects up to 60% of 
horses undergoing abdominal surgery and has reported mortality rates as high as 
86%. POI also increases the duration of post-operative hospitalisation and increases 
costs. Most published studies in the field of equine POI report on associated risk 
factors or have tried to evaluate the efficacy of various treatments. There remains a 
lack of study of the mechanisms underpinning POI in the horse, with applicable data 
largely extrapolated from human and rodent studies. The aims of this thesis were to 
study the mechanisms of POI in the horse, specifically targeting immune cells in the 
intestine called macrophages. These cells become activated by manipulation of the 
intestine during surgery, with subsequent initiation of a sequence of events which 
ultimately results in dysfunction of the intestine. 
Firstly, the normal population of macrophages in the equine intestine was 
determined. Macrophages were present in all tissue layers of the intestine. Next, 
equine macrophages were grown in culture and their response to the toxin, 
lipopolysaccharide (LPS) was studied. This toxin has been shown in rodent models to 
activate intestinal macrophages. Equine macrophages responded to LPS as expected; 
however, although this response was similar to that reported for rodent 
macrophages, certain differences were observed between species. Next, intestinal 
tissue from horses undergoing abdominal surgery was collected and levels of specific 
genes relating to macrophage activation were measured and compared to normal 
horses. These results showed activation of macrophages in the intestine of horses 
undergoing colic surgery. In the final part of the study a therapeutic agent which 
targets the macrophage population in the intestine was administered to mice. This 





Post-operative ileus (POI) is the functional inhibition of propulsive intestinal motility 
which is a frequent occurrence following abdominal surgery in the horse and in 
humans. Rodent and human-derived data have shown that manipulation-induced 
activation of the resident muscularis externa (ME) macrophages in the intestine 
contributes to the pathophysiology of the disease. Most studies of the disease, 
specifically in the horse, have focussed on identification of risk factors, descriptive 
studies of the disease or the assessment of the efficacy of various therapeutic and 
prophylactic interventions. As a result, the proposed pathogenesis of equine POI is 
largely reliant on the translation of data from rodent models. The aims of this thesis 
were to identify macrophage populations in the normal equine gastrointestinal tract 
(GIT) and to study equine macrophage activation by stimulating equine bone marrow-
derived macrophages (eqBMDMs) with lipopolysaccharide (LPS) as a model for 
intestinal macrophage activation. 
Firstly, the normal population of macrophages in the equine GIT was determined. 
Using CD163 as an immunohistochemical marker for macrophages.  CD163+ve cells 
were present in all tissue layers of the equine intestine: mucosa, submucosa, ME and 
serosa. CD163+ve cells were regularly distributed within the ME, with accumulations 
adjacent to the myenteric plexus, and therefore to intestinal motility effector cells 
such as neurons and the Interstitial Cells of Cajal.  
The differentiation and survival of intestinal macrophages depends upon signals 
from the macrophage colony-stimulating factor (CSF-1) receptor.  LPS translocation 
from the gut lumen is thought to be a key activator of ME macrophages. To provide 
a model for gut macrophages, a protocol was optimised to produce pure populations 
of equine bone marrow-derived macrophages (eqBMDMs) by cultivation of equine 
bone marrow in CSF-1.   Macrophage functionality was assessed using microscopy, 
flow cytometry and phagocytosis assays. EqBMDMs responded to LPS stimulation 
with increases in expression of positive control genes, tumour necrosis factor alpha 
(TNF-α) and Indoleamine 2,3-dioxygenase (IDO1).  The same mRNA was subjected to 
transcriptomic (RNA-Seq) analysis. Differential gene expression and network cluster 
analysis demonstrated an inflammatory response characterised by the production of 
pro-inflammatory cytokines such as interleukin 1 beta (IL-1β) and interleukin 6 (IL-6). 
However, in contrast to rodent macrophages, eqBMDMs failed to produce nitric oxide 
in response to LPS, showing species-specific variation in innate immune biology. 
vii 
  
Using these data, we compared gene expression in normal equine intestine and in 
intestine from horses undergoing abdominal surgery for colic (abdominal pain). 
Horses undergoing abdominal surgery showed evidence of increased expression of 
IL-1β, IL-6 and TNF-α in the mucosa and ME when compared to control tissue. Horses 
with post-operative reflux (POR), a clinical sign of POI, had increased gene expression 
of IL-1β, IL-6 and TNF-α compared to horses that did not develop POR following 
abdominal surgery. These preliminary data suggest that there is macrophage 
activation within the ME of the intestine during abdominal surgery in the horse, and 
that a greater activation state is present in horses that subsequently develop POR.  
The final part of this study was to investigate the effect of a long-acting form of CSF-
1, an Fc fusion protein (CSF1-Fc), as a potential treatment for POI using a mouse 
model.  This work, performed in collaboration with another research group, found 
that mice lacking the C-C chemokine receptor type 2 (CCR2) gene, which is required 
for monocyte recruitment into tissues, had a longer recovery period following 
intestinal manipulation (IM) than wild type (WT) mice. With the administration of 
CSF1-Fc, infiltration of neutrophils to the ME was reduced and the number of 
macrophages in the ME was increased in both WT and CCR2-/- mice following IM. 
Administration of CSF1-Fc in CCR2-/- mice improved recovery of gastrointestinal 
transit three days following IM, to the same extent as WT mice. Network cluster 
analysis and RT-qPCR of the ME revealed clusters of genes induced and 
downregulated by CSF1-Fc, with increased expression of anti-inflammatory and pro-
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 General Introduction 





The gastrointestinal tract (GIT), which goes from the mouth through the oesophagus, 
stomach, small intestine, caecum, large intestine and rectum to the anus is the largest 
mucosal surface in the body. Its function, of absorbing nutrients and water, 
necessitates a simple barrier. Consequently, microbiota, food products and 
potentially pathogenic organisms with the capability to generate significant 
pathology are only a few cells away from possible translocation across the epithelial 
barrier. In part to deal with this threat, the resident gastrointestinal (GI) macrophages 
are the largest pool of tissue macrophages in the body (Lee et al., 1985). Resident 
intestinal macrophages are made up of two distinct populations, namely mucosal, or 
lamina propria macrophages (LpM) and muscularis externa (ME) macrophages (MM) 
(Gabanyi et al., 2016). LpM maintain epithelial barrier integrity and sample luminal 
content (Muller et al., 2014, Bain and Mowat, 2014).  It is crucial to their function that 
they do not respond excessively to microbial stimuli to generate inflammation. Less 
is known about the role of MM, which are the major focus of this thesis.   
Colic is a term used to describe the ‘display of abdominal pain’ in the horse. It usually 
occurs because of disruption to the normal function of the GIT because of 
obstruction, distention or torsion to part of the GIT, or due to abnormal intestinal 
motility. It is of great concern to horse owners (Mellor et al., 2001) and is reported by 
insurance companies and universities as the single most common cause of equine 
mortality (White, 1990), with a reported incidence of up to 10 cases per 100 horse 
years (Tinker et al., 1997, Traub-Dargatz et al., 2001). Furthermore, with the estimated 
cost associated with colic in the USA exceeding $115 million dollars per annum 
(Traub-Dargatz et al., 2001) it is also a significant economic issue for horse owners.  
Whilst most cases resolve spontaneously, or with medical treatment alone, 1.4% to 
10% of horses require surgery (Hillyer et al., 2001, Traub-Dargatz et al., 2001). Any 
horse undergoing abdominal surgery is at risk of developing post-operative ileus (POI) 
which is a serious post-operative complication, not only reported in the horse but 
also in humans (Delaney et al., 2005, Earnshaw et al., 2015, Vather and Bissett, 2013, 
Vather et al., 2014, Vather et al., 2013).  The term POI describes the cessation of, or 
reduction in, gastrointestinal transit (GT) following surgical stress (Gero et al., 2017). 
Activation of MM has been shown to contribute to the pathogenesis of POI following 
abdominal surgery (Wehner et al., 2007, Kalff et al., 2003). However, in keeping with 
the additional macrophage functions of tissue repair and maintaining tissue 
homeostasis, infiltrating monocytes (destined to become macrophages) to the 




intestine are required for resolution of POI in rodent models (Farro et al., 2017). POI 
is a condition involving complex interactions between immune cells and motility 
effector cells. In addition, several pre-, intra- and post-operative factors not only 
further complicate its pathophysiology but also its diagnosis, treatment and 
management. 
Efforts have been made in human medicine to establish a standardised definition of 
POI (Vather et al., 2013, Kehlet et al., 2005), an exercise which, based on the variation 
in POI definitions used amongst equine clinicians (Hunt et al., 1986, Blikslager et al., 
1994, Lefebvre et al., 2016a, Merritt and Blikslager, 2008, Roussel et al., 2001, 
Lefebvre et al., 2016b, Freeman, 2008), also appears warranted in the field of equine 
veterinary medicine. In the horse, POI is almost exclusively associated with 
gastrointestinal (GI) surgery. In human medicine, it has also been reported following 
non-GI surgeries, including orthopaedic and gynaecological procedures. POI has the 
potential to significantly increase hospitalisation time, treatment costs and post-
operative morbidity and mortality and is therefore of significant concern to both the 
medical and veterinary professions. The estimated financial impact of human POI in 
North America alone approximates US $1.46 billion/year as a result of increased 
hospitalisation and treatment costs (Goldstein et al., 2007). Horses that develop POI 
are much less likely to survive after surgery (Morton and Blikslager, 2002, Mair and 
Smith, 2005c). In recent years, equine POI research has largely focused on (a) the 
provision of descriptive statistics relating to the syndrome (e.g. incidence and 
survival rates), (b) the identification of associated risk factors, and (c) determining 
the efficacy of certain therapeutic and prophylactic interventions. There are little 
research-derived data focused on the pathogenesis of the syndrome in the horse, with 
reliance placed on the translational application of data derived from other species.1  
 Macrophages and the mononuclear phagocyte 
system  
The mononuclear phagocyte system (MPS) is comprised of cells derived from bone 
marrow progenitors which differentiate into blood monocytes prior to entering the 
circulation before ultimately entering tissues to become resident tissue macrophages 
                                                 
1 Paragraph reproduced from: An update on equine post‐operative ileus: Definitions, 
pathophysiology and management, Z. M. Lisowski, R. S. Pirie, A. T. Blikslager, D. 
Lefebvre, D. A. Hume & N. P. H. Hudson, Equine Veterinary Journal 50 (3), © 2017 EVJ 
Ltd 




(Van Furth, 1992). Since their discovery by Ellie Metchnikoff in the 19th Century, 
macrophages have been described in most tissues and organs of the body (Figure 1-1 
and Figure 1-2) where they may make up to 15% of the total cell population within 
the tissue. Their roles within the innate immune system include phagocytosis, 
extracellular killing and induction of inflammation.  They also contribute to acquired 
immunity through presentation of antigen to T lymphocytes. Macrophages are also 
effector cells for the acquired immune system, utilising antibodies to opsonise 
pathogens for enhanced uptake and clearance/killing and responding to T cell 
products such as interferon gamma (Schroder et al., 2004, Gordon, 2003) and 
interleukin 4 (Gordon, 2003).  They are often found in close association with epithelial 
surfaces, such as blood vessels and the lamina propria of the GIT. They are well 
adapted to detecting pathogen-associated molecular patterns (PAMP) via pattern 
recognition receptors (PRR) such as toll-like (TLR) and nod-like (NLR) receptors. In 
addition to these roles within innate and adaptive immunity, macrophages also have 
functions in embryonic development, tissue homeostasis and repair (Chazaud, 2014, 
Davies et al., 2013, Geissmann et al., 2010, Hume et al., 2002)  
Macrophages distributed in tissues are referred to as resident tissue macrophages. 
Tissue macrophages are heterogenous in terms of function and surface marker 
expression (Hume, 2008a). The development of the monoclonal antibody, F4/80, first 
permitted the number of macrophages in tissues to be established, as well as 
identifying specific anatomical niches that they occupy (Hume et al., 1984). 
Macrophages from different tissues will all differ functionally and phenotypically as 
a result of their adaptation to specific functions in differing organs (Mass et al., 2016, 
Gosselin et al., 2014, Ginhoux and Guilliams, 2016, Guilliams and Scott, 2017). 
Differences in macrophage populations and functions also occur within the same 
tissue; lamina propria macrophages (LpM) are different to ME macrophages (MM) 
despite both subpopulations residing in the GIT (Gabanyi et al., 2016, Kalff et al., 
1998b, Weigmann et al., 2007, Pohl et al., 2017). 
 





1.2.1 Identification of macrophages 
Mononuclear phagocytes were originally identified by shared characteristics such as 
their morphology, the expression of enzymes and the non-specific uptake of particles 
(Table 1-1); however, none of these define a tissue macrophage (Hume, 2006). The 
development of monoclonal antibodies, permitting the identification of surface cell 
proteins, has been instrumental, not only in defining mononuclear phagocytes, but 
also demonstrating the diverse phenotypes attributable to these cells. 





Ultrastructural evidence of endocytic activity 
Expression of enzymes 





Non-specific - uptake of latex or colloidal carbon 
Specific – endocytic receptors especially for the Fc portion of 
immunoglobulin and complement-coated particles 
Figure 1-1 Summary of the main macrophage populations in tissues in the steady 
state 
Macrophages are distributed throughout the body. Each tissue macrophage population will 
have specialised functions. 





Figure 1-2 Expression of mApple and EGFP tagged with the Csf1r in adult mouse 
tissues 
Distribution of Csf1r-mApple and Csf1r-EGFP transgenes throughout different tissues in the 
mouse. Figure adapted from Hawley et al. 2018. (Appendix 9.1) 




The most commonly used marker in mice is F4/80 (Austyn and Gordon, 1981). 
Cloning of the mouse cDNA encoding F4/80 revealed orthology with a previously 
cloned human cDNA, called Emr1.  The cDNA encodes seven calcium-binding 
Epidermal Growth Factor (EGF)-like domains linked to seven transmembrane domains 
characteristic of a G protein coupled receptor (McKnight et al., 1996). Subsequent 
studies identified related receptors called EGF-TM7 proteins (McKnight and Gordon, 
1998), but more recently, these receptors have been reclassified to a subdivision of 
adhesion G protein coupled receptors (ADGRE). Therefore, F4/80 is encoded by the 
Adgre1 gene (Hamann et al., 2015). Comparative analysis in the Hume laboratory, 
based upon RNA-Seq data, including data generated as part of this thesis (see Chapter 
4) indicate that ADGRE1 is expressed by macrophages in all large animals, including 
the horse (Waddell et al., 2018).  The sequence and number of extracellular EGGF-like 
domains varies greatly between species ((Waddell et al., 2018).  Other commonly used 
markers include CD68, CD11b and CD115 (Sasmono et al., 2003). In addition, CD14, 
CD16, CCR1, CCR2 and CX3CR1 have also been used to subgroup monocytes and 
macrophages in both blood and tissues (Hume, 2006, Gordon and Taylor, 2005). 
Species differences in marker expression exists as does variation in expression on the 
same mononuclear phagocyte subsets. For example, in humans, monocytes can be 
classified as CD14hiCD16- cells and CD14+CD16+ monocytes. Human monocytes will 
express MHC class II whereas mouse monocytes do not (Gordon and Taylor, 2005).  
CD14, a GPI-anchored protein and LPS co-receptor, and CD16 (FcRIII), are the 
markers most commonly used to differentiate between monocyte subsets in both 
humans and mice.  
The task of categorising macrophages into ‘populations’ seems almost futile as the 
number of cell types that we attempt to define is exponentially related to the number 
of markers that we apply to those cells (Hume, 2006). Each cell has its own 
transcriptional profile and a cell expressing one gene does not mean another gene 
will, or will not, be expressed as a result.  










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   




1.2.2 Macrophage origins and development 
The differentiation of monocytes from CD34+ve haematopoietic stem cells (HSCs) 
requires the cells to go through several distinct intermediate stages (Figure 1-3). 
Studies in mice have identified the yolk sac as the region where developing 
macrophages are first found (Hume et al., 1995). As the embryo develops, the fetal 
liver becomes the main site of haematopoiesis, in the mouse by embryonic day 10.5 
to 11 (Lichanska and Hume). Once a neonate or adult, the bone marrow becomes the 
primary site of haematopoiesis. 
 
Figure 1-3 Differentiation of cells from the mononuclear phagocyte system  
Pluripotent haematopoietic stem cells (HSCs) differentiate into granulocyte monocyte colony 
forming unit (GM-CFU) before committing to more specific lineages; macrophage colony-
forming unit (M-CFU) or granulocyte colony-forming unit (G-CFU). Figure reproduced with 
permission from Springer Nature: Nature Reviews Immunology. Monocyte and macrophage 
heterogeneity, Gordon, S., Taylor, P.R., Nat Rev Immunol. 5 (12), © 2005. 




All monocytes are derived from the same common progenitor cell, the granulocyte 
macrophage colony forming unit (GM-CFU), which is also a progenitor cell for 
granulocytes. The GM-CFU then further commits to specific lineages of either the 
macrophage colony forming unit (M-CFU) or granulocyte colony forming unit (G-CFU). 
These committed progenitors further differentiate through monoblastic and pro-
monocyte stages before becoming a monocyte/macrophage (Gordon and Taylor, 
2005). The differentiation of cells from HSCs to GM-CFU, M-CFU and G-CFU requires 
a group of cytokines called growth factors (Barreda et al., 2004). Examples of growth 
factors include macrophage colony-stimulating factor (M-CSF or CSF-1), granulocyte-
macrophage colony-stimulating factor (GM-CSF or CSF-2), granulocyte colony-
stimulating factor (G-CSF or CSF-3) and multi colony-stimulating factor (multi-CSF or 
IL-3) (Figure 1-4).  
The entry of monocytes into the circulation requires chemokine signals generated by 
ligands of the chemokine receptor, CCR2, which is itself a marker for the ‘classical’ 
subset of blood monocytes in both mice and humans.   Mice lacking the Ccr2 gene 
have reduced circulating monocytes (Serbina and Pamer, 2006). Resident tissue 
macrophages originate from blood monocytes (van Furth and Cohn, 1968). Cells 
either remain as monocytes (Ly6Chi or Ly6Cmed) in the blood or enter tissues (Ly6Clow) 
to differentiate into tissue resident macrophages (Figure 1-3) (Gordon and Taylor, 
2005). Several papers have questioned this model of monocyte replenishment of 
resident tissue macrophages, instead suggesting that resident cells are embryonic in 
origin and maintained by local proliferation (Greter and Merad, 2013, Geissmann et 
al., 2010, Epelman et al., 2014, Hashimoto et al., 2013, Volkman et al., 1983). Jenkins 
and Hume have highlighted questions around the interpretation of lineage trace 
systems used to argue for the embryonic origin of tissue macrophages (Jenkins and 
Hume, 2014).  What is clearly the case is that LpM of the intestine turn over rapidly 
and are constantly replaced by blood monocytes (Bain et al., 2014).  
1.2.3 Colony Stimulating Factor-1 (CSF-1) 
CSF-1 is the growth factor required for the differentiation, proliferation and survival 
of cells in the macrophage lineage (Stanley et al., 1978). Administration of 
recombinant human CSF-1 (rhCSF-1) to mice first highlighted its role as a circulating 
regulator of the mononuclear phagocyte system, whereby it resulted in a significant 
increase in both circulating monocytes and the tissue macrophage population (Hume 
et al., 1988). Its receptor, CSF-1R (or CD115) is required for definitive macrophage 
differentiation and is expressed in all progenitors and cells of the myeloid lineage 
(Figure 1-2), mediated by the ligands CSF-1 and IL-34. Administration of an antibody 




against the CSF-1R results in depletion of both monocytes and tissue resident 
macrophages (MacDonald et al., 2010). The function of these ligands in macrophage 
development was studied in natural mutant mice (Csf1op/op), Csf1r knockout mice 
(Csf1r(-)/Csf1r(-)) and IL-34 ligand knockout mice. Csf1op/op or Csf1r(-)/Csf1r(-)  rodents 
highlight the importance of CSF-1 in macrophage development. These animals are 
deficient in tissue macrophage and osteoclast populations with pleiotropic effects on 
growth and development (Dai et al., 2002). The more severe Csf1r(-)/Csf1r(-) phenotype 
revealed the existence of IL-34 as a second ligand of the CSF1-R (Wang et al., 2012b), 
thus explaining why the Csf1r(-)/Csf1r(-) had a more severe phenotype compared to the 
Csf1op/op mouse. 
 
Figure 1-4 Growth factors in the mononuclear phagocyte system 
Progenitor cells in the bone marrow differentiate into several lineages, under the control of 
growth factors. Reproduced with permission from Springer Nature: Nature Reviews 
Immunology. Trophic macrophages in development and disease, Pollard, J.W., Nat Rev 
Immunol. 9 (4), © 2009. 




Recombinant human CSF-1 (rhCSF-1) has been shown to be active on several species-
derived macrophages, including the horse (Kapetanovic et al., 2012, Karagianni et al., 
2013, Gow et al., 2013). Cross reactivity between species is constrained in some 
measure by variation in sequences between species in CSF-1 and IL-34 sequences 
(Gow et al., 2013), although equine CSF-1 has not been cloned.  
Therapeutic applications of Fc conjugate of CSF-1 (CSF1-Fc) 
Tissue damage or injury triggers an inflammatory response consisting of several cell 
types including macrophages, neutrophils, NK Cells, B and T cells, epithelial cells and 
stem cells that collectivly contribute to a well regulated tissue repair response  (Wynn, 
2008). Macrophages are critical regulators of repair  and are required for tissue repair 
in several organs (Chazaud, 2014).  Consequently, macrophages are an obvious choice 
as theraputic targets. 
CSF-1 is present in the circulation. In patients with liver injury, low circulating CSF-1 
was associated with reduced survival (Stutchfield et al., 2015). The addition of CSF-1 
to monocytes in vitro drives the polarisation of differentiated macrophages towards 
an immunosuppresive role (Hume, 2008a), and are therefore occasionally referred to 
in the literature as alternatively-activated (M2-like) (Martinez et al., 2006). Based on 
in vitro data, CSF-1 can be considered as a stimulus for macrophages that promote 
tissue repair and suppress cell-mediated immunity (Hume and MacDonald, 2012). 
Several studies have evaluated the use of CSF-1 as a potential therapeutic tool in 
various experimental scenarios which might reflect a clinical need; these include liver 
disease (partial hepatectomy) (Stutchfield et al., 2015), fracture repair (Alexander et 
al., 2011), ischaemic kidney (Alikhan et al., 2011) and heart (Okazaki et al., 2007) 
injury, promotion of angiogenesis (Okuno et al., 2011) and amyloid deposition in the 
brain (Boissonneault et al., 2009). Resolution of POI requires monocyte-derived 
macrophages (Farro et al., 2017); in this study the adminstration of CSF1-Fc promoted 
tissue recovery by reducing tissue neutrophil infiltration and increasing ciculating 
monocytes and tissue macropahges, thus promoting repair.   
 Macrophage activation 
Disruption to tissue homeostasis by inflammation or trauma causes macrophage 
activation. The recognition of pathogens by macrophages is dependent on the 
expression of various surface and intracellular pattern recognition receptors (PRRs) 
that enable the macrophage to distinguish between self and non-self or 




altered/damaged self.  PRRs bind specifically to pathogen associated molecular 
patterns (PAMPs) such as lipopolysaccharide (LPS) (Eskandari et al., 1997) and damage 
associated molecular patterns (DAMPs) such as adenosine triphosphate (ATP) (Ozaki 
et al., 2004). The recognition of microorganisms, toxins, cytoplasmic PAMPs and/or 
endogenous DAMPs by PRR triggers a signalling cascade referred to as the 
inflammasome (Takeuchi and Akira, 2010) Examples of PRRs include toll-like 
receptors (TLRs) and nucleotide oligomerisation domain (NOD)-like receptors (Taylor 
et al., 2005, Zhou et al., 2015). PRRs can be divided into two classes; those that 
mediate phagocytosis and those that trigger an inflammatory cascade (Aderem and 
Ulevitch, 2000). Different PRR will recognise different microorganisms self and non-
self-molecular patterns (Takeuchi and Akira, 2010). Macrophage activation is defined 
as the acquisition/induction of effector functions that mediate some components of 
T cell-mediated immunity.  By analogy with the two major classes of CD4-positive 
helper T lymphocyte, Th1 and Th2, attempts have been made to classify macrophage 
activation into two polarised ‘states’ in the literature; classical (M1) or alternative (M2) 
(Mantovani et al., 2005, Mantovani et al., 2004, Gordon, 2003). Classical activation of 
macrophages occurs in response to microorganisms. The classical activating factors 
for macrophages are interferon-gamma (Schroder et al., 2004) and LPS. LPS, a 
component of gram-negative bacterial cell walls, is also a well characterised PAMP 
that leads to macrophage activation (Hume et al., 2001). The alternatively-activated 
macrophage is associated with the cytokines IL-4 and IL-13 (Gordon, 2003) and is 
associated with wound healing, fibrosis and homeostasis (Mantovani et al., 2004).   
However, more recently it has been argued that due to the diversity of environmental 
stimuli and macrophage heterogeneity that it is over simplistic to fit macrophages 
into either a ‘classical’ or ‘alternative’ category (Mosser and Edwards, 2008).  A recent 
review refers to the many alternative faces of macrophage activation (Hume, 2015). 
An alternative model recognises that individual macrophages may exist in a broad 
spectrum of activation states, intermediate between or distinct from, the M1/M2 
polarisation states.  Indeed, intestinal macrophages for example have been 
characterised as having overlapping states between M1 and M2 (Bain and Mowat, 
2011, Mowat and Bain, 2011).   
1.3.1 LPS activation of macrophages 
Pathogen associated molecular patterns 
Pathogens and PAMPs are recognised by PRR, such as TLRs and NLRs. Each PRR 
detects specific ligands; TLR4 with its co-receptors CD14 and MD2, recognises the 
Lipid A part of LPS.; TLR2-TLR-1 recognise microbial lipoproteins; TLR3 recognises 




single or double stranded RNA; TLR5 recognises flagellin; TLR9 recognising 
unmethylated DNA (Kawai and Akira, 2010, Aderem and Ulevitch, 2000). Recognition 
of its ligand by a TLR will initiate a signalling cascade which leads to the production 
of cytokines and chemokines which promotes recruitment of cells to the area of 
inflammation (Hume, 2008b). 
Toll-like receptors 
The TLR receptors have been extensively studied. Ten have been identified in human 
and horse and 13 in mice. TLRs are broadly divided into 2 groups; TLR1,2,4,5,6, and 
10 are expressed on the cell surface and predominantly recognise microbial 
membrane components such as lipid; and TLR3, 7, 8 and 9 are found intracellularly 
and mainly recognise microbial nucleic acids (Blasius and Beutler, 2010, Kawai and 
Akira, 2010, Miyake, 2004). Each TLR is a type 1 transmembrane protein with 
cytoplasmic Toll/IL-1R homology (TIR) domain. The TIR domains have several 
adaptors (Takeuchi and Akira, 2010): 
• Myeloid differentiation primary response 88 (MyD88) 
• MyD88 adapter-like (MAL) also called TIRAP  
• TIR domain-containing adaptor inducing IFN-β (TRIF) 
• TRIF-related adaptor molecule (TRAM) 
Each TLR differs in their TIR domain-contain adapter and this results in specific 
responses by individual TLRs. As an example, TLR4 generates both type 1 IFN and 
inflammatory cytokine response whereas TLR1 mainly induces inflammatory 
cytokines (Kawai and Akira, 2010). TLR signalling is divided into two distinct 
pathways depending on the usage of MyD88 (MyD88-dependent pathway which 
drives the production of inflammatory cytokines) and TRIF (MyD88-independent 
pathway which drives the production of type 1 IFN and inflammatory cytokines) 
(Kawai and Akira, 2010).  
MyD88-dependent TLR signalling pathway 
In the MyD88-dependent pathway, MyD88 is recruited to the TIR domain, triggering 
the phosphorylation of IL-1 receptor associated kinases (IRAK) 4. IRAK-4 activates 
other kinases from the IRAK family, IRAK1 and IRAK2. These bind to TNF receptor 
activated factor (TRAF) 6. The IRAK-TRAF6 complex separates from the MyD88 
adapter and binds to TGFβ-activated kinase (TAK). The TAK complex phosphorylates 
Iβ kinase (IKK)-β, which in turn phosphorylates IB-A which is an inhibitory protein 




of NF-β. This causes the release of NF-β, which translocates from the nucleus 
(Takeuchi and Akira, 2010, Aderem and Ulevitch, 2000). 
MyD88- independent TLR signalling pathway 
This pathway activates both IFN-regulatory factor (IRF) 3 and NF-β. Unlike TLR3. 
TLR4 requires TRAM to activate TRIF. Following activation of TRIF, TRIF associates 
with and TRAF3 and TRAF6. TRAF6 activates TAK1 for NF-β activation, in a similar 
way to the MyD88-dependent pathway. TRAF3 with TANK (a TRAF-binding protein) 
bridge IKK related kinases which mediate phosphorylation of IRF3. Phosphorylated 
IRF3 translocates to the nucleus, inducing the expression of Type 1 IFN genes  (Kawai 
and Akira, 2010, Mogensen, 2009). 
Toll-like receptor 4  
The recognition of LPS by its receptor TLR4, is activated in endotoxemia as well as 
being involved in the activation of intestinal macrophages in POI.  Mice lacking Tlr4 
do not respond to pure LPS (Deng et al., 2013, Hoshino et al., 1999). The TLR4 receptor 
requires its co-receptors CD14 and MD-2 to bind to the Lipid A component of LPS to 
form an active complex (Shimazu et al., 1999). LPS is removed from circulation in the 
plasma by the serum protein lipopolysaccharide binding protein (LBP) (Steinemann et 
al., 1994), after which the Lipid A component of LPS is transferred to the TLR4-MD2 
complex via CD14 (Wright et al., 1990, Shimazu et al., 1999). The recognition of the 
LPS ligand results in a conformational change in the TLR4 receptor, TIR domains and 
results in recruitment of the adaptors TIRAP, MyD88, TRIF and TRAM (Aderem and 
Ulevitch, 2000, Takeuchi and Akira, 2010). TLR4 triggers both MyD88-independent 
and MyD88-dependent signalling. 
1.3.2 Inhibitory Feedback mechanisms in response to LPS 
As discussed in the section above LPS induces inflammation via the TLR4-CD14-MD2 
complex. Prolonged or sustained exposure to LPS can result in tissue injury and sepsis 
(Bone et al., 1992, Hotchkiss and Karl, 2003). The macrophage response to LPS 
triggers a sequences of inducible gene expression, which occurs in waves (Baillie et 
al., 2017). Each wave is likely to include induced genes or transcripts that inhibit 
genes or transcripts already upregulated in response to LPS. A well-known inhibitory 
cytokine released in response to LPS is IL-10 (Bogdan et al., 1992). Other inhibitory 
genes that target the MyD88 signalling pathway that were upregulated in human 
MDMs in response to LPS include NF-β inhibitors (NFKBIA, NFKBIB, NFKBIE, NFKBIZ, 
BCL3), multiple members of the TRIM family of E3 ubiquitin ligases which promote 




degradation of signalling molecules (TRIM5, TRIM10, TRIM25, TRIM35, TRIM36, 
TRIM38) and the TRAF inhibitor TANK (Baillie et al., 2017).  
Macrophages in vivo can develop ‘endotoxin tolerance’, whereby they become 
refractory to subsequent endotoxin challenges which provides some protection 
against continued LPS exposure. These macrophages show a down regulation in 
inflammatory cytokines (e.g. TNF-α, IL-6) and an upregulation in anti-inflammatory 
cytokines (e.g. IL-10) (Biswas and Lopez-Collazo, 2009).  
 Resident Intestinal Macrophages 
Intestinal macrophages are tissue resident macrophages i.e. macrophages that occur 
in specific sites in normal, non-inflamed tissue. They are heterogeneous, as a 
consequence of tissue and anatomical specific functions that are integral to tissue 
homeostasis (Davies et al., 2013). The GIT, although an internal organ, has the largest 
surface area in contact with the external environment of all the body organs. This 
provides a vast and constant antigenic challenge. It is therefore not surprising that 
the GIT has the largest number of immune cells and represents the largest reservoir 
of mononuclear phagocytes in the body (Lee et al., 1985), comprised of two 
phenotypically-distinct groups: LpM and MM. LpMs have been extensively studied 
(LeFevre et al., 1979, Hume, 1985, Hume et al., 1987, Pavli et al., 1990, Smith et al., 
1997, Smith et al., 2001, Denning et al., 2007, Geem et al., 2012, Bain et al., 2014, Bain 
and Mowat, 2012). The recent increasing knowledge base regarding MM has clearly 
demonstrated their significance in inflammation of the GIT, particularly in POI 
(Behrendt et al., 2004, Cailotto et al., 2014, Eskandari et al., 1997, Farro et al., 2017, 
Gabanyi et al., 2016, Hoffman and Fleming, 2010, Hori et al., Kalff et al., 1999b, Kalff 
et al., 1999a, Kalff et al., 1998b, Kalff et al., 2003, Matteoli et al., 2014, Pohl et al., 
2017).   
1.4.1 Ontogeny of resident intestinal macrophages 
In the mouse, Ly6Chi monocytes replenish LpMs in inflamed and steady-state tissue 
where they differentiate into F4/80hi CXC3CR1hi MHCII+ve macrophages, which show 
phagocytic activity and are resistant to TLR stimulation (Bain et al., 2014). Upon 
consideration of the lifespan of embryonic-derived macrophages in the intestine, it 
became clear that cells of embryonic origin failed to persist in adulthood. Rather 
these cells were replenished by infiltration of monocyte-derived macrophages, a 
process that was dependent on the CCR2 receptor and commensal microbiota (Bain 
et al., 2014). However, there remains two theories regarding the ontogeny of MMs. 




Firstly, those that arise from progenitors in the bone marrow, with infiltrating 
monocytes representing the immediate precursors of tissue macrophages (as in the 
lamina propria (LP) of the intestine) (Bain et al., 2014). Secondly, those that arise from 
embryonic precursors during embryonic development with subsequent self-renewal 
of this tissue population with little or no influx from blood monocytes (Jenkins and 
Hume, 2014). The relative contribution of either mechanism to the ultimate 
establishment of the tissue macrophage population remains to be fully determined. 
Whilst no studies have addressed this question directly, administration of CSF1-Fc in 
adult mice only resulted in an influx of monocytes into the LP, yet not the ME (Figure 
1-5) (Sauter et al., 2014). Whilst not conclusive, it suggests that MM are not renewed 
by monocytes. Alternatively, there is replacement of the MM; however, due to a lower 
turnover of cells, this is less apparent than the influx observed with the LpMs. 
  
1.4.2 Distribution of resident intestinal macrophages 
LpM are found in the mucosa of the GI tract, predominantly in the LP (Hume et al., 
1984). LpM numbers differ between the small intestine and colon of rodents and 
humans, with higher numbers of macrophages found in the colon (Bain and Mowat, 
Figure 1-5 Expression of the MacBlue (ECFP) transgene in the lamina propria of mice 
injected with CSF1-Fc  
Mice were injected with CSF1-Fc or PBS for 4 days prior to sacrifice. Tissues were examined 
via confocal microscopy for expression of ECFP. CSF1-Fc administration increased 
expression of ECFP in the lamina propria of the intestine. White arrow: villi. Red arrow: sub-
epithelial dome. Image adapted from Sauter et al. 2014. 




2011). Macrophage numbers in the human colon appear to be similar throughout its 
length, whereas in the mouse there appears to be a continuous increasing density 
from proximal to distal ends of the entire mouse intestine (Nagashima et al., 1996, 
Bain et al., 2014).  
Several studies investigating the phenotype of LpMs have shown them to differ from 
other tissue macrophages (Rogler et al., 1998). Unlike other tissue macrophages, they 
appear to be in a state of ‘hypo-responsiveness’ (Kristek et al., 2015). Macrophages 
isolated from the jejunum of both mice and humans express CD163, do not express 
either CD16 (Mahida et al., 1989) or CD14 (Smith et al., 1997) and low numbers 
express CD11b (Malizia et al., 1991). As CD14 promotes LPS binding and intestinal 
luminal fluid can contain large amounts of bacteria, the absence of CD14 prevents 
the LpMs from being in a constant state of activation. Furthermore, LpMs do not 
express TLR4 (which also detects LPS) (Schenk and Mueller, 2007) and TLR2 is also 
down regulated (Abreu et al., 2005). A gene expression study in the pig found that 
the number of genes for C-type lectins including CLEC7A (dectin), CD68 (macrosialin) 
and SIGLEC1 (sialoadhesin) were down regulated in the GIT, compared to alveolar 
macrophages, again suggesting intestinal macrophages are adapted to be hypo-
responsive to intestinal luminal contents (Freeman et al., 2012).  
MM in the mouse are located in the serosa, at the level of the myenteric plexus (MP) 
and in the circular muscle layer. Macrophages are regularly distributed in the serosa 
and MP and in close association with ICC (Mikkelsen, 1995, Kalff et al., 1998b). In 
addition, MMs within the smooth muscle were observed to encircle blood vessels 
penetrating the smooth muscle (Kalff et al., 1998b). In adult mice, multiple markers 
for identification of MM have been used. In adult mice MM, are constitutively MHCII+ve, 
F4/80+ve, CD11b+ve and CD169+ve (Mikkelsen, 2010) with two different subtypes 
proposed, depending on the state of activation (Mikkelsen et al., 2008). In the human, 
CD68+ve and CD11b+ve cells have been identified in the serosa, muscle layers, the 
connective tissue of the serosa and submucosa as well as in the lining of Auerbach’s 
Plexus. MHCII+ve cells were scarce in the serosa and submucosa (Mikkelsen, 2010). 
Interestingly, MMs may participate in endotoxin-mediated responses within the 
muscularis as just over half were identified to express the CD14 receptor (Kalff et al., 
1998b). 
There are little data relating to the distribution of macrophages in the normal horse 
GIT. Macrophages have been found in the mucosa of the colon (Grosche et al., 2011) 
and jejunum (Packer et al., 2005). They have been identified in the ME, however, their 
distribution has not been described in detail (Yamate et al., 2000).  




1.4.3 CSF-1 regulates intestinal macrophage homeostasis 
An important element in the homeostasis of resident macrophage populations is the 
regulator CSF-1. As previously mentioned, CSF-1 controls proliferation, 
differentiation, adaptation and survival of cells in the mononuclear phagocyte 
system. The majority of cells designated as mononuclear phagocytes express the CSF-
1 receptor (CSF-1R). Treatment of mice with an antibody against CSF-1R resulted in 
an almost complete disappearance of the Csf1r-EGFP-positive stellate macrophage 
population in the small intestine (MacDonald et al., 2010).  
 Macrophage reporter mice 
The development of Mac-Green (Sasmono et al., 2003), mApple (Hawley et al., 2018) 
and Mac-Blue (Sauter et al., 2014) transgenic mice has permitted the detection of 
macrophages in embryos through to adult mice (Figure 1-2). In Mac-Green and 
mApple mice the Csf-1r promotor (encoded by the c-fms proto-oncogene) directs 
expression of enhanced green fluorescent protein (EGFP) to cells of the mononuclear 
phagocyte lineage. The Mac-Blue mice use the Mac-Green transgene to create a binary 
transgene in which the Csf-1r promoter driving the transcription factor, gal4-VP16, is 
integrated with a Gal4-responsive UAS-CFP (cyan fluorescent protein) cassette.  
In Mac-Green and mApple adult mice, EGFP and mApple was detected in all of the 
major macrophage populations of the body (Figure 1-2) (Sasmono et al., 2003, Hawley 
et al., 2018). Within the intestine, there was a large population of macrophages in the 
intestinal lamina propria (Figure 1-6) (Sasmono et al., 2003). In the adult Mac-Blue 
mice, CFP was expressed in monocytes (both Ly6C+ve and Ly6C-ve) and in a large 
majority of microglia and Langerhans cells (Sauter et al., 2014). However, CFP 
expression was lost from most tissue macrophages, including those in the intestine 
(Figure 1-8). Those that were positive were identified as classical dendritic cells or 
blood monocytes. Immunohistochemistry showed large numbers of CFP+ve cells in the 
Peyer’s patch and isolated lymphoid follicles. CFP+ve cells were visible in the ME of the 
oesophagus in adult mice (Figure 1-7). 





Figure 1-6 EGFP+ve macrophages in the intestinal lamina propria  
EGFP-positive macrophages in the lamina propria of the colon (A) and small intestine (B). 
Images on the left are low magnification. Images on right are high magnification. Images 
reproduced from www.macrophages.com (Robert et al. 2011). 
Figure 1-7 Oesophagus from MacBlue mice  
ECFP expression examined in the submucosa (A) and muscularis (B) of MacBlue mice. 
Image adapted from Sauter et al. 2014. 






Figure 1-8 Comparison of expression of MacBlue and MacGreen transgenes in the 
small intestine.  
White arrows indicate isolated lymphoid follicles in the MacBlue mouse. Yellow arrow 
indicates the dome region of a Peyer's patch in the MacGreen. The large numbers of EGFP+ve 
macrophages in the lamina propria highlight the individual villi in the lower image. Image 
reproduced from Sauter et al. 2014.  




 Response of equine macrophages to LPS 
Studies of equine macrophages to date have included monocyte-derived macrophages 
(MDMs) (Watson et al., 1990, Raabe et al., 1998, Moore et al., 2003, May et al., 1990), 
a macrophage cell line derived from equine bone marrow cells(eCAS) (Werners et al., 
2004), alveolar macrophages (Watson et al., 1990, Karagianni et al., 2017) and 
peritoneal macrophages (Karagianni et al., 2013). In comparison to rodents, humans 
and horses are sensitive to LPS. The lethal estimated dose of LPS in humans is thought 
to be 1-2µg (Dinges and Schlievert, 2001) and 50-200 µg/kg in the horse (Burrows, 
1981). In contrast, the LD50 dose in the mouse is 25.6mg/kg (Tateda et al., 1996).  
The Lipid A component of LPS is detected by macrophages by the PRR TLR4 and the 
co- receptors, CD14 and MD2. The Lipid A component varies in structure in different 
bacterial species. This results in varying host responses at the TLR4 (Bryant et al., 
2010). These variations in Lipid A structure also results in differences between 
species in ligand recognition. For example, the Lipid A from Salmonella entericia 
serovar Typhimurium (S. Typhimurium) is an agonist in all species. The Lipid IVa 
structure of Escherichia coli is a partial agonist in horses (Walsh et al., 2008) whereas 
in humans it is a full antagonist (Kovach et al., 1990) and a full agonist in mice (Vogel 
et al., 1984). Again, differences in Rhodobacter sphaeroides Lipid A recognition also 
exist between mice, humans and the horse (Lohmann et al., 2007) Likewise, there are 
species differences in the recognition of lipopeptides by the PRRs TLR2 and TLR1 
(Irvine et al., 2013). Walsh et al. (2008) found sequence differences in the MD2-TLR4 
complex between species. A consequence of these differences was variation in the 
local charge distribution on the MD2-TLR4 complex. This suggests that the ability of 
Lipid IVa recognition and subsequent signal transduction is governed by electrostatic 
forces and partial contact of the ligand to the MD2-TLR4 complex interface is the 
cause of reduced signalling and the reason for differences in response to Lipid IVa 
between species (Walsh et al., 2008). The full clinical significance of these differences 
is not yet fully understood. However, variation in innate immunity between species 
clearly exists and that these differences may affect how equids deal with LPS, or 
indeed other PAMPs and DAMPs. These differences may necessitate alternative 
therapeutic targets. 
In response to PAMPs such as LPS, TLRs in macrophages initiate a signalling cascade 
through either MyD88 and TRIF-dependent pathways. These pathways trigger the 
transcription factor NF-β, resulting in proinflammatory cytokine and chemokine 
release (Mogensen, 2009, Mantovani et al., 2004). MyD88 associated cytokines include 




TNF-α, IL-10, IL-1β and IL-6 whilst TRIF associated genes include IFN-ß, IP-10, RANTES 
and TRAF1 (Figueiredo et al., 2009, Mogensen, 2009). In contrast to monocytes 
derived from other species, equine monocytes predominantly respond via the MyD88 
pathway (Figueiredo et al., 2009). 
 RNA-Seq and microarray analysis 
In 2006, the first horse to be sequenced was Twilight, a Thoroughbred mare. A second 
horse, a Quarter Horse, was sequenced in 2015 as part of the Horse Genome Project 
by the Broad Institute (https://www.broadinstitute.org/horse/horse-genome-
project). In total, 85% of the horse genome has been sequenced, with the remainder 
proving difficult to sequence (Ramery et al., 2009). The next challenge is to annotate 
the sequences, a process which is currently in progress by the Horse Genome Project. 
In comparison to other species, coverage of the horse genome is poor (6.8x in the 
horse compared to 166.0x in the sheep [Table 1-3]).  
Differences in a cell’s state can be correlated to changes in mRNA levels of genes 
(DeRisi et al., 1997). Microarrays can be used to measure expression changes in genes 
and preliminary microarray studies in the horse used provisionally annotated genes 
(Gu and Bertone, 2004). These preliminary findings facilitated further annotation of 
the genome including a multi-tissue gene expression atlas (Huang et al., 2008). An 
alternative to equine-specific microarrays is to use human or mouse microarrays 
(Barrey et al., 2006). Microarray analysis is limited to the identification of sequences 
that the array is designed to detect, meaning genes not annotated to the genome will 
not be detected (Bumgarner, 2013). Given the poor annotation of the horse genome, 
this limits the information microarray analysis can provide. RNA-Seq analysis 
provides an advantage over microarray analysis in that whole transcriptome analysis 
can be performed without previous fore-knowledge of the transcriptome, and is 
therefore useful in species, such as the horse, that have an incomplete annotation 
(Coleman et al., 2013). Reads from the RNA-Seq analysis can either be mapped to the 
current genome or a de novo assembly can be performed. A recent example is the 
high-resolution atlas for sheep, which is the largest transcriptomic dataset for any 
livestock species (Clark et al., 2017). This transcriptomic dataset improved the 
annotation of the current reference genome for sheep. By improving the 
transcriptome, it is possible to annotate the functional elements of the genome. 
Whilst not on the same scale as the sheep atlas, several studies have contributed 
towards improving the equine transcriptome using single and pooled tissues, 




including lamellar tissue, peripheral blood, brainstem, cerebellum, muscle and skin 
(Mansour et al., 2017). 
















Coverage 166.0x 65.0x 9x 6.8x 




2,615,516,299 2,501,912,388 2,615,516,299 2,474,929,062 
Total assembly 
gap length 
28,000,626 29,864,641 28,000,626 46,138,889 
Gaps between 
scaffolds 
0 93 0 51 
Number of 
scaffolds 
5,466 706 5,466 9,688 
Scaffold N50 100,009,711 88,231,837 100,009,711 46,749,900 
Scaffold L50 8 9 8 19 
Number of 
contigs 
48,482 1,118 48,482 55,317 
Contig N50 150,472 48,231,277 150,472 112,381 
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In the horse, RNA-Seq analysis and Next-Generation sequencing have been used to 
study the LPS response in equine peripheral blood mononuclear cells (PBMCs) 
(Parkinson et al., 2017, Pacholewska et al., 2017). Parkinson et al. discovered that LPS 
induced the upregulation of miR-155, a finding consistent with human- and mouse-
derived data (Parkinson et al., 2017).  Pacholewska et al. also reported some similarity 
to humans with respect to the response of equine PBMCs to LPS (Pacholewska et al., 
2017). Whilst mice are commonly used as models of human disease, in light of the 
similarities between horse and human LPS responses, these data suggest that the 
horse may be a more appropriate model for human inflammatory disease.  




 Definitions and clinical features of post-
operative ileus2 
1.8.1 General and human 
The word ileus derives from the Greek word εἰλεός or eileós (meaning “twisting” or 
“rolling”) and was initially defined in human medicine as “severe and prolonged 
twisting of the intestine”.   The term could be applied to several conditions (e.g. 
intussusception, volvulus) which shared several presenting symptoms. This 
particular use of the term ceased in the 19th century following the adoption of a 
classification system of intestinal obstruction based on specific cause (Ballantyne, 
1984) and more recently its use was further restricted to a state of reduced or absent 
peristalsis as a result of a non-mechanical pathological response of the GI tract (Gero 
et al., 2017, Livingston and Passaro, 1990). Consequently, the majority of references 
to the term POI in current literature define the syndrome as a delay in the return of 
normal GI motility following surgery, or ‘a syndrome of functional inhibition of 
propulsive bowel motility’ (Livingston and Passaro, 1990).  
In humans, overall intestinal motility should be normal by 5 days post-operatively. 
The small intestine (SI) recovers within 5 -10 hours, followed by return of gastric 
function at 24 – 48 hours, with a more prolonged time for restoration of colonic 
function (3-5 days) (Nachlas et al., 1972, Waldhausen et al., 1990). Defaecation and 
tolerance of solid food ingestion are considered to reflect recovery of GIT motility 
following surgery in humans and are regarded as appropriate primary outcome 
measures in clinical trials of POI and decision-informing criteria relating to readiness 
for discharge (van Bree et al., 2014). 
In humans, various additional qualifying terms have been applied to POI, such as 
‘physiological (or normal) POI’, ‘pathological (or prolonged) POI’ (PPOI) and ‘recurrent 
PPOI’ (RPPOI). The criteria used for classification vary greatly, which probably 
contributes to the disparity in certain study-derived data. For example, the reported 
prevalence of human POI ranges from 2% to 60% depending on the POI or PPOI 
descriptors applied in the study (Vather and Bissett, 2013, Venara et al., 2016). Efforts 
                                                 
2 Reproduced from: An update on equine post‐operative ileus: Definitions, 
pathophysiology and management, Z. M. Lisowski, R. S. Pirie, A. T. Blikslager, D. 
Lefebvre, D. A. Hume & N. P. H. Hudson, Equine Veterinary Journal 50 (3), © 2017 EVJ 
Ltd 




to establish more specific criteria for each of these POI subcategories (Vather et al., 
2013) might facilitate comparisons between individual studies.   
1.8.2 Equine 
Similar differences in diagnostic criteria probably underlie marked variation (0 – 62%) 
in the reported equine POI prevalence rates following abdominal surgery. The 
presence of nasogastric reflux on intubation represents a universally-applied 
diagnostic criterion which, along with ultrasonographic and palpable (via per rectum 
examination) evidence of distended SI are the most commonly applied diagnostic 
indications (Lefebvre et al., 2016a, Lefebvre et al., 2016b).  The ambiguity in POI 
definition is largely attributable to variations in the volume or rate of reflux as well 
as the inclusion or omission of associated clinical signs such as tachycardia and 
abdominal discomfort. There is a wide disparity in the volume of reflux considered 
to reflect the presence of POI, either on a single intubation and/or over multiple 
intubations within a 24-hour period. In an effort to standardise the definition of POI 
across all studies, Merritt and Blikslager (2008) proposed the following clinical 
criteria: gastric reflux of ≥4 l upon any given intubation, or >2 l/h on repeated 
intubation, of gastric contents of pH >4.0; persistent tachycardia (>40 beats/min); 
mild to severe signs of abdominal discomfort; rectal and/or ultrasonographic 
evidence of multiple loops of fluid distended small bowel (Merritt and Blikslager, 
2008). Recent surveys of European and American equine clinical specialists confirmed 
the presence of nasogastric reflux as the most important criterion for defining POI 
but there was no consensus with respect to the rate and volume of reflux adopted as 
diagnostic markers (Lefebvre et al., 2016a, Lefebvre et al., 2016b).   Agreement on, 
and adherence to, a universal syndrome definition would be a significant advance in 
equine POI research. 
The term post-operative reflux (POR), proposed to describe solely the presence of 
reflux following surgery without any causal assumptions (Freeman, 2017) includes 
both mechanical obstructions and functional motility inhibition as potential 
underlying mechanisms. In the interest of clarity, this thesis will focus on POI; 
namely, the functional inhibition of motility following abdominal surgery.  
As in humans, a transient decrease in intestinal motility likely occurs normally 
following equine abdominal surgery. Data are available on the influence of 
anaesthesia (with or without orthopaedic surgery) on the GIT motility. Orally-
administered chromium oxide was detected in faeces for 18-90 hours following 
general anaesthesia alone (Teixeira Neto et al., 2004) and 15-105 hours following 




general anaesthesia (isoflurane) and orthopaedic surgery (Durongphongtorn et al., 
2006).  Following experimental jejunocaecostomy, Sasaki et al. (2008) demonstrated 
an immediate reduction in caecal motility which lasted 2 days; this was followed by 
an unstable period lasting 7 days and then a period of gradual recovery lasting up to 
31 days (Sasaki et al., 2008). However, unlike humans, where large intestinal (LI) 
dysmotility is commonly recognised and reflected in a delay in defaecation (van Bree 
et al., 2014, Waldhausen et al., 1990), the clinical significance of POI in the horse is 
predominantly related to the SI. Therefore, data on the time taken for normal 
restoration of SI motility in a cohort of horses following abdominal surgery would 
have greater clinical relevance. 
The greater clinical significance of SI dysmotility in equine POI may mask LI 
involvement. Nelson et al. (2013) demonstrated a greater delay in post-operative 
passage of first faeces in horses which had post-operative GI complications, 
compared with those that did not, following elective non-GI surgery (Nelson et al., 
2013). Little et al. (2001) independently demonstrated only a 12% prevalence of post-
operative colic in horses with reduced faecal output following non-GI surgery (Little 
et al., 2001).   Faecal output measurement might enable the early identification of 
cases with ‘LI POI’, thus enabling the implementation of treatment before the 
development of caecal or large colon impactions.  
 Diagnosis of equine post-operative ileus - 
mechanical versus functional3 
As discussed above, equine POI is most frequently diagnosed by the presence of 
reflux following nasogastric intubation. The ultrasonographic and/or palpable (via 
per rectum examination) detection of distended SI, tachycardia, abdominal 
discomfort, reduced faecal output and reduced/absent borborygmi are also valuable 
means of POI diagnosis (Lefebvre et al., 2016a, Lefebvre et al., 2016b). Importantly, 
the above clinical signs may also be present in other conditions, particularly those 
associated with a mechanical obstruction to the aboral passage of SI ingesta and fluid. 
In the immediate post-operative period, most consideration is given to an obstruction 
at the surgical anastomosis site (Freeman, 2008). Clinical distinction between a 
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functional and physical obstruction is challenging. Although mechanical obstructions 
associated with leakage at the anastomosis site would likely result in worsening pain, 
increasing rectal temperature and cardiovascular deterioration, those attributable to 
adhesions or simple intestinal kinking may, like POI, simply result in distended SI 
and persistent gastric reflux. The absolute distinction between these differing 
disorders may require a second laparotomy, re-examination of the anastomosis site 
and confirmation that no physical obstruction is present.  In one study of 27 horses 
that underwent relaparotomy (out of 254 that survived the first surgery) the most 
common diagnoses were functional ileus (25.9%) and obstruction at the site of 
anastomosis (22.2%). However, of those that underwent a second laparotomy 62% 
developed POI (Mair and Smith, 2005a). In a more recent study of 22 horses that 
underwent relaparotomy, 16 out of 19 horses with precipitating clinical signs (POR 
and post-operative colic) had these clinical signs eliminated by relaparotomy; 
furthermore, the authors reported that relaparotomy did not appear to exacerbate 
the POR (Bauck et al., 2017). 
 Epidemiology and risk factors for equine post-
operative ileus4 
Equine surgical cases with SI lesions are consistently associated with an increased 
risk of POI. Extensive manipulation of the intestines associated with decompression 
and performing resections and anastomoses of the intestine is likely to induce a 
greater degree of tissue damage and a more profound inflammatory response in the 
muscularis (Hopster-Iversen et al., 2014). Additionally, studies in mice have 
demonstrated that even exteriorisation of SI from the abdominal cavity is also likely 
to contribute to the inflammatory response (van Bree et al., 2012). While some equine 
studies have reported a greater risk of POI in cases with strangulating, compared with 
non-strangulating, SI lesions (Freeman et al., 2000, French et al., 2002), others have 
failed to identify such an association (Mair and Smith, 2005c, Blikslager et al., 1994, 
Roussel et al., 2001).  The onset of pathology is probably attributable to endotoxin 
release from ischaemic bowel resulting in systemic endotoxemia (King and Gerring, 
1988), which, in itself, will result in reduced intestinal motility (King and Gerring, 
1991). One study identified the presence of a strangulating pedunculated lipoma as 
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a specific risk factor for POI, a finding which may reflect a dual association with both 
intestinal ischaemia and age, the latter also being reported as a significant risk factor 
for POI (Holcombe et al., 2009). 
Other common risk factors relate to cardiovascular and haematological status. High 
packed cell volume (PCV) at the time of admission (French et al., 2002, Blikslager et 
al., 1994, Roussel et al., 2001, Cohen et al., 2004, Holcombe et al., 2009), increased 
serum total protein concentration (Cohen et al., 2004, Roussel et al., 2001) and 
tachycardia (Blikslager et al., 1994) have all been associated with an increased risk of 
horses developing POI. These parameters all reflect a degree of dehydration and/or 
hypovolaemia resulting from both haemodynamic consequences of endotoxemia and 
fluid sequestration within obstructed bowel and, therefore, may simply reflect the 
strangulating nature of the underlying intestinal lesion.   
Performing a pelvic flexure enterotomy may reduce POI risk (Mair and Smith, 2005c, 
Roussel et al., 2001); although this may be restricted to cases with LI, but not SI 
lesions (Cohen et al., 2004). Although the protective influence of this procedure may 
be attributable to a reduction in the intraluminal source of endotoxin, the potential 
value of evacuating the colon should be weighed against the increased anaesthesia 
and surgical time required to perform the surgery, as both of these factors have been 
associated with an increased risk of POI (Little et al., 2001, Roussel et al., 2001). 
 Pathophysiology of post-operative ileus5  
The development of POI has been attributed to several causes and mechanisms. These 
include the following: anaesthetic agents, opioids, intravenous fluids, electrolyte 
imbalances, disruption to GI hormones and neuropeptides, disruption of neural 
continuity, autonomic dysfunction and inflammatory cell activation (Vather et al., 
2014). Such contributory factors may act in isolation or in combination, ultimately 
resulting in a common endpoint; namely, impaired contractility of the intestinal 
smooth muscle (SM).   
The majority of POI research has been performed on rodent models with only a 
relatively small number of studies in the horse. The most commonly used rodent POI 
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model relies on small intestinal manipulation (IM) to induce ileus (Kalff et al., 1998a, 
van Bree et al., 2012), thus replicating, in part, the processes normally involved in 
abdominal and GI surgery. This model does not account for the additional processes 
of intestinal resection, enterotomies and large intestinal manipulation which are 
regularly undertaken and associated with an increased risk of equine POI. It is 
currently accepted that the pathogenesis of POI involves two phases: an initial 
neurogenic phase resulting in immediate post-operative impairment of bowel motility 
and a subsequent inflammatory phase lasting for several days. Despite representing 
distinct phases in POI progression, recent findings support a bi-directional 
interaction between the nervous and immune systems. 
1.11.1 Neurogenic phase 
The enteric nervous system and normal regulation of gastrointestinal 
motility 
The autonomic nervous system is made up of three components; sympathetic 
(noradrenergic) and parasympathetic (cholinergic) systems which originate in the 
central nervous system (CNS) and the enteric nervous system (ENS) which is found in 
the wall of the GI tract. Unlike other organs in the body, the GI tract has an intrinsic 
nervous system, the ENS, which can function independently of the CNS, as first 
demonstrated by Starling and Bayliss in 1899 (Bayliss and Starling, 1899). The ENS is 
not fully autonomous and it does retain some communications with the CNS via 
sympathetic and parasympathetic afferent and efferent neurons (Furness and Costa, 
1980). The part of the CNS that is connected with the ENS is known as the central 
autonomic neural network (Goyal and Hirano, 1996). Together, these connections 
provide neural control of the numerous functions of the GI tract; these include 
regulation of motility (Kunze and Furness, 1999), control of exocrine and endocrine 
secretions (Cooke, 1994), circulation of the GI tract (Goyal and Hirano, 1996) and 
regulation of immune and inflammatory processes (Lundgren et al., 1989, de Jonge, 
2013). 
The enteric neurons are organised in two interconnected ganglionated plexuses: the 
myenteric plexus located between the longitudinal and circular muscle layers of the 
ME, and the submucosal plexus located in the submucosa (Furness, 2012). The 
myenteric plexus is primarily involved in motor innervation of the two muscle layers 
and secretomotor innervation to the mucosa and extends the entire length of the 
intestine. The submucosal plexus functions locally to control intestinal secretion and 
absorption and contraction of the submucosal muscle and submucosal blood vessels 




and is best developed in the small intestine (Goyal and Hirano, 1996, Sharkey et al., 
1998).   
Both ganglia consist of tightly-packed nerve cell bodies, nerve fibres, glial cells and 
their processes (Goyal and Hirano, 1996). Although the ENS is responsible for 
innervation of the intestine, it frequently acts through various intermediary cell types 
between nerves and the target tissues (Sharkey and Savidge, 2014). For example, 
motor activity is regulated by interstitial cells of Cajal (ICC), platelet derived growth 
factor receptor alpha-positive (PDGFRα) cells (Sanders et al., 2006, Sanders et al., 
2010) and MM (Muller et al., 2014). Secretion is partly regulated by enteric mast and 
glial cells (Sharkey and Savidge, 2014).  
The ENS is connected to the CNS through both motor and sensory innervation via the 
sympathetic and parasympathetic nervous systems (Goyal and Hirano, 1996) The 
parasympathetic nervous system, via the vagal and sacral preganglionic neurons, 
innervates enteric neurons in the myenteric plexuses of the foregut and distal hind 
gut respectively (Furness, 2012) and serves the broad function of stimulating an 
increase in activity of the entire ENS.  A small population of myenteric neurons, the 
intestinofugal neurons, project from the myenteric plexus back to the same 
prevertebral sympathetic neurons in the abdominal prevertebral ganglia, creating a 
peripheral sympathetic-enteric neural control circuit that regulates motility (Sharkey 
and Savidge, 2014, Lomax et al., 2010). 
The majority of studies looking at the organisation of the ENS have been 
predominantly conducted on the small intestine of the guinea pig (Kunze and 
Furness, 1999, Furness and Costa, 1980, Gunn, 1968, Christensen et al., 1992) and 
more recently, the colon (Chen et al., 2015, Sharkey et al., 1998). It should not be 
considered unexpected to find variation in structure of the ENS and the chemical 
coding of neurons between species, especially as differences in structure and 
organisation of the ENS of the horse and small mammals have been documented 
(Pearson, 1994). Studies suggest that primary neurotransmitters are strongly 
conserved, meaning that the same neurotransmitter will be used in functionally 
equivalent neurons in differing regions of the GI tract and in different species 
(Furness et al., 1995, McConalogue and Furness, 1994) although organisational 
differences between species have been reported. 
Our knowledge of the equine ENS is very basic. In small animals, the submucosal 
plexus forms a single layer (Kunze and Furness, 1999). Studies of the submucosal 
plexus of the horse in the small intestine have identified two separate networks, 




found on the inner and outer laminae of the submucosa respectively (Pearson, 1994). 
This has also been reported in the pig (Gunn, 1968) and human (Hoyle and Burnstock, 
1989). Unlike the pig, no structural differences were observed between the plexus 
submucosus internus and the plexus submucosus externus of the horse 
(Timmermans et al., 1990, Pearson, 1994).  
As with the submucosal plexus, variations between small mammals and large 
mammals also occur in relation to the myenteric plexus. Distinctive form variations 
between the large and small intestinal myenteric plexuses have been reported in the 
horse, similar to that also been reported in other large mammals, such as sheep and 
cattle (Freytag et al., 2008). Additionally, further differences between different 
regions of small intestine have also been reported. The neurons of the myenteric 
plexus in the ileum extend well into the longitudinal muscle layer, and small numbers 
of neurons are found to extend to near the serosa. This is in contrast to the myenteric 
plexus of the jejunum, where neurons appear to be confined to the inter muscular 
layer (Doxey et al., 1995). The distal ileum represents a highly specialised intestinal 
region in which the flow of ingesta is dramatically slowed and this organisation of 
the ENS appears to be a unique feature in the equine GI tract (Doxey et al., 1995).  
The term ‘motility’ is used to describe the contraction of the longitudinal and circular 
muscle and encompasses two different muscular movements – propulsion via 
peristaltic contractions and mixing via segmental contractions. Contraction of the 
circular muscle narrows the intestinal lumen and lengthens the segment, while 
contraction of the longitudinal muscle is associated with widening of the intestinal 
lumen and shortening of the segment (Wong et al., 2011a). Control of the muscles 
varies with the region of the GI tract. For example the CNS has a role in determining 
the movements of the oesophagus, controlling the volume in the stomach, controlling 
contractions of the stomach wall, regulating acid secretion and the regulating 
defecation (Furness, 2012). The ENS regulates motility of the small and large 
intestines, with some secondary input from the extrinsic nervous system. 
Components involved in the regulation of motility include smooth muscle cells, ICC, 
PDGFRα+ve cells, excitatory and inhibitory enteric motor neurons, afferent neurons and 
the CNS.  Additionally, hormones and immune cells such as mast cells and resident 
ME macrophages also affect motor output (De Winter et al., 2012, Muller et al., 2014). 
Peristalsis is closely dependent upon parasympathetic stimulation and is inhibited by 
sympathetic stimulation. 




Neurons and neurotransmitters 
Over 30 different types of neurons have been identified in the ENS, which have been 
classified by their morphology and physiology, with up to 25 chemical mediators, or 
neurotransmitters, having been identified. The majority of neurons will utilise 
numerous transmitters, comprising a primary neurotransmitter and subsidiary 
transmitters (Furness and Costa, 1980, McConalogue and Furness, 1994, Goyal and 
Hirano, 1996).  
The primary neurotransmitter of the sympathetic neurons supplying the intestine is 
noradrenaline acting on adrenoreceptors, which inhibit motility (Finkleman, 1930, 
Costa and Furness, 1984) and cause vasoconstriction (Dresel and Wallentin, 1966). 
Acetylcholine is the predominant neurotransmitter of the parasympathetic nervous 
system affecting digestive function (McConalogue and Furness, 1994). However, 
enteric inhibitory motor neurons utilise nitric oxide (NO) as their primary 
neurotransmitter (Furness, 2012). ATP and vasoactive intestinal peptide (VIP) are 
thought to be subsidiary transmitters of these neurons, although in some regions 
they may have a primary transmitter role (McConalogue and Furness, 1994). VIP is 
the primary transmitter of non-cholinergic secretomotor neurones (Furness, 2012). 
Smooth muscle activity is dependent upon excitatory and inhibitory 
neurotransmitters. Myenteric neurons are either excitatory or inhibitory. 
Acetylcholine is the main excitatory neurotransmitter (Kunze and Furness, 1999), 
including in the horse (Malone et al., 1999). Neurokinins (of which substance P has 
been studied in the horse (Sonea et al.) activate similar pathways to acetylcholine by 
binding to NK1, NK2 and NK3 receptors. In the horse, these are widely distributed 
throughout the GIT (Cummings et al., 1985, Belloli et al., 1994, Sonea et al.).  
Tachykinins are used by sensory neurons, particularly those that detect painful 
stimuli. They constrict equine enteric smooth muscle (Belloli et al., 1994) and are 
thought to contribute to acute and chronic inflammation of the GI tract.  
Interstitial cells of Cajal 
The ICC are commonly referred to as the pacemaker cells of the GI tract. As opposed 
to pacemaker cells in the heart, the ICC do not occupy a single region, but form a 
continuous electrically-coupled network of cells that extends from the stomach to 
the colon. The ICC generate spontaneous electrical slow waves in the GI tract which 
leads to the depolarisation of the membrane of smooth muscle cells, initiating 
calcium entry into the smooth muscle cell, resulting in muscle contraction. These 




slow waves result in phasic contractions of the GI muscle, resulting in peristalsis and 
segmentation (Sanders et al., 2006).  
Morphologically, the ICC are arranged in close proximity to neurons and smooth 
muscle cells (Mikkelsen, 2010). The second main motility-associated function of ICC 
relates to their role as intermediaries of nitrergic and cholinergic neural inputs to 
smooth muscle cells (Publicover et al., 1993, Burns et al., 1996, Vannucchi, 1999, Ward 
et al., 2000). Other receptors related to neurotransmission on the surface of ICC 
include NK1 (tachykinins), somatostatin receptor and nitric oxide synthase 
(Vannucchi, 1999).  
Several subsets of ICC have been described according to their anatomical location 
and these differing locations may relate to their various described functions (Table 
1-4). There are limited studies in the horse, however the distribution of ICC cells in 
the equine GI tract have been described (Hudson et al., 1999). This revealed no 
specific accumulation of ICC in the deep myenteric plexus (DMP) of the small intestine 
or the submucosal surface of the colonic circular muscle layer but did reveal an 
increase in ICC cells in the inner third of the circular muscle layer. However, the small 
intestine did have a higher number of ICC in the myenteric plexus region, compared 
to the large intestine where the majority of ICC were seen throughout the circular 
muscle layer. This difference is potentially reflective of slow waves in the stomach 
and small intestine originating in the myenteric region, whilst in the large intestine 
they originate from the circular muscle layer. 
Table 1-4 Summary of anatomical locations and functions of ICC in the GI tract 
(Adapted from Ward and Sanders, 2001) 
 
Classification Description of location Function 
ICC – MY 
Within the intermuscular space between the 
circular and longitudinal muscle layers 
(myenteric region) 
Slow wave generation 
(pacemaker)  
(Ward and Sanders, 
2001) 
ICC – SM 
Along the submucosal surface of the 
circular muscle of the colon 
Slow wave generation 
(pacemaker)  
(Ward and Sanders, 
2001) 
ICC – DMP 
Found within the deep muscularis plexus of 
the small intestine 




ICC - IM 
Intramuscular ICC of the oesophagus, 
lower oesophageal sphincter, stomach, 
pylorus, cecum and colon. 
Mediators of circular 
muscle inhibitory 
innervation 
(Matini, 1997)  




Platelet derived growth factor receptor alpha-positive cells  
PDGFRα+ve cells are a more recently documented type of interstitial cell in the 
gastrointestinal muscles, which have been shown to respond to purines, which are 
inhibitory neurotransmitters released from enteric motor neurons (Sanders et al., 
2012). Limited data are available, but it is thought that PDGFRα+ve cells are more likely 
to mediate purine (inhibitory) neurotransmission than smooth muscle cells. There are 
no data to date on these cells in the horse. 
Immune cells 
Little is known about the role of immune cells in motility in the non-inflammatory 
state. Macrophages and ICC in the mouse ME are in close spatial contact with each 
other and have a constant and regularly distributed cell population, strongly 
suggesting that macrophages and ICC can functionally interact (Mikkelsen, 2010). 
Muller et al. 2014 demonstrated in mice that resident MM found along nerve fibres 
regulate motility in the non-inflamed intestine through the production of bone 
morphogenetic protein-2 (BMP2) (Muller et al., 2014). Enteric neurons were also 
shown to contribute to the maintenance of ME macrophages through secretion of the 
macrophage growth factor CSF-1. This study, alongside another demonstrating a 
vagal anti-inflammatory pathway modulating the MM (Matteoli et al., 2014) show a 
bidirectional communication between the ENS and MM, maintaining a physiological 
homeostasis in the resting state. This was highlighted by disrupted contractility in 
the colon occurring after depletion of the MM (Muller et al., 2014). What these studies 
have highlighted is the similarity between the neuroimmune crosstalk in the ENS and 
CNS; namely that the specialised macrophages of the brain (the microglia) and MM 
are both under the continuous control of neurons and support neuronal homeostasis 
(Verheijden et al., 2015). Resident MM differ from other tissue-resident macrophages, 
such as macrophages resident in the lung, spleen, peritoneum and BMDMs, as they 
share several marker genes with the CNS microglia, notably Cx3cr1, Fcrls, P2ry12, 
Olfml3, Mertk and Gas6. In addition, they express the transcription factors Egr1, Atf3 
and Junb, meaning both populations undergo similar transcriptional process in order 
to establish their phenotype (Verheijden et al., 2015).  
Disruption to the enteric nervous system in colic and post-operative 
ileus 
Reduction of neurons and interstitial cells of Cajal in colic cases  
A reduction in the number of neurons, in the caecum and large colon, has been 
reported in horses with colic as a result of chronic obstruction of the colons or 




recurrent caecal impactions (Schusser et al., 2000, Schusser and White, 1997). It is 
unclear if the reduction in neurons was the cause of disease or occurred as a result 
of disease. Likewise, a reduction in the density of ICC in horses with large intestinal 
lesions has also been reported (Fintl et al., 2004). However, no studies have shown a 
relationship between a reduction in neurons and ICC and an increased risk in 
developing POI. 
Activation of neural pathways in abdominal surgery 6 
During abdominal surgery, the surgical incision, peritoneal breach and intestinal 
manipulation (IM) act as nociceptive stimuli that activate neural pathways. Surgical 
incision of the abdominal wall of rats creates a somatic wound activating adrenergic 
pathways (Boeckxstaens et al., 1999, Bueno et al., 1978). This pathway involves a 
spinal reflex; afferent splanchnic nerves synapse in the dorsal column of the spinal 
cord, stimulating glutamate release. Both activate spinothalamic projections, causing 
the perception of pain at the surgical incision and mediate a sympathetic efferent 
response, resulting in reduced motility (Zittel et al., 1994a, Livingston and Passaro, 
1990, Uemura et al., 2004, Fukuda et al., 2007, Bueno et al., 1978). The degree of ileus 
relates to the length of incision (Uemura et al., 2004) and depletion of adrenergic 
innervation prevents this from occurring (Plourde et al., 1993, De Winter et al., 1997, 
Fukuda et al., 2007). 
IM and breach of the peritoneum is a more intense stimulus than the skin incision 
alone, and in turn results in a longer period of inhibition of motility (Boeckxstaens et 
al., 1999, Bueno et al., 1978), which, in rats, is only partially blocked by adrenergic 
antagonists (Zittel et al., 1998). As early as 1899, Starling and Bayliss observed a 
reduction in intestinal motility following intestinal handling in the dog, a 
phenomenon which was abolished by sectioning the vagus and splanchnic nerves 
(Bayliss and Starling, 1899). As largely deduced from rodent studies, sensory 
information from the peritoneum and intestine is conveyed via the vagus nerve 
which, through the expression of interleukin-1 receptors (IL-1R) (Ek et al., 1998), is 
also sensitised by inflammatory stimuli. Afferents travel to the nucleus tractus 
solitarius of the brainstem, resulting in corticotrophin-releasing factor-mediated 
stimulation of neurons in the supraoptic nucleus of the hypothalamus. Hypothalamic 
neurons then project to sympathetic preganglionic neurons in the spinal cord, 
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activation of which inhibits GI motility (Zittel et al., 1993, Zittel et al., 1994b, Barquist 
et al., 1996). Intense stimulation of splanchnic afferents also triggers an inhibitory 
non-adrenergic, non-cholinergic vagally-mediated pathway that impairs motility via 
local release of nitric oxide (NO) and vasoactive intestinal peptide (Boeckxstaens et 
al., 1999, Lefebvre et al., 1995).  
Neuronal inhibition of GI motility is self-limiting, with normalisation of function 
returning upon cessation of nociceptor and mechanoreceptor stimulation. In 
comparison, the subsequent inflammatory response, and its effect on motility, results 
in a significantly more prolonged period of ileus. These two periods, an early 
neurogenic phase, and a later inflammatory phase have been recognised in humans 
(Boeckxstaens and de Jonge, 2009) and hypothesised in horses (Doherty, 2009). 
1.11.2 Inflammatory phase7 
Results derived predominantly from rodent studies have attributed the prolonged 
phase of POI to inflammation within the intestinal muscularis (Kalff et al., 1999b, 
Kalff et al., 1998a, Farro et al., 2017).  Accordingly, the experimental induction of POI 
by IM has been prevented by the inhibition of mast cells (de Jonge et al., 2004), 
macrophages (Wehner et al., 2007) or more general leukocytic infiltration (The et al., 
2005, De Jonge et al., 2003). 
The activation of peritoneal mast cells, located within the serosa and mesentery and 
in close association with afferent nerve fibres (Williams et al., 1997), is an early event 
during abdominal surgery reported in the mouse (de Jonge et al., 2004) and human 
(The et al., 2008). Neuropeptides (substance P or calcitonin gene-related peptide) 
released from afferent nerves have been hypothesised as playing a role (Overman et 
al., 2012, Suzuki et al., 1999). In addition to the release of histamine, mast cell 
proteinase-1, tryptase and IL-6 (The et al., 2008), activated mast cells also release IL-
8 which, along with intercellular adhesion molecule-1 (ICAM-1), may directly result in 
neutrophil chemotaxis (Compton et al., 1998).  Alternatively, their close association 
with mesenteric blood vessels may facilitate the diffusion of mediators directly into 
the mesenteric circulation, resulting in the recognised increase in epithelial 
permeability following intestinal manipulation. This may in turn permit either the 
translocation of luminal-derived pathogen-associated molecular patterns (PAMPs) 
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across the intestinal mucosa and/or stimulate the production of damage-associated 
molecular patterns (DAMPs), both of which may trigger a subsequent key step in the 
inflammatory cascade; namely, the activation of resident muscularis macrophages 
(MM) (Kalff et al., 1998a). Notwithstanding these findings, intestinal inflammation and 
delayed GIT following IM were still present in a mast cell-deficient mouse strain 
(Gomez-Pinilla et al., 2014).  
Activation of MM occurs through DAMPs, such as adenosine triphosphate (ATP) 
(Ozaki et al., 2004), and PAMPs, such as lipopolysaccharide (LPS) (Eskandari et al., 
1997). In mice, the activation of toll-like receptors (TLR) and receptors for advanced 
glycation end products (RAGE) by PAMPs and DAMPs, results in recruitment of 
intracellular signalling pathways (p38, JNK/SAP), the activation of which are 
increased within an hour of IM (Wehner et al., 2009). This subsequently leads to the 
release of pro-inflammatory cytokines, including tumour necrosis factor-α (TNF-α), IL-
1β and IL-6, and chemokines, including macrophage inflammatory protein -1α (MIP-
1α) and monocyte chemoattractant protein-1 (MCP-1), with a resultant upregulation 
of ICAM-1 in the endothelium and the influx of leukocytes (Choi et al., 2013, Hopster-
Iversen et al., 2014, Kalff et al., 1998a). The leukocytic infiltrate, which predominantly 
comprises monocytes, mast cells and neutrophils, is detectable within 3 hours 
following surgery and continues to increase until it peaks at approximately 24 hours 
(Kalff et al., 1999a, Farro et al., 2017). Inducible NO synthase (iNOS) and 
cycloogygenase-2 (COX-2) (Schwarz et al., 2001) upregulation has been reported in 
MM in rodents, thus facilitating the production of NO and prostaglandins, both of 
which impair the contractile activity of SM cells (Schwarz et al., 2001). Prostaglandins 
also increase the sensitivity of spinal afferent nerves (Ek et al., 1998). Macrophage 
depletion (with chlodronate liposomes and using a mutant mouse with an inactivated 
colony stimulating factor-1 gene resulting in absence of muscularis macrophages) 
prevents intestinal inflammation and the development of POI (Wehner et al., 2007), 
strongly supporting their role in the inflammatory phase of POI. 
As mentioned previously, most of the studies of POI are performed on the SI. A recent 
study by Pohl et al. has shown differences in the inflammatory response of resident 
cells in the SI and colon in a mouse model of POI (Pohl et al., 2017). Whilst activation 
of resident MM in the SI results from translocation of luminal derived DAMPs or 
PAMPs, this does not occur with the colonic MM, due to the colonic MM macrophages 
being less reactive, most likely reflecting the larger microbial load in the colon. In 
addition, differences in the response of infiltrating monocytes, and evidence that 




monocytes in the colon are affected by the microbiota, highlights significant regional 
differences in the response of the SI and colon to IM (Pohl et al., 2017). 
As in every tissue injury, immune cells and their products also contribute to the 
resolution of inflammation and POI; one key effector is IL-10.  IL-10 knockout mice 
fail to resolve their muscularis inflammatory response compared to wild type mice, 
resulting in high mortality rates (Stoffels et al., 2009). Administration of exogenous 
IL-10 improved GIT post-operatively and reduced inflammatory cytokines, 
chemokines and NO.  Additionally, whilst the initial leukocytic infiltrate of 
neutrophils and monocytes to the muscularis has been associated with SM 
dysfunction leading to POI, the role of monocytes/macrophages in resolution of POI 
has not been studied, until recently. Farro et al. (2017) demonstrated that blocking 
the influx of monocytes to the muscularis did not prevent POI but resulted in a 
prolonged period of smooth muscle dysfunction and an increased neutrophilic 
inflammatory response (Farro et al., 2017). The administration of macrophage colony 
stimulating factor-1 fusion protein (CSF1-Fc) (Gow et al., 2014) not only restored 
monocyte and MM numbers but reduced neutrophil infiltration in the muscularis, 
increased anti-inflammatory gene expression and improved GIT transit time 
following IM (Farro et al., 2017). Continued work focusing on the recovery process is 
warranted, with the potential to inform the development of therapeutic interventions 
which accelerate this process rather than solely targeting the onset of inflammation.  
In the horse, post-operative neutrophilic and eosinophilic inflammation of the 
jejunum has been identified up to 18 hours post-operatively (Little et al., 2005, 
Hopster-Iversen et al., 2011, Hopster-Iversen et al., 2014). Direct manipulation of the 
LI in the horse resulted in an inflammatory response; this also occurred following 
manipulation of the SI alone (Hopster-Iversen et al., 2011). A similar response has 
been reported in rodents (Schwarz et al., 2004). In addition to this pan-enteric 
response, an increase in apoptotic cells (neurons, SM and glial cells) has been 
demonstrated in strangulating lesions of the LI and SI at sites distant to the lesion, 
most likely reflective of a generalised stress response of the GI tract to ischaemia, 
reperfusion and inflammation (Rowe et al., 2003). A localised stress response in the 
SM and neurons has been reported in the borders of healthy resection margins (De 
Ceulaer et al., 2011). Activation of MM by manipulation-induced translocation of 
luminal-derived LPS is a recognised phenomenon in humans and rodents leading to 
loss of SM contractility (Snoek et al., 2012, Eskandari et al., 1997). In light of IM-
induced loss of mucosal epithelial cells in the horse it is likely that a similar LPS 
translocation process also occurs in this species (Hopster-Iversen et al., 2011). IM-




induced inflammation in a TLR-2 and TLR-4 double knockout mouse model was only 
partially protective against a delay in GIT (Stoffels et al., 2014), demonstrating that 
alternative TLR-2 and TLR-4 independent pathways of macrophage activation must 
also exist. 
Although the translational application of data derived from rodent models can 
provide a valuable insight into the basic cellular and molecular responses of the 
equine GI tract to laparotomy and IM there are significant species-related differences 
in innate immune biology.  For example, handling-induced NO liberation by murine 
MM contributes towards intestinal SM dysfunction in the mouse GI tract (Kalff et al., 
2000); however, as in other large animals (pigs and humans (Kapetanovic et al., 2012)), 
equine alveolar and peritoneal macrophages do not produce NO. Consequently, this 
mediator is not likely to be involved in equine inflammation (Karagianni et al., 2013).  
Another important factor to consider when extrapolating findings from rodent 
studies to equine colic cases is the absence of pre-existing conditions, such as 
ischaemic bowel, peritonitis and endotoxaemia in the rodent models of IM used to 
study POI. A model of caecal ligation and perforation in rats resulted in reduced GI 
motility and a leukocytic inflammatory response within the muscularis (Overhaus et 
al., 2004). Whilst not the most commonly adopted rodent model of POI, it does 
demonstrate the effect of polymicrobial sepsis on GI motility. Horses undergoing 
abdominal surgery will usually have significant primary disease, such as ischaemic 
bowel, peritonitis associated with non-viable intestine and intestinal distention 
secondary to a strangulation/amotility. As previously mentioned, endotoxin release 
from ischaemic bowel can cause reduced intestinal motility (King and Gerring, 1991, 
King and Gerring, 1988). Horses with amotile intestine may also have increased bowel 
oedema because of reduced lymphatic drainage (Drake et al., 1998, Shah et al., 2011). 
How these pre-surgical factors affect the pathogenesis of equine POI is not completely 
understood; however, in light of the fact that horses presenting with compromised 
cardiovascular status/endotoxemia (Blikslager et al., 1994, Roussel et al., 2001) and 
with pre-operative reflux (Mair and Smith, 2005c) are at increased risk of developing 
POI (see section above), one could assume that they play a significant role in the 
pathogenesis of equine POI.  
1.11.3 Pharmacological/therapeutic influences on the 
development of post-operative ileus 
In addition to the key neurogenic and inflammatory phases of POI, a variety of 
pharmacologic agents and therapeutic interventions have also been identified as 




either increasing the risk or duration of POI. These include the use of opioids, and 
anaesthetic agents and a failure to correct any disease-associated fluid and electrolyte 
imbalances.  
 Aims of thesis 
Macrophages are important for the initiation and resolution of inflammation, 
including in POI. Despite all macrophages deriving from the same progenitor cells, 
different macrophage populations will develop different phenotypes according to 
their intended function. In addition, species-related differences in phenotype may 
also result in differing functions between species. Therefore, reliance on rodent- or 
human-derived data to elucidate the pathophysiology of equine POI may yield 
inappropriate conclusions as a result of subtle inter-species differences in innate 
immunity. In humans and mice, the activation of resident MMs initiates an 
inflammatory response within the ME which ultimately results in smooth muscle 
dysfunction. Therefore, the overall aim of this thesis was to determine if a similar 
process of macrophage activation occurs in the horse. The administration of CSF1-Fc, 
a conjugate protein of the growth factor needed for macrophage development, has 
been shown to be beneficial in several disease models, such as liver, kidney and bone 
injury. The secondary aim of this thesis was to evaluate if administration of CSF1-Fc 
will have a beneficial effect in a mouse model of manipulation-induced POI. 
To address this question the aims of the project were subdivided, as follows: 
1.   Characterise the number, distribution, phenotype and functional status of 
different macrophage populations (mucosal and ME) within healthy equine intestine.  
2.   Analyse the effect of LPS stimulation on eqBMDMs. 
3.  a) Compare healthy intestine and intestine excised from small intestinal 
surgical resections (the “healthy margin”) by evaluating markers of resident 
macrophage activation, the choice of markers being informed by Aim 2.  
b) Determine if there is a correlation between markers of macrophage 
activation in resected intestine (“healthy margin” of resection) and (i) time from 
abdominal incision, (ii) type of colic lesion and (iii) presence of clinically-apparent 
POI.  
4.  Evaluate the effect of CSF1-Fc, a growth factor for macrophages, on the murine 
GIT, in the steady state and in a model of POI. 





The distribution and density of macrophages in the equine intestine is similar to other 
species 
Abdominal surgery will induce a macrophage inflammatory response in the equine 
gastrointestinal tract 






 Materials and Methods 
 






Horse details and tissues collected from each horse are summarised in Table 2-1 and 
Table 2-2. 
Non-colic horses 
Twenty-two horses (median age 16 years., range 6 - 26 years) of various breeds, were 
admitted to the Equine Hospital at the Royal (Dick) School of Veterinary Studies for 
elective euthanasia. Horses were euthanased with secobarbital sodium 400mg/ml and 
cinchocaine hydrochloride 25mg/ml (SomuloseTM; Arnolds/Dechra), at a dose of 
1ml/10kg bodyweight via a pre-placed intravenous (i.v) catheter in the left jugular 
vein. All animals were systemically healthy and did not have any recent history of 
gastrointestinal (GI) disease. Post mortem examination confirmed the absence of 
gross GI pathology in all animals. One animal did have large volumes of sand in the 
right ventral colon, but no associated gross pathology of the GI tract was seen. The 
study was approved by the School of Veterinary Medicine Ethical Review Committee.  
Colic cases 
Twelve horses (median age 21.5 years, range 14 – 25 years) of various breeds were 
admitted to the Bell Equine Veterinary Clinic, Kent, or the Dick Vet Equine Hospital, 
Edinburgh for further investigation of abdominal pain. Tissues were collected at 
laparotomy from horses that required intestinal resection (from resection margins) 
because of strangulating lesions of the intestine. Owner permission was granted for 
the collection of tissues and tissue collection was approved by the School of 
Veterinary Medicine Ethical Review Committee.
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mice were kept under specific pathogen-free (SPF) conditions at the Biomedical 
Research Facility (BRF), University of Edinburgh, UK and KU Leuven Mouse Facility 
(KU LMF), University of Leuven, Belgium. Procedures were performed when the mice 
were aged 8-12 weeks. Table 2-3 summarises the strains used. Procedures were 
performed according to UK Home Office regulations and approved by the University 
of Edinburgh Animal Welfare and Ethical Review Committee. Procedures performed 
at Leuven (Chapter 6) were approved by the Animal Care and Animal Experiments 
Committee of the University of Leuven (Leuven, Belgium). 
Table 2-3 Details of mouse strains used 
 
Strain Supplier Description 
MacGreen (Csf1r-EGFP)1 
BRF, University of 
Edinburgh, UK 
Macrophage green 
fluorescent reporter mouse 
MacBlue (Csf1r*-
GAL4/VP16,UAS-ECFP)2 
BRF, University of 
Edinburgh, UK 
Macrophage cyan 
fluorescent protein reporter 
mouse 
MacApple (Csf1r-RFP)3 
BRF, University of 
Edinburgh, UK 
Macrophage red fluorescent 
reporter mouse 
MacApple x MacBlue 
BRF, University of 
Edinburgh, UK 
Generated by crossing 
MacApple with MacBlue 
MacGreen x MacBlue 
BRF, University of 
Edinburgh, UK 
Generated by crossing 
MacGreen with MacBlue 
C57BL/6 
Kindly provided by Prof 
Gianluca Matteoli (KU 
Leuven)  
Wild type  
B6.129S4-Ccr2tm1Ifc/J 
Kindly provided by Prof 
Gianluca Matteoli (KU 
Leuven) 
Ccr2 receptor deficient mice 
 
1 SASMONO, R. T., OCEANDY, D., POLLARD, J. W., TONG, W., PAVLI, P., 
WAINWRIGHT, B. J., OSTROWSKI, M. C., HIMES, S. R. & HUME, D. A. 2003. A 
macrophage colony-stimulating factor receptor-green fluorescent protein transgene is 
expressed throughout the mononuclear phagocyte system of the mouse. Blood, 101, 1155-
63 
2 SAUTER, K. A., PRIDANS, C., SEHGAL, A., BAIN, C. C., SCOTT, C., MOFFAT, L., ROJO, 
R., STUTCHFIELD, B. M., DAVIES, C. L., DONALDSON, D. S., RENAULT, K., MCCOLL, B. 
W., MOWAT, A. M., SERRELS, A., FRAME, M. C., MABBOTT, N. A. & HUME, D. A. 2014. 
The MacBlue binary transgene (csf1r-gal4VP16/UAS-ECFP) provides a novel marker for 
visualisation of subsets of monocytes, macrophages and dendritic cells and responsiveness 
to CSF1 administration. PLoS One, 9, e105429 
3 HAWLEY, K.A., ROJO, R., RAPER, A., SAUTER, K. A.., LISOWSKI, Z.M, GRABERT, K., 
BAIN, C.C., DAVIS, G. OSTROWSKI, M.C., HUME, D. A., PRIDANS, C., JENKINS, S.J. 
(2018) Csf1r-mApple transgene expression and ligand binding in vivo reveal dynamics of 
CSF1R expression within the mononuclear phagocyte system. The Journal of Immunology 
200 (6), 2209-2223 




2.1.3 Collection of whole blood 
Five millilitres of whole blood were collected from the non-colic horses prior to 
euthanasia via a pre-placed i.v catheter into tubes containing EDTA (BD Vacutainer) 
as an anticoagulant.  
2.1.4 Collection of samples from the gastrointestinal tract 
Non-colic Horses 
Once euthanased, an incision was made in the ventral midline to expose the 
abdominal cavity. The GIT was removed from the body by transecting the oesophagus 
at the level of the diaphragm, removing the mesenteric and body wall attachments 
and transecting the small colon at the junction with the rectum. The spleen and liver 
were removed, and the GIT placed on a clean working area. Gross contamination of 
blood was removed with water.  
Tissues were collected as follows: 
a) Full thickness 4 cm x 4 cm sections were removed from 14 anatomical locations 
from the stomach to the small colon (Table 2-4). Tissue sections were rinsed in cold 
phosphate-buffered saline (PBS) (Dulbecco’s Phosphate Buffered Saline; Sigma-
Aldrich) before being trimmed into smaller segments and placed in 10% neutral 
buffered formaldehyde (4% formaldehyde in neutral buffered solution) (Sigma-
Aldrich). 
b) Three 0.5 cm x 0.5 cm full thickness sections were taken from the greater curvature 
of the stomach, mid jejunum and colonic pelvic flexure. The mucosa and muscularis 
were separated (submucosa remained on the mucosa) and thoroughly rinsed in cold 
PBS. Tissues were placed in ammonium sulphate (RNAlater Stabilization Solution; 
Thermo Fisher Scientific) and stored at 40 C for at least 24 hrs. Excess solution was 
removed by tapping on a sterile surface before being transferred for storage at -800C. 
Colic Cases 
Collection from healthy margins (proximal and distal) of surgically-resected tissue 
was conducted between October 2016 and March 2017. Full thickness sections were 
placed in 10% formalin for immunohistochemistry (IHC). Mucosa and muscularis were 
separated, each placed in RNAlater (Thermo Fisher Scientific) and stored at 40C for 
no more than 30 days, before being stored at -800 C. Case details are summarised in 
Table 2-2.  





A 4 cm x 4 cm section from the right liver lobe was removed. Smaller pieces 
measuring no more than 0.5 cm in any dimension were then cut and placed in 
RNAlater (Thermo Fisher Scientific) and stored at 40 C for no more than 30 days, 
before being removed from RNAlater and stored at -800 C. 
Table 2-4 Description of anatomical locations used for tissue collection of the 
gastrointestinal tract 
 
GC = greater curvature; LC = lesser curvature 
 Isolation and generation of equine bone marrow 
derived macrophages 
The protocol used was adapted from Kapetanovic et al. (2012). Following euthanasia, 
the horse was exsanguinated and suspended by the hind limbs. Two ribs (ranging 
from T8-T11) were disarticulated and removed, ensuring they did not fracture or 
expose any bone marrow (BM) cavity upon removal. The ribs were thoroughly cleaned 
by removing any attached muscle and connective tissues and were stored in PBS on 
ice until processing.  
The ribs were rinsed in ethanol and, under a fume hood, cut into segments 5-8 cm in 
length. Using a 10 ml syringe and 18 G needle, the ribs were flushed with RPMI 1640 
(Sigma-Aldrich) with 5mM EDTA (10 mM KHCO3, 150 mM NH4Cl, 0.1 mM EDTA [pH 
7.0]) at both cut ends until the media ran clear. The media was collected in a falcon 
ID # Location Description of location 
1 Stomach GC Greater curvature “at the greatest curve” 
2 Stomach LC Midpoint of lesser curvature on inside of curve 
3 Duodenum mid approx. 50-75cm from pylorus 
4 Jejunum ¼ 
Full circumferential sample and then further samples cut 
from anti-mesenteric aspect 
5 Jejunum mid 
6 Jejunum ¾ 
7 Ileum mid 
Ileum defined by ileocaecal fold, approx. 1m long. 
Midpoint ileum is midpoint of ileocaecal fold. Anti-
mesenteric border. 
8 Caecum mid 
Find ileocaecal fold and follow towards apex. Sample 
taken 2 inches away from end of ileocaecal fold including 
taenial band 
9 
Right ventral colon 
mid 
Midpoint over taenial band 
10 Left ventral colon mid Midpoint over taenial band 
11 Pelvic flexure At apex from the anti-mesenteric aspect 
12 Left dorsal colon mid Midpoint on outer edge 
13 
Right dorsal colon 
mid 
Midpoint on outer edge over taenial band 
14 Small colon Midpoint overlying anti-mesenteric taenial band 




tube and passed through a 100 µm filter to remove any bone debris and/or fat, prior 
to being centrifuged at 400 rcf for 5 minutes to pellet the cells. Once pelleted, the 
supernatant was carefully removed, and the pellet re-suspended in 5ml of red blood 
cell lysis buffer and incubated in the dark at room temperature (RT) for 5 minutes.  
Forty-five mls of PBS were added to the tube and centrifuged at 400 g for 5 minutes. 
The supernatant was discarded, and the pellet re-suspended in an appropriate 
volume of PBS with 2% heat-inactivated (HI) horse serum (Sigma Aldrich) and the cells 
then counted.  
 Alveolar macrophages 
Cryopreserved alveolar macrophages were obtained from Anna Karagianni (Roslin 
Institute, University of Edinburgh). Cells were cultured overnight before being 
harvested for flow cytometry (Karagianni, 2015). 
 Equine macrophage cell culture conditions 
(optimised) 
Cryopreserved cells (thawed in a water bath at 37˚C for 5 minutes) or freshly isolated 
cells were seeded on bacteriological plates in medium containing RPMI 1640 with 20% 
heat-inactivated (HI) horse serum (Sigma), 1 mmol/l GlutaMAX (Life Technologies), 
100 U/ml penicillin, 100 µg/ml (Thermo Fisher Scientific). Cells were cultured at a 
density of 2.5 x 106 cells/ml and medium was supplemented with 104 U/ml (100 
ng/ml) recombinant human macrophage colony-stimulating factor 1 (CSF-1) 
(recombinant human CSF-1 (rhCSF1); a gift from Chiron, USA). Fresh media was added 
at Day 3. On Day 5, adhered cells were removed with medium using a blunt 18G 
needle and 10ml syringe. Adhered cells and supernatant were centrifuged at 400 x 
rcf for 5 minutes and cells were re-suspended in fresh medium and re-plated on new 
bacteriological plates. Cells were analysed between Days 7 and 10. 
 Cell viability assay 
To optimise culture conditions, cells were seeded at varying densities (5 x 104 to 4 x 
105 cells/well) in a 96-well plate in 200µl of varying mediums (RPMI 1640 with 1 
mmol/l GlutaMAX, 100 U/ml penicillin, 100 µg/ml and either 10% or 20% fetal calf 
serum (FCS) or 10% or 20% horse serum (HS) and with or without 104 U/ml (100 ng/ml) 
rhCSF-1. On Days 7, 10 and 14 the supernatant was removed from the wells and the 




well imaged with brightfield microscopy to visualise the cells. Fifty microlitres of 
1mg/ml MTT solution (3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium 
Bromide) were added to each well and incubated for 1 hour at 37˚C. The MTT solution 
was removed and 100 µl of solubilisation buffer added and incubated at 370C for 10 
minutes. Absorbance was read at 570 nm. 
 In vitro stimulation of macrophages 
2.6.1 Lipopolysaccharide (LPS) 
On Day 7, adhered differentiated cells were detached with medium using a blunt 18G 
needle and 10ml syringe. These were washed and counted and seeded on 6- well 
tissue culture plates with 2 x 106 cells per well in medium supplemented with rhCSF-
1, and incubated for 24 hours at 37˚C. After 24 hours, supernatant was removed 
from each well and replaced with either fresh medium (control) or medium containing 
LPS from Salmonella enterica serotype Minnesota Re 595 (L9764; Sigma-Aldrich) at a 
final concentration of 100 ng/ml. 
 Cryopreservation of cells 
Cells were counted prior to cryopreservation in freezing medium (90% heat-
inactivated horse serum and 10% DMSO). Cells were frozen overnight at -80˚C and 
then transferred to -155˚C for long term storage. 
 Phagocytosis assay 
Phagocytic activity of cells was assessed using either Zymosan A S. cerevisiae 
BioParticles labelled with Fluorescein or pHrodo Red E.coli BioParticles (both Thermo 
Fisher Scientific).  
2.8.1 Zymosan A S.cerevisiae BioParticles  
Cells were seeded in duplicate at 5 x 104 cells/well in a 4-well plate or placed on glass 
coverslips in full medium and cultured overnight. The medium was removed and 
Zymosan A S. cerevisiae BioParticles were added at a ratio of 100 particles/cell in 
fresh medium and cultured for 1 hour at 370 C. A control well had particles added but 
was kept at 40 C. Ice-cold PBS was added after 1 hour and the cells were washed three 
times in PBS. The cells were fixed with 4% paraformaldehyde (PFA) for 20 minutes at 
room temperature (RT) and then washed with PBS twice. Cells on plates were viewed 




by fluorescence microscopy at this stage. The number of phagocytic cells was counted 
and percentage of cells that had phagocytosed was calculated.  
Cells on glass coverslips were permeabilised with 0.1% Triton X-100 for 5 minutes 
then washed three times with PBS. Cells were blocked with 3% bovine serum albumin 
(BSA) in PBS for 1 hour and then stained for 1 hour with a 1/500 dilution of phalloidin 
(Texas Red-X Phalloidin, ThermoFisher Scientific) in 3% BSA/PBS. Cells were washed 
three times with PBS and then stained for 10 minutes with 1:1000 Hoechst stain 
(Hoechst 33258, Sigma-Aldrich), followed by three washes with PBS. Coverslips were 
mounted using fluorescence mounting medium (Fluorescence Mounting Medium, 
DAKO) and analysed by confocal microscopy (Zeiss LSM710).  
2.8.2 pHrodo red E. coli BioParticles  
pHrodo Red E.coli BioParticles were added to cells in 100 µl medium and placed in a 
water bath in the dark at 370 C for 1 hour. A control sample containing BioParticles 
was kept at 40 C during this period. Samples were analysed by flow cytometry. 
 Nitrite (Griess) assay 
Nitrite concentration of medium harvested from wells with cells stimulated with LPS 
was measured by the Griess assay. One hundred microlitres of nitrite standards in 
triplicate or 100µl medium was added in duplicate in a 96-well plate. To each well 
100 µl of Griess reagent (0.1% α-naphthyl ethylene diamine dihydrochloride, 1% 
sulphanilamide in 2.5% phosphoric acid in dH20) were added and incubated for 30 
minutes at 37˚C. Absorbance was read at 570 nm.  
  Immunohistochemistry 
2.10.1 Tissue fixation 
Formalin fixed tissue paraffin embedding 
For tissue histology, tissue samples were fixed in formalin for 24-72 hours then 
processed (see Table 2-5 for procedure details) using an Excelsior tissue processor 
(Thermo Fisher Scientific). Sections were placed in moulds and embedded in paraffin 
wax and left to cool before storage at RT prior to sectioning. 
 




Table 2-5 Programme used for processing tissue for formalin fixed paraffin embedded 
tissue sections 
Step Reagent Time 
1 70% ethanol 1 hour 
2 90% ethanol 1 hour 
3 100% ethanol 1 hour 
4 100% ethanol 1 hour 
5 Xylene 1 hour 
6 Xylene 1 hour 
7 Xylene 1 hour 
8 Paraffin (600C) 1 hour 
9 Paraffin (600C) 1 hour 
10 Paraffin (600C) 1 hour 
Formalin-fixed paraffin embedded tissue sectioning 
Sections 5 µm in thickness were cut on a microtome, placed on a 370 C water bath and 
collected on slides (Superfrost Plus, Thermo Fisher Scientific). Tissues were cut both 
in transverse section and also in whole mounts. Sections were air dried for one hour 
followed by further drying at 550 C for 1 hour. Slides were stored at RT until prior to 
staining.  
Deparaffinising formalin-fixed paraffin embedded tissue sections prior to 
immunohistochemistry 
Prior to IHC or staining, tissue sections were deparaffinised in xylene, rehydrated in 
a graded ethanol series and washed in tap water (Table 2-6) using an automated 
processor (Leica Autostainer; Leica Biosystems). Routine haematoxylin and eosin 
(H&E) staining was performed on all sections to assess for any pre-existing underlying 
pathology.  
Table 2-6 Rehydration steps for formalin fixed paraffin embedded tissue sections 
 
Step Reagent Time 
1 Xylene 5 mins 
2 Xylene 5 mins 
3 Xylene 5 mins 
4 100% ethanol 2 mins 
5 100% ethanol 2 mins 
6 95% ethanol 1 min 
7 Running water 3 mins 
2.10.2 Antigen retrieval 
Heat-mediated antigen retrieval was performed for all antibodies by placing slides in 
600 ml 0.01M sodium citrate buffer (pH 6.0) in a microwaveable pressure cooker at 
approximately 110o C for 20 minutes.  




2.10.3 Antibody incubation 
Prior to staining, endogenous peroxidase activity was inhibited in 3% hydrogen 
peroxide (Peroxidase-blocking solution; Dako REALTM, Agilent Technologies) in 
methanol for 30 minutes at RT. Slides were incubated with 100-200 µl blocking serum 
(1% normal goat serum [NGS]) and 5% BSA in tris-buffered saline [50 mM Tris-Cl, pH 
7.6; 150 mM NaCl; TBS]) for 30 minutes at RT in a humidity chamber.   
The primary antibody was applied diluted in blocking serum (See Table 2-7 for details 
of primary antibodies and dilutions used) in 100-300 µl aliquots to fully cover tissue 
sections. Slides were incubated for 2 hours at RT in a humidity chamber. Following 
incubation, a secondary anti-mouse or anti-rabbit antibody was applied (ImmPRESS 
HRP Anti-Mouse Ig [peroxidase] Polymer Detection Kit and ImmPRESS HRP Anti-
Rabbit Ig [peroxidase] Polymer Detection Kit; Vector Labs) for 15-30 minutes at RT, 
followed by 3,3'-diaminobenzidine (DAB) (3-solution DAB kit; Vector Labs) for 10 
minutes. Slides were then either dehydrated and mounted with no counterstain 
(Table 2-8), or counterstained with haematoxylin (and mounted using a xylene based 
mountant) (Table 2-9). Once dried, slides were scanned using a Nanozoomer 
(Hamamatsu Photonics) and analysed using NDP.view2 (Hamamatsu Photonics) and 
ImageJ.  
Table 2-7 List of antibodies used for immunohistochemistry 
 
Antibody Clone Supplier Host Target Dilution 
CD163 AM-3K TransGenic Mouse Human 
Did not work (Dilutions from 1:50 to 
1:1000) 
CD163 EDHu1 Abcam Mouse Human 1:200 
CD117  - Dako Rabbit Human 1:100 – did not work very well 
PGP 9.5 - Dako Rabbit Human 1:400 
      
Table 2-8 Dehydration program for slides (no counterstain) 
  
Step Reagent Time 
1 Running water 3 mins 
2 70% ethanol 20 secs 
3 95% ethanol 20 secs 
4 95% ethanol 30 secs 
5 100% ethanol 30 secs 
6 100% ethanol 30 secs 
7 Ethanol/xylene 1 min 
8 Xylene 1 min 
9 Xylene 1 min 
10 Xylene 1 min 
 
 




Table 2-9 Counterstain and dehydration program for slides 
 
Step Reagent Time 
1 Running water 3 mins 
2 Haematoxylin 3 mins 
3 Running water 5 mins 
4 Scott’s tap water 2 mins 
5 Running water 5 mins 
6 70% ethanol 20 secs 
7 95% ethanol 20 secs 
8 95% ethanol 30 secs 
9 100% ethanol 30 secs 
10 100% ethanol 30 secs 
11 Ethanol/xylene 1 min 
12 Xylene 1 min 
13 Xylene 1 min 
14 Xylene 1 min 
 Cell imaging 
2.11.1 Light microscopy 
Cells in culture dishes were placed under a light microscope for imaging. Prior to 
imaging, the media was replaced with fresh media to discard any non-adhered cells 
or debris. Images were obtained and analysed using Zen Blue (Zeiss). 
2.11.2 Confocal microscopy 
Cells were placed on glass coverslips in media and left overnight at 370 C to adhere. 
The media was removed, and cells were permeabilised with 0.1% Triton X-100 for 5 
minutes then washed three times with PBS. Cells were blocked with 3% BSA in PBS for 
1 hour and then stained for 1 hour with a 1:500 dilution of phalloidin (Texas Red-X 
Phalloidin, ThermoFisher Scientific) in 3% BSA in PBS. Cells were washed 3 times with 
PBS and then stained for 10 minutes with 1:1000 Hoechst stain (Hoechst 33258, 
Sigma-Aldrich), followed by three washes with PBS. Coverslips were mounted using 
fluorescence mounting medium (Fluorescence Mounting Medium, DAKO) and 
analysed by confocal microscopy (Zeiss LSM710). Images were obtained using Zen 
Black (Zeiss). 
  Mouse intestinal whole mount imaging 
The whole gastrointestinal tract (GIT) was removed whole from distal oesophagus to 
rectum. Luminal contents were cleared by gently flushing with ice cold Krebs solution 
(Sigma-Aldrich). The caecum and stomach were removed and discarded. The small or 
large intestine were opened on the anti-mesenteric border with scissors and the 




mucosal surface was thoroughly washed. For mucosal imaging, the tissue was placed 
mucosal side up onto a slide (Superfrost Plus, Thermo Fisher Scientific) and mounted 
using fluorescence mounting medium (Dako). For muscularis imaging, segments were 
pinned out onto a dish and the mucosa and submucosa removed. The remaining 
muscularis was then mounted on to a slide as described above. Images were acquired 
using Zeiss LSM710 confocal or Zeiss Axio Zoom.V16 Fluorescence Stereo Zoom 
microscope. 
  Image software 
All light microscope and confocal images were created using Zen Blue (Light 
microscopy) or Zen Black (confocal microscopy and multiphoton microscopy) 
software (Zeiss International). Slides were scanned using a Nanozoomer (Hamamatsu 
Photonics) which generated images of the slide. These were viewed using NDP.view2 
(Hamamatsu Photonics). Images were analysed using ImageJ (Schneider et al., 2012) 
CellProfiler (Jones et al., 2008) or NDP.view2 (Hamamatsu Photonics).  
 Image analysis pipelines 
Pipelines for image analysis were developed with the help of Dr Kristin Sauter, Roslin 
Institute, University of Edinburgh (ImageJ) and Dr Barbara Shih, Roslin Institute, 
University of Edinburgh (CellProfiler). 
 Quantification of cells in the equine 
gastrointestinal tract  
Slides were visualised using NDP.view2 (Hamamatsu Photonics). Three areas within a 
2 mm region were selected for counting for each layer; 2 mm from the left side edge 
of tissue, the mid-point of tissue section and 2 mm from the right-side edge of tissue 
section. Areas to be analysed were drawn using either the rectangle function, or 
freehand region function. For the mucosa, submucosa and muscle layers, a 0.5 mm2 
area was measured. For the myenteric plexus and serosa, a 0.1 mm2 area was 
measured. Values were then either multiplied by 2 or 10 respectively, to give values 
per mm2. Cells were marked manually and counted. The three values for each area 
were averaged for further analysis. See Figure 2-1 for a summary of the quantification 
method. 





  RNA Extractions 
2.16.1 Cells 
For extraction of adhered bone marrow-derived macrophages TRIzol (Ambion, Life 
Technologies) was added to cell culture wells, after removal of the supernatant, to 
lyse the adhered cells. After 5 minutes, the TRIzol solution was collected and stored 
at -800 C. 
Figure 2-1 Example of cell quantification method 
A 2 mm region was identified in the left, middle (A) and right-hand side of the tissue section. 
Using the rectangle or freehand function in NDP2.view areas measuring either 0.5 mm2 (A, 
B, C, E) or 0.1 mm2 (D, F) were drawn within the 2 mm section (region represented by dotted 
line in A). Positive staining cells were marked to facilitate counting (B and C). 
Magnification (A) X2 Bar=1 mm, (B) X5 Bar=250 µm, (C) X10 Bar=500 µm 




RNA was extracted using the RNeasy Mini kit (Qiagen), following manufacturer’s 
instructions. The TRIzol and cell solution was thawed and 200 µL of 1-Bromo-3-
chloropropane (BCP) (Sigma-Aldrich) was added. The mixture was shaken vigorously 
for 15 seconds and incubated at RT for 3 minutes. The solution was centrifuged at 
12000 rcf for 15 minutes at 40C. Four hundred microlitres of the upper aqueous phase 
were transferred to a new tube. To each tube, 400 µL of 70% ethanol were added and 
mixed with a pipette. Four hundred microlitres of the ethanol-RNA mix were 
transferred to a RNeasy Mini spin column (Qiagen) in a collection tube and 
centrifuged at RT for 10,000 rcf for 30 seconds. The flow through was discarded and 
the remaining ethanol-RNA mix was transferred to the same spin column and 
centrifuged at 10000 rcf for 30 seconds. Again, the flow through was discarded and 
700 µL of Buffer RW1 (Qiagen) was added to the RNeasy column and centrifuged for 
30 seconds at 16000 rcf. The flow through was discarded and the Buffer RW1 step 
repeated. Next, 500 µL Buffer RPE (Qiagen) were added to the RNeasy column and 
centrifuged for 2 minutes at 16,000 rcf and the flow through discarded. This step was 
repeated but the column centrifuged at 16,000 rcf for 30 seconds. To dry the 
membrane the RNeasy column was placed in a new 2 ml collection tube and 
centrifuged at full speed for 1 minute. The spin column was transferred into a new 
1.5 ml tube and 34 µL of RNase free water (Qiagen) were added to the spin column to 
elute the RNA. The column was centrifuged at 10,000 rcf for 1 min. RNA was either 
stored at 40 C for a maximum of 4 hours or at -800 C for long term storage. 
2.16.2 Tissues 
RNA from tissues was extracted using a RNeasy Plus Mini kit (Qiagen) following 
manufacturer’s instructions. Briefly, 50 µg of frozen tissue was added to 600 µL of β-
mercaptoethanol (β -ME) in an eppendorf with CK14 beads (Bertin Instruments). 
Tissues were homogenised (Precellys, Bertin Instruments) using the following 
settings; horse mucosa and liver 1 x 5800 rpm for 30 seconds and horse muscularis 
2 x 6500 rpm for 30 seconds with 30 seconds rest. The muscularis was added to 
ProteinaseK (Dako) for 30 minutes at 600 C. The homogenates were centrifuged at 
16,000 rcf for 3 minutes and the supernatant transferred to a gDNA Eliminator 
column (Qiagen) and centrifuged for 30 seconds at 10,000 rcf. Six hundred 
microliteres of 70% ethanol were added to the flow through and mixed with a pipette. 
Six hundred microlitres of the RNA-ethanol mix were transferred to a RNeasy Mini 
spin column (Qiagen) in a collection tube and centrifuged at RT for 10,000 rcf for 30 
seconds. The flow through was discarded and the remaining ethanol-RNA mix was 




transferred to the same spin column and centrifuged at 10000 rcf for 30 seconds. 
The remainder of the protocol is identical to that described for cells in Section 2.16.1. 
  RNA quantification and quality analysis 
2.17.1 Nanodrop 
RNA was quantified by testing 1 uL of sample using an ND-1000 Nanodrop 
spectrophotometer (ThermoFisher Scientific, Wilmington, USA). RNA purity was 
assessed by measuring absorbance at 230 nm, 260 nm and 280 nm. A 260/280 or 
260/230 ratio of 2 indicates good purity of RNA (Desjardins and Conklin, 2010).  
2.17.2 Qubit 
Samples to be sent for microarray analysis and RNA-Sequencing were quantified 
using the Qubit 3.0 Fluorometer (ThermoFisher Scientific) following manufacturers 
protocol for the Qubit RNA BR Assay Kit. Briefly 2uL of sample was added to the 
Qubit working solution to a total volume of 200uL in thin-walled PCR tubes. After 
incubation at RT for 2 minutes, RNA concentration was measured using the Qubit 3.0 
Fluorometer.  
2.17.3 TapeStation 
RNA sample integrity was measured using 2200 TapeStation System (Agilent 
Technologies) using RNA ScreenTape. One microlitre of sample was added to 5 uL 
Sample Buffer in PCR tubes. The sample was vortexed at 2000 rpm for 1 minute, 
heated at 720C for 3 minutes and cooled for 2 minutes at 40C before being loaded into 
the 2200 TapeStation System. An RNA integrity number (RIN) greater than 7 was used 
for all further work (Schroeder et al., 2006). 
  cDNA Synthesis from RNA 
cDNA was synthesised from 1µg RNA using the SuperScript III First-Strand synthesis 
system (Invitrogen). One microgramme of RNA was combined with 50 µM oligo(dT)20, 
10 mM dNTP mix and nuclease free water (added to make 10 µL) in a nuclease-free 
tube. The solution was incubated at 650 C for 5 minutes followed by rapid cooling at 
40 C for 1 minute. Ten microlitres of cDNA synthesis mix (2 µL 10X RT buffer, 4 µL 25 
mM MgCl2, 2 µL 0.1 M DTT, 1 µL RNaseOUT (40U/µL) and 1 µL SuperScript III RT (200 
U/µL) per reaction) were added to each RNA mixture and incubated at 50 minutes for 
500C, terminated at 850C for 5 minutes and then fast cooled to 40C. Samples were 




briefly centrifuged and 1 µL of RNaseH was added to each tube and incubated for 20 
minutes at 370 C. Samples were stored at -20o C. 
  Primer design 
Primers were designed using Primer3 (Untergasser et al., 2012, Koressaar and Remm, 
2007) based on known or predicted equine sequences. Gene sequences were obtained 
from www.ensembl.org (Ensembl) and the sequence blasted to SeqBuilder13 (DNAStar 
Lasergene 13). The exons were mapped out manually in SeqBuilder13 and suggested 
primers from Primer3 were mapped out to ensure that they covered more than one 
exon. Primer sequences used are listed in Table 2-10.  
Table 2-10 Primers used in Real – Time quantitative PCR 
 
Gene Forward Reverse 
GAPDH GGAGTCCACTGGTGTCTTCA AGCAGAAGGAGCAGAGATGAT 
TNF-α CCTGTAGCCCATGTTGTAGCA GGACCTGGGAGTAGATGAGGT 
IDO1 ACTTCTTGTCTACGCAACGC CGCCTTCATAGAGCAGACCT 
NOS2 CCCAAGCTCTACACCTCCAA TCTGTAGATTCTGCCGCGAT 
IL6 CCACTACTCACCACTGCAGA TTTCATCAGGCAGGTCTCCT 
TLR4 GGACCTGAGCTTTAACCCCT CAATTTCACACCTGGACAAA 
PTGS2 TCACCCAGTTTGTTGAATCTTTC CCTCAATCGACCAGAGCAGA 
IL1B GGGACGAAAGATGGGAAGCC TCCCATCTTTCGTCCCACAA 
CSF1R TCTGGTCCTACGGCATCCTG  CATTTGGTATCCGTCCTTGACC 
CCL2 AGTCACCAGCAGCAAGTGTC AGCATCCTGGACCCACTTC 
  Real – Time quantitative polymerase chain 
reaction (RT qPCR) 
For real-time quantitative PCR (qPCR), cDNA was amplified with Power SYBR Green 
PCR Master Mix using the 7500 fast Real Time PCR system (ThermoFisher Scientific). 
Primer efficiency was validated with a standard curve of five serial dilution points 
(three for NOS2) with efficiency ranging between -3.304 and -3.511. Amplification was 
performed in triplicate and relative gene expression was calculated using the 
2^−ΔΔCT method (Livak and Schmittgen, 2001). Lucas Lefevre assisted with the design 
and optimisation of primers as well as performing the qPCR for the colic cases.  




  Experimental model of post-operative ileus 
All work was performed on mice at TARGID, KU Leuven, Leuven, Belgium. A standard 
model of intestinal manipulation was used (van Bree et al., 2012). Briefly, under 
general anaesthesia, a midline laparotomy was performed and the small intestine 
exteriorised, avoiding manipulation of the colon. The small intestine was manipulated 
three times by the same individual using a purpose designed device with a 
standardised weight (9g) to allow even and consistent application of pressure (van 
Bree et al., 2012). The small intestine was placed back in the abdomen and the 
abdomen closed. Mice were placed on a heat pad until they recovered from the 
surgery. Naïve mice underwent laparotomy alone, with no manipulation of the 
intestine. Dr Giovanna Farro (TARGID, KU Leuven) performed all intestinal 
manipulations.  
  Gastrointestinal transit measurement 
Gastrointestinal transit was measured as described by Wehner et al. 2011. Briefly, 
mice were administered 10 μl of a liquid non-absorbable fluorescein isothiocyanate-
labelled dextran (FITC-dextran, 70,000 Da; Invitrogen) per os after being starved for 
90 minutes. After a further 90 minutes, animals were culled by CO2 overdose followed 
by cardiac bleeding and/or cervical dislocation. The GIT was removed avoiding excess 
manipulation thus avoiding disruption of contents. The stomach, small intestine, 
caecum and large intestine was laid lengthways, avoiding overstretching of the tissue, 
and the small intestine and colon divided into equal parts (10 for small intestine; 3 
for colon). Each segment was placed into an Eppendorf tube with 1 ml of ice-cold 
Krebs solution (Sigma-Aldrich). Each segment was then minced using scissors and the 
tube vortexed for 10 seconds. The homogenate was centrifuged at 12,000 rcf for 10 
minutes and 200 µl of supernatant in triplicate transferred into a 96-well plate. 
Fluorescence was read at 488nm using a multi-mode plate reader (BioTek 
Instruments). By calculating the geometric centre (GC) (Σ (percent of total fluorescent 
signal in each segment x the segment number)/100), a comparison of the distribution 
of fluorescent dextran in the GIT was made between groups (van Bree et al., 2012, 
Wehner et al., 2011). 




 Treatment of mice with an FC conjugate of CSF-1 
Mice were injected subcutaneously with 0.75 mg/kg of an Fc conjugate of pig CSF-1 
(CSF1-Fc) (Zoetis) (Gow et al., 2014) at 24-hour intervals for 3 to 5 days (duration 
specified for each specific study). The control group were injected with PBS. 
  Flow cytometry 
Cells were pelleted and re-suspended in blocking solution for 30 minutes in 1% NGS 
in a 96 well plate on ice. One million (1 x 106) cells per well were used. Following 
centrifugation for 5 minutes at 400 x rcf, supernatant was removed, and cells were 
re-suspended in 50 µl PBS containing either primary or secondary antibody or isotype 
controls. Samples were incubated in the dark at 4° C for 60 minutes before washing 
twice with 100 µl PBS. Cells were resuspended in 500 µl of PBS with 0.1% Sytox blue 
(Invitrogen) used as a dead cell marker. Data were acquired using a BD Fortessa LSR 
(Beckton Dickinson) flow cytometer. Blood was prepared for flow cytometry after 
staining with the Dako Uti-lyse™ kit (Dako, Denmark).  
Primary antibodies used were mouse anti-equine CD14 (Clone 105, 1:100, Wagner 
Laboratory) or mouse anti human CD163 (Clone EDHu-1, 1:100, Bio-Rad). Secondary 
antibodies used were rat IgG1-APC (1:100, Bio-Legend). The isotype control used was 
mouse IgG1 (Bio-Rad).  Details of antibodies and concomitant dilutions are shown in 
Table 2-11. 
Data were analysed with FlowJo software (FlowJo, LLC, Ashland, USA). Dr Anna Raper 
(Roslin Institute, University of Edinburgh) provided assistance with the generation of 
graphs. 
Table 2-11 Antibodies used for flow cytometry 
 
Antibody Clone Isotype Supplier Host Target Dilution 
CD163 EDHu-1 IgG1 Bio-Rad Mouse Human 1:100 
CD14 105 IgG1 Wagner Laboratory Mouse Equine 1:100 
CSF1R n/a n/a Produced in-house Pig  1:2000 
 Microarray analysis 
Total RNA was extracted from jejunal muscularis of C57BL/6 mice (n=3) and 
B6.129S4-Ccr2tm1Ifc/J mice (n=3) that underwent intestinal manipulation and had been 
pre-treated with CSF1-Fc for 48 hours prior to surgery. Treatment with CSF1-Fc 




continued for three days post-operatively at which point the mice were culled. The 
control group (n=3 for both genotypes) were treated with PBS. Total RNA was 
extracted from whole gut (jejunum) from C57BL/6 mice that were treated with CSF1-
Fc (n=2) or PBS (n=2) for 5 days but did not undergo intestinal manipulation (See 
2.16.2 above for extraction method). Muscularis RNA extractions were performed by 
Michelle Stakenborg (TARGID, KU Leuven, Belgium). Microarrays were processed by 
Edinburgh Genomics, The University of Edinburgh using the Affymetrix Mouse Gene 
1.1 ST Array Strip. 
  RNASeq analysis 
Total RNA was extracted from eqBMDMs with or without exposure to LPS for 7 hours 
(n=3 per group) and was used for paired end library preparation and sequenced using 
HiSeq4000 (Illumina, San Diego, USA) at >100 million paired end reads per sample by 
Edinburgh Genomics, University of Edinburgh. 
2.26.1 Data quality control 
Raw data were obtained in the form of fastq. files. 
2.26.2 Differential expression analysis 
Expression level was quantified, as both transcripts per million (TPM) and estimated 
read counts, using Kallisto v0.42.4 (Bray et al., 2016). Transcript-level read counts 
were summarised to the gene level using the R/Bioconductor package tximport v1.0.3 
(Soneson et al., 2015), with gene names obtained from the EquCab2.0 annotation (via 
Ensembl BioMart v90 (Yates et al., 2016, Kinsella et al., 2011)). The tximport package 
aggregates Kallisto output into a count matrix, useable by the R/Bioconductor 
package edgeR v3.14.0 (Robinson et al., 2010) for differential expression analysis, as 
well as calculating an offset that corrects for changes to the average transcript length 
between samples (which can reflect differential isoform usage). Using edgeR, gene 
counts were normalised using the ‘trimmed mean of M values’ (TMM) method, with a 
negative binomial generalized log-linear model fitted, and p-values corrected for 
multiple testing according to a false discovery rate (FDR) (Benjamini and Hochberg, 
1995). 
2.26.3 Gene ontology (GO) term enrichment 
Clusters were analysed using the Bioconductor package ‘topGO’ to examine if genes 
within clusters shared similar functions and pathways, based on gene ontology (GO) 




(Alexa and Rahnenfuhrer, 2016). GO term enrichments are given for every cluster 
containing ≥10 genes. GO terms are listed only if a) p<0.05 and b) there are ≥10 genes 
across the entire genome annotated with that GO term. 
  Statistical analysis 
Statistical analysis was performed using GraphPad Prism 7.0 for Windows (GraphPad 
Software). Significance was assumed at p < 0.05. Significance in CD163 staining 
between regions was determined by paired two-tailed Student’s t-test. Significance 
between colic case relative gene expression and controls was determined with a non-
parametric Mann-Whitney U test. All graphs were created using GraphPad Prism 7.0 





 Distribution of macrophages in the 
equine gastrointestinal tract 
 




Resident tissue macrophages, such as those found in the gastrointestinal tract (GIT), 
are specialised cells with tissue-specific roles. They are a heterogenous population 
(Gordon and Taylor, 2005), yet are broadly made up of two distinct sub-populations: 
lamina propria (LpM) or mucosal macrophages and muscularis macrophages (MM). 
LpM are replenished by circulating monocytes, in the presence of the macrophage 
growth factor CSF-1 (Bain et al., 2014, Baillie et al., 2017). MM have not been studied 
as extensively as LpM. In comparison to LpM, MM have a slower turnover rate 
(Mikkelsen et al., 2004) and it is yet to be determined whether this population are 
monocyte derived or derived from yolk sac progenitors and sustained by self-renewal. 
Their distribution in mouse embryos is similar to their distribution in adult mice 
(Mikkelsen et al., 2004), yet low numbers of monocytes have been detected in the 
normal muscularis of rats, which increase in number with intestinal inflammation 
(Hori et al., 2008). Rodent and human derived data show that, during intestinal 
surgery, activation of MM plays a role in the pathogenesis of post-operative ileus 
(Kalff et al., 1998a, Farro et al., 2017, Kalff et al., 2003). 
Except one study which quantified the immune cell populations in the lamina propria 
of the equine jejunum (Packer et al., 2005), there are no studies to date describing or 
quantifying resident macrophage populations in muscularis externa (ME). Yamate et 
al. (2000) demonstrated the presence of CD163+ve cells, consistent with macrophages, 
in the mucosa and muscularis of the equine GIT (Yamate et al., 2000) but did not 
investigate their number or distribution. 
Immunohistochemistry (IHC) followed by light microscopy allows the identification 
of positive staining cells (in this case, macrophages). This allows the study of both 
their location within the tissue and an estimation of their density. By using dual 
staining techniques, where different chromogens are applied to different antibodies, 
the relationship of macrophages with other cells, such as the motility effector cells 
of the GIT (e.g. interstitial cells of Cajal [ICC] and enteric neurons), can be studied. 
When quantifying cells, it is important to use quantitative methods using a number-
weighted, and not size or shape-weighted, method to give accurate results of density 
within the tissue (Mikkelsen et al., 2011). Other methods of imaging macrophages in 
mice include the use of transgenic reporters such as those based upon the Csf1r 
promoter (Sauter et al., 2014, Sasmono et al., 2003). The use of these mice is discussed 
in further detail in Chapter 1 and Chapter 6.  Such reporters are clearly not available 
for the horse.  
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Markers used to identify macrophages in the GIT of other species are summarised in 
Table 3-1, with most of the studies focusing on LpM, rather than MM, populations. 
Studies of GIT macrophage populations in various species have adopted the use of 
antibodies against the following targets: adhesion G-protein coupled receptor F4/80 
(Hume et al., 1984, Mikkelsen et al., 1988), macrophage scavenger receptor for the 
haemoglobin-haptoglobin complex (CD163) (Yamate et al., 2000, Kalff et al., 2003, 
Dijkstra et al., 1985, Phillips and Powley, 2012), interferon regulatory factor 1 (IRF1) 
(Hume et al., 1987) major histocompatibility complex (MHC) II (Mikkelsen and 
Rumessen, 1992), sialoadhesin (Siglec1/CD169) (Dijkstra et al., 1985), class D 
scavenger receptor (CD68) (Mikkelsen and Rumessen, 1992) and CD11b (Itgam) 
(Mikkelsen and Rumessen, 1992, Mikkelsen et al., 1988). The use of multiple labelled 
antibodies can also be used to identify different subsets of macrophages and thus 
potentially provide information on functional differences between different 
macrophage subsets, based on their regional location within the GIT. Previously used 
markers for macrophages in the horse include CD163 (clone AM-3K) (Yamate et al., 
2000, Grosche et al., 2011) in small and large intestine and MAC387 (MRP-8 and MRP-
14) in brain tissue and jejunum (Packer et al., 2005); however both MAC387 and 
lysozyme are non-specific for macrophages since both are present in granulocytes. 
Table 3-1 Summary of antibodies used to identify macrophages in the GIT of species 



















Intestinal macrophages are located in all cross-sectional regions of the intestine; the 
lamina propria, the submucosa, the circular muscle, between the longitudinal and 
circular muscle (at the level of the myenteric plexus [MP]), the longitudinal muscle 
and the serosa (Mikkelsen, 1995, Mikkelsen et al., 2004, Kalff et al., 1998b), Their 
morphology varies depending on their location. In the mouse, serosal macrophages 
are bipolar, slender, orientated parallel to the longitudinal muscle and occasionally 
have bifurcated processes (Mikkelsen, 2010). Cells within the circular and 
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longitudinal muscle layers are found between the muscular bundles and have an 
elongated thin shape, with those in the longitudinal muscle being less elongated 
compared with those within the circular muscle (Kalff et al., 1998b). Macrophages 
between the circular and longitudinal muscle layers, at the level of the MP (also 
termed Auerbach’s Plexus) are stellate with multiple dendrites (Kalff et al., 1998b, 
Mikkelsen, 2010).  
In contrast to serosal and MM associated with the myenteric plexus (MP) which have 
a regular distribution, those found within the muscle layers have a slightly more 
heterogeneous distribution, being located lining muscle layers and septa (Mikkelsen, 
2010). Compared with mouse serosal macrophages, human serosal macrophages 
appear rounder and less ramified although the morphology of mouse and human MP 
macrophages is similar (Mikkelsen and Rumessen, 1992). In horses, humans and mice, 
LpM are found beneath the epithelium (Nagashima et al., 1996, Mahida et al., 1989, 
Hume et al., 1987, Packer et al., 2005). In mice, LpM have a ramified structure 
(Sasmono et al., 2003, Robert et al., 2011), but have reduced dendrite ramifications 
when compared to MM. Despite shorter ramifications, LpM have increased movement 
of dendrites (Gabanyi et al., 2016) reflecting their role in luminal sampling across the 
epithelium. This contrasts with the reported structure of human LpM which were 
predominantly large and round (Mahida et al., 1989).   
The main objective of this chapter was to immunohistochemically identify and plot 
the distribution of resident macrophages in the normal equine GIT and, using dual 
staining techniques, study their spatial relationship to motility effector cells such as 
ICC and enteric neurons. Protein gene product 9.5 (PGP 9.5) was used to detect enteric 
neurons as described previously (Ramos-Vara et al., 2014, Hudson et al., 2014). ICC 
identification was attempted using CD117 and the methodology of Hudson et al. 
(1999), with the exception that formalin-fixed paraffin embedded tissues (FFPE) were 
used rather than cryosections. For the detection of macrophages, an antibody against 
CD163 was used. CD163 is a member of the class B scavenger receptor cysteine-rich 
family and along with M160, is the only one expressed on both monocytes and 
macrophages (Van den Heuvel et al., 1999). As mentioned above, CD163 has 
previously been used to identify rat and human intestinal macrophages (Mikkelsen, 
2010, Mikkelsen and Rumessen, 1992, Kalff et al., 2003) and has also been used to 
study equine intestinal (Yamate et al., 2000) and non-intestinal macrophage 
populations, including the uveal tract and laminae (Faleiros et al., 2011, Sano et al., 
2016, Yamate et al., 2000). In the horse, CD163 is highly expressed on alveolar 
macrophages, but not peritoneal macrophages (Karagianni et al., 2013).  




3.2.1 Optimisation of immunohistochemistry protocols 
CD163 
The initial aim of this chapter was to optimise and establish a protocol for CD163 
staining, to ensure the antibody was targeting the expected antigen (Ramos-Vara et 
al., 2008). Initially the protocol used by Yamate et al. 2000 was used, which used the 
AM-3K clone of CD163; however, it was not possible to get this antibody to work for 
immunohistochemistry of intestinal tissues in this study. The CD163 clone KT-103 
was used by our laboratory group in other species (Sauter et al., 2016), so further 
optimisation was performed with the KT-103 clone of CD163. 
Tissue Fixation 
Fixation of tissues in 10% neutral-buffered formalin is commonly used as it avoids 
the use of fresh or snap (fresh) frozen tissues and allows for relatively easy long-term 
storage of tissue sections. Advantages of formalin fixation include the prevention of 
tissue necrosis and retention of tissue and cellular architecture (Ramos-Vara, 2005). 
Conversely, as formalin fixation results in the cross linking of peptides, through the 
formation of hydroxymethyl groups on certain amino acid chains, it can change the 
conformation of macromolecules. When affecting specific antigens, this 
conformational change can interfere with antibody recognition (Ramos-Vara, 2005). 
In light of the large numbers of tissues collected from each horse in this current 
study, formalin fixation in 10% neutral-buffered formalin was highly convenient, 
compared with tissue freezing. To minimise any risk of antigen detection loss 
resulting from prolonged fixation (Webster et al., 2009), tissues were stored in 
formalin for no more than 6 weeks.  
Antigen retrieval 
An antigen retrieval protocol can be adopted prior to antibody labelling to reverse 
some of the changes associated with cross-linked tissue fixation; such protocols are 
based on either heat-mediated or enzymatic processes (Ramos-Vara, 2005). 
Enzymatic protocols, such as ficin, proteinase K, pepsin and trypsin work by the 
digestion of cross linked proteins formed during fixation (Hecke, 2002). 
Disadvantages of enzymatic protocols include the low number of epitopes on which 
the enzymes work, alteration of tissue morphology and alteration or damage to the 
target epitopes (Ramos-Vara, 2005). Heat-induced retrieval involves breaking the 
bonds between formalin and the epitope protein by high temperatures and strong 
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alkaline hydrolysis although the exact mechanism of action is not known (Ramos-
Vara, 2005) For this study, protocols were adapted from www.ihcworld.com. Various 
enzyme and heat-mediated antigen retrieval methods were applied to the equine 
fixed intestinal tissue samples; results associated with each method are summarised 
in Table 3-2.  
Table 3-2 Summary of results with various antigen retrieval techniques for CD163 





 Pepsin No staining 
 Trypsin Some staining 
(weak) 
 Proteinase K Some staining 
(weak) 




 0.01M sodium citrate buffer (pH 6.0) Good staining 
 0.01M sodium citrate buffer (pH 7.0) No staining 
 0.01M sodium citrate buffer (pH 9.0) No staining 
 1mM EDTA buffer (pH 6.0) No staining 
 1mM EDTA buffer (pH 7.0) No staining 
 1mM EDTA buffer (pH 9.0) No staining 
From Table 3-2, several different sections of jejunum were stained for CD163 (Figure 
3-1). The use of trypsin and proteinase K resulted in positive staining in the 
submucosa and muscularis, but no positive staining of LpM in the villi. The use of 
sodium citrate antigen retrieval resulted in the positive identification of CD163+ve cells 
in all layers of this intestine. Therefore, for all subsequent IHC, antigen retrieval using 
0.01M sodium citrate buffer (pH 6.0) was adopted. 




Figure 3-1 Comparison of antigen retrieval techniques for CD163 staining in equine 
jejunum 
Antigen retrieval was performed on formalin-fixed paraffin-embedded jejunum using either 
trypsin, proteinase K or heat-mediated 0.1mM sodium citrate buffer (pH 6.0). Tissues were 
then stained for CD163 in a 1:200 dilution and a polymer detection system was used with 
3,3'-diaminobenzidine (DAB) to detect positive staining. Images obtained by light microscopy 
using Zen software at X10 magnification. Image representative of sections of jejunum, right 
ventral colon and small colon of 3 horses.  Bar = 50µm. Images representative of 5 horses. 
CM, circular muscle; LM, longitudinal muscle; MP, myenteric plexus. 




In contrast to PGP 9.5, there was only weak staining of ICC cells using the optimised 
protocol with CD117 (Figure 3-2). In previous studies, horse ICC immunostaining was 
achieved on frozen sections (Hudson et al., 1999). It is possible that alternative 
antigen retrieval protocols would expose the antigenic epitope; however further 
exploration of this theory was not considered a core objective of the current study.  
 
PGP 9.5  
As previously reported in the equine GIT (Hudson et al., 2014) expression of PGP 9.5 
was detected in all small and large intestinal sections stained in the current study. 
Expression was also detected in all layers; namely, mucosa, submucosa and ME 
(Figure 3-3). Neuronal axons were visible at the base of the villi, the submucosa, the 
circular muscle and longitudinal muscle layers. Within the longitudinal muscle layers, 
the axons were more punctate, as the orientation of the muscle was in transverse 
section, compared to the circular muscle where neurons were longer, reflecting their 
parallel orientation to muscle fibres.  
 
Figure 3-2 CD117 staining in equine jejunum 
Staining for CD117 at the level of the myenteric plexus in equine jejunum with (A) and 
without (B) haematoxylin counterstain. Staining for interstitial cells of Cajal was present 
where expected (at the level of the myenteric plexus (black arrows) in between the circular 
(CM) and longitudinal (LM) muscle layers)  
Magnification X20 Bar= 500 µm. Images representative of 5 horses. 




Figure 3-3 PGP 9.5 staining in equine small colon 
Equine small colon was stained with PGP 9.5, using 3,3'-diaminobenzidine (DAB) as a 
chromogen with no counterstain. Positive staining was visible in all layers (A X1.25 
magnification; Bar=2.5mm). B (X10 magnification; Bar= 250µm) shows immunoreactivity 
for PGP 9.5 in the mucosa where nerve fibres (black arrows) are seen at the villi base and 
the submucosal plexus ganglion (asterisk). Nerve fibres can be seen within the muscularis 
externa (C & E X10 magnification; Bar=250µm) and in the myenteric plexus (MP) (D X20 
magnification; Bar=500µm). Images representative of samples taken from 5 horses. 
CM, circular muscle; SM, submucosa, LM, longitudinal muscle; MP, myenteric plexus. 
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3.2.2 Distribution of macrophages in the equine GIT 
Following optimisation of CD163 staining in the equine GIT, sections from 14 regions 
of equine GIT collected from 10 horses were stained for CD163. CD163+ve cells were 
identified in all intestinal layers (mucosa, submucosa, muscularis and serosa) in all 
regions of the GIT (stomach to small colon).  
Quantification of macrophages in the equine GIT 
Figure 3-4 shows the number of CD163+ve macrophages per mm2 of tissue in all layers 
and regions of the equine GIT. The distribution of cells across layers was not uniform. 
The highest densities of cells per mm2 of tissue for all regions were found in the 
mucosa, submucosa, MP and serosa. Both the circular and longitudinal muscle layers 
had the lowest density of cells in all sections, and the lowest variation in numbers i.e. 
cell numbers were consistent throughout the muscle layer. With the exception of the 
submucosa, the number of cells/mm2 did not vary significantly throughout the length 
of the GIT (Figure 3-5). In the submucosa, a significant increase in cells/mm2 was 
observed from the distal jejunum and the ileum. This increase in number then 
remained consistent for the remainder of the GIT. This change in cell numbers was 
not mirrored in the lamina propria population, where the cell numbers remained 
relatively consistent from stomach to small colon.     
























































































































































































































































































































































































Figure 3-5 Distribution of CD163+ve macrophages in the layers of the equine 
gastrointestinal tract 
Scatter plots showing cells/mm2 for each layer along the length of the equine gastrointestinal 
tract from (L-R) stomach (Sto) lesser curvature (LC), stomach greater curvature (GC), 
duodenum (duo), jejunum (jej), ileum, caecum, right ventral colon (RVC), left ventral colon 
(LVC), pelvic flexure (PF), left dorsal colon (LDC), right dorsal colon (RDC) and small colon. 
Red line represents median. Significant difference (p<0.0001) between cells/mm2 in 
submucosa between jeunum (3/4) and ileum as measured by paired t-test. ****p<0.0001. 
n=10 
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Morphology of macrophages in the equine GIT 
Morphological staining characteristics at each location are detailed below: 
Mucosa 
As previously reported in humans and rodents, all macrophages within the mucosa 
were observed in accumulations below the epithelial layer within the lamina propria 
(Nagashima et al., 1996, Hume et al., 1984). This was evident both in the stomach and 
the small and large intestines (Figure 3-6). In the current study, equine LpMs were 
predominantly bipolar each with two to three processes (Figure 3-7). Other studies 
in mice have shown LpMs to sample luminal contents via processes extending 
through the basement membrane, between epithelial cells into the lumen (Muller et 
al., 2014). In contrast, the current study revealed equine LpMs to be located entirely 
beneath the basement membrane; no cells or processes were observed crossing the 
basement membrane and epithelial layer.  
Submucosa 
CD163+ve macrophages were present in the submucosa of all tissue sections (Figure 
3-8 and Figure 3-9). This region had amongst the greatest density (cells/mm2) of 
positive staining cells (Figure 3-4). In the small intestine, submucosal macrophages 
were a mix of round and bipolar cells (Figure 3-8); whilst in the large intestine, 
macrophages were predominantly round (Figure 3-9). Macrophages were also 
commonly observed adjacent to gut associated lymphoid tissue (Figure 3-10).  
 




Figure 3-6 Lamina propria macrophages in the equine stomach, jejunum and right 
ventral colon 
Staining for CD163 using 3,3'-diaminobenzidine (DAB) as a chromogen in the mucosa of the 
equine stomach (A), jejunum (B) and right ventral colon (C). DAB is not visible in the epithelial 
layer (red line represents basement membrane). 
Magnification X10. Bar=250µm. Images representative of samples taken from 10 horses. 




Figure 3-7 Morphology of lamina propria macrophages in the equine jejunum and 
right dorsal colon 
Staining for CD163 in the lamina propria of the equine jejunum (A) and right dorsal colon 
(B) using 3,3'-diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. 
(A) is a cross section. (B) is a whole mount. Macrophages in the lamina propria are 
predominantly bipolar with (yellow arrow) with occasional cells having 3 or more 
ramifications (green arrow). 
(A) and (B) X20 magnification Bar=100µm. Inset X80 Bar=25µm. Images representative of 
of samples taken from 10 horses. 




Figure 3-8 Morphology of macrophages in the submucosa of the equine small 
intestine 
Staining for CD163 in the submucosa of the equine jejunum (A) and ileum (B) using 3,3'-
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. Macrophages 
in the submucosa are either bipolar (green arrow, blue inset) or round (yellow arrow, red 
inset). (A) and (B) X20 magnification; Bar=100µm. Inset X80 Bar=25µm. Images 
representative of samples taken from 10 horses. 




Figure 3-9 Morphology of macrophages in the submucosa of equine large intestine 
Staining for CD163 in the submucosa of the equine pelvic flexure (A) and left dorsal colon 
(B) using 3,3'-diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. 
Macrophages in the submucosa are predominantly round (red inset) with occasional bipolar 
cells (blue inset). 
(A) and (B) X20 magnification Bar=100µm. Inset X80 Bar=25µm. Images representative of 
samples taken from 10 horses. 




Muscularis externa (comprising serosa, muscularis and myenteric plexus)  
In mice, macrophages have been described in three areas of the ME; namely, the 
serosa, MP and the level of the deep muscular plexus between inner and outer circular 
muscle (Mikkelsen, 2010). In the rat, ED2+ve/CD163+ve macrophages were also seen 
within the longitudinal muscle, between the muscle layers and within the circular 
muscle itself (Kalff et al., 1998a, Phillips and Powley, 2012). In humans, CD68+ve cells 
are also found within the serosa and ME. Within the human ME, CD68+ve positive 
staining cells have been shown to be present within intermuscular septa, 
intralamellar septa between muscle cells and the lining of the MP (Mikkelsen, 2010). 
In comparison, CD163+ve macrophages in humans were located between the distinct 
lamina of the intermuscular bundles of the ME in the jejunum (Kalff et al., 2003). In 
the current study, CD163+ve equine macrophages were present in four areas of the ME; 
the serosa, within the longitudinal (outer) muscle, at the level of the MP and within 
the circular (inner) muscle (Figure 3-11).  
Figure 3-10 Macrophages in gut- associated lymphoid tissues in the equine large 
intestine 
Staining for CD163 in the equine right ventral colon using 3, 3’-diaminobenzidine (DAB) as a 
chromogen with haematoxylin as a counterstain.  
(A) X2.5 magnification; Bar=1mm. Inset (B) X20 Bar=100µm. Images representative of 
samples taken from 5 horses. 




Figure 3-11 Macrophages in the equine muscularis externa 
Staining for CD163 in the equine duodenum using 3, 3’-diaminobenzidine (DAB) as a 
chromogen with haematoxylin as a counterstain. (A) shows a low power view X5 
magnifiaction of the muscularis externa (ME). CM, MP, LM and S represent high power view  
X 20 magnification of circular muscle (CM), myenteric plexus (MP), longitudinal muscle (LM) 
and serosa (S). 
(A) X5 magnification Bar=500µm. (CM, MP, LM, S) X20 magnification  Bar=100µm. Images 
representative of samples taken from 10 horses. 




Serosal macrophages in rodents are bipolar with several ramifications (Mikkelsen, 
2010). In the current study, equine serosal macrophages were relatively regular in 
their distribution. (Figure 3-12). As sections were examined in cross section only, 
most macrophages appeared bipolar (Figure 3-12) and it was not possible to visualise 
whether cells were ramified in this view, although occasional ramified cells were 
observed (Figure 3-13).  
Muscularis 
As previously reported in humans (Kalff et al., 2003), equine CD163+ve macrophages 
in this study were found within the muscularis, predominantly lying between 
intermuscular bundles (Figure 3-14) (Kalff et al., 2003). These cells were uniformly 
distributed and orientated with the muscle fibres (Figure 3-15). Most cells appeared 
bipolar or were identified by single areas of circular positive staining, attributable to 
the orientation of the cross sections (Figure 3-16).  
In order to look at the phenotype of muscularis macrophages in more detail, 
wholemounts of the ME were prepared and stained. In rodent wholemounts, 
macrophages can be seen regularly and uniformly distributed throughout the 
muscularis, with no overlap of processes (Phillips and Powley, 2012, Mikkelsen et al., 
2011). In equine tissue wholemounts in the current study, the MM were 
predominantly bipolar but only the occasional CD163+ve cell was observed within the 
whole mount preparations, similar to that observed in cross section (Figure 3-14). 
This apparent interspecies difference may be attributable to the relatively greater 
thickness of the equine ME and the associated difficulty in visualising the full network 
of cells within the one 5 µm section. In comparison, it is possible, using light 
microscopy, to examine the full thickness of the rodent muscularis as a whole mount.  
Myenteric plexus 
Between the two muscle layers (circular and longitudinal) lies the MP, which provides 
parasympathetic and sympathetic innervation of the GIT. In rodents, the close 
proximity of macrophages to the MP has been clearly documented (Mikkelsen, 2010, 
Phillips and Powley, 2012). The functional importance of this co-localisation has been 
demonstrated in mice. Macrophages regulate GI motility by altering smooth muscle 
contraction via the secretion of bone morphogenetic protein 2 (BMP2) which activates 
the BMP receptor on enteric neurons. In return, enteric neurons produce CSF-1 which 
is necessary for macrophage development (Muller et al., 2014).  
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In this study, equine CD163+ve macrophages were observed in close proximity to the 
MP (Figure 3-11). These cells were predominantly on the periphery of the MP, 
although some were also observed in the centre (Figure 3-17). Positive staining cells 
were bipolar and stellate-shaped in this region (Figure 3-18). The macrophage density 
(cells per mm2) was greater adjacent to the MP compared to observed within the ME 
(Figure 3-8) and similar to that in the mucosa and submucosa. This is consistent with 
the reported findings in rodents, whereby macrophages are found in close association 
to neurons and appear to make contact with their axons and dendrites (Phillips and 
Powley, 2012). As proposed in rodent studies, the reason for this close relationship 
may reflect either a functional role in motility (Muller et al., 2014) and/or a role in 





















Figure 3-12 Serosal macrophages in the equine gastrointestinal tract 
Staining for CD163 in the serosa of the equine duodenum (A), ileum (B) and caecum (C) 
using 3, 3’-diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain.  
Magnification X40 magnification; Bar=50µm. Images representative of samples taken from 
10 horses. 





Figure 3-13 Ramified macrophages in the serosa of equine left ventral colon 
Staining for CD163 in the serosa of equine left ventral colon using 3, 3’-diaminobenzidine 
(DAB) as a chromogen with haematoxylin as a counterstain. Black arrow shows macrophage 
with ramified morphology. 
Magnification X40 magnification. Bar=50µm. Image representative of samples taken from 5 
horses. 
 
Figure 3-14 Muscularis macrophages in the equine ileum 
Staining for CD163 in the muscularis (circular muscle) of the equine ileum colon using 3, 3’-
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. Macrophages 
were predominalty found between muscle bundles (black arrows) although occasional 
staining for CD163 was observed within a muscular bundle (red circle). 
Magnification X10. Bar=250µm. Image representative of small and large intestinal samples 
in 10 horses.  






Figure 3-15 Muscularis macrophages in equine duodenum 
Staining for CD163 in the muscularis (longitudinal layer) of the equine duodenum using 3, 3’-
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. Macrophages 
were observed between muscle bundles running longitudinally with the muscle (inset). 
Magnification X20. Bar=100µm. Inset X40. magnification. Bar=50µm Image representative 
of small and large intestinal samples in 10 horses.  






Figure 3-16 Morphology of intermuscular muscularis macrophages in equine ileum 
Staining for CD163 in the muscularis (circular muscle) of the equine ileum colon using 3, 3’-
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. Macrophages 
were predominalty bipolar (black arrows) although occasional cicular cell bodies were 
observed (red circle). 
Magnification X40. Bar=50µm. Image representative of small and large intestinal samples in 
10 horses.  
Figure 3-17 Macrophages associated with the myenteric plexus in the equine 
gastrointestinal tract 
Staining for CD163 in the myenteric plexus (MP) of the equine jejunum using 3, 3’-
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. Macrophages 
were observed both on the edge of the MP (black arrows) and within the MP (red arrows). 
Magnification X40. Bar=50µm. CM, cricular muscle. LM, longitudinal muscle. Image 
representative of small and large intestinal samples in 10 horses.  




Figure 3-18 Morphology of myenteric plexus macrophages in the equine 
gastrointestinal tract 
Staining for CD163 in the myenteric plexus of the equine jejunum using 3, 3’-
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. The 
morphology of myenteric plexus macrophages was either round (A) or ramified (B).  
Magnification X80. Bar=25µm. Image representative of small and large intestinal samples in 
10 horses.  




This chapter was designed to provide an overview of the distribution of macrophages 
in the equine GIT, with a focus on the resident MMs. As previously reported in 
rodents, macrophages were present in all sections of the equine GIT and occupied all 
layers of the intestine. Distribution of LpM and serosal macrophages was similar to 
that reported in other species. The MM distribution in the horse in this study 
resembled that of rats and humans; namely, cells were present within the muscle 
layers, between muscular bundles. The identification of macrophages within the 
longitudinal muscle of the ME was consistent with findings in humans and rats, yet 
inconsistent with findings in mice, in which macrophages have not been identified at 
this site (Mikkelsen et al., 1988). The similarity of the distribution of macrophages 
along the MP suggests that, as in other species, they may play a role in regulation of 
motility and clearance of apoptotic neurons.   
As macrophages are such heterogenous cells with tissue-specific, and indeed region-
specific roles within tissues, it is perhaps not unsurprising that they vary in number 
in relation to the anatomical region studied and the markers used for their 
identification. Such variation likely reflects a level of macrophage diversity which is 
dependent on their location, function and activation status (Gordon et al., 1995). 
Therefore, by using CD163 as a marker, this current study was limited to the 
quantification and distribution of a CD163+ve subgroup of macrophages in the equine 
GIT. CD163 is a pattern recognition receptor (PRR) belonging to the scavenger 
receptor cystine rich (SRCR) domain family and is restricted to cells of monocytic 
lineage (Hogger et al., 1998, Van den Heuvel et al., 1999) and has been used to identify 
subpopulations of tissue macrophages in humans (Van den Heuvel et al., 1999), pig 
(Sauter et al., 2016), rat (ED2) (Dijkstra et al., 1985) and horse (Yamate et al., 2000, 
Sano et al., 2016). In the colon of mice, once Ly6C+ve monocytes enter tissues, they 
undergo a differentiation process which involves the loss of Ly6C expression and 
upregulation of F4/80, CX3CR1, CD163, CD11c and MHCII expression. Similarly, in 
humans, the differentiation of CD14+ve monocytes into intestinal macrophages 
involves the down regulation of CD14 and upregulation if MHCII and CD163 (Bain et 
al., 2013). In humans the expression of CD163 on monocytes and macrophages is 
regulated by both pro- and anti-inflammatory signals. Pro-inflammatory mediators, 
such as LPS, TNF-α and IFN-,  suppress CD163 expression; whereas, anti-
inflammatory signals, such as IL-10, upregulate CD163 expression (Buechler et al., 
2000). The development of monocyte-derived macrophages in CSF-1 also results in 
the upregulation of CD163 mRNA and protein expression. Consistent with the 
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response of human monocyte-derived macrophages, LPS stimulation of equine bone 
marrow-derived macrophages (eqBMDMs) cultured in CSF-1 resulted in a reduced 
expression of CD163, as determined by RNA-Seq analysis of eqBMDMs performed in 
Chapter 4 (Table 3-3).  However, flow cytometric analysis of the same eqBMDMs 
cultures in CSF-1 revealed very low expression of CD163 (Chapter 4) which is similar 
to what has been previously reported in pig BMDMs (Kapetanovic et al., 2012). Equine 
monocytes also express CD163 (Ibrahim et al., 2007, Steinbach et al., 2005), as do 
equine alveolar and peritoneal macrophages (Karagianni et al., 2013) and prior 
studies have demonstrated the presence of CD163+ve macrophages in the equine GIT 
(Grosche et al., 2011, Yamate et al., 2000). The mechanisms underpinning the absence 
of cell surface expression in eqBMDMs may be similar to those in the pig, whereby 
monocytes mature to a more ‘resident’ phenotype in the circulation, and not the bone 
marrow. Unfortunately, the lack of availability of other macrophage markers in the 
horse precluded the adoption of an alternative and comparative method of 
macrophage identification. Such an approach may have shed light on the issue of 
whether CD163 expression was universal amongst, or limited to a specific sub-set of, 
equine GIT resident macrophages. Considering the lack of availability of appropriate 
antibodies in the horse, an alternative approach might have involved the use of in situ 
hybridisation (RNAscope) technology, whereby a labelled cDNA or RNA strand could 
be labelled with a probe to locate a macrophage-specific sequence within the tissue 
(Wang et al., 2012a). 
Table 3-3 Transcripts per million (TPM) of CD163 in equine bone marrow derived 
macrophages cultured in CSF-1 (Data from Chapter 4) 
 
Gene TPM 0 hours 
(resting) 
TPM 7 hours post LPS 
stimulation 
CD163 166.586 91.132 
In the horse, CD163+ve cell density varied across the tissue layers of the GIT (Figure 
3-4). The muscularis had the lowest cell density. Cell density in the ME was consistent 
along the full length of the GIT. In comparison, the density of ME MHCII+ve and 
CD169+ve cells increased aborally in the mouse small intestine and was lower in the 
colon (Mikkelsen et al., 2011). Referring to the same study, it would appear that the 
cell densities in the mouse ME were greater than those in the horse; approximately 
200 MHCII+ve and CD169+ve cells/mm2 in the mouse, compared to < 100 CD163+ve 
cells/mm2 in the horse. Despite these apparent differences, it is hard to draw any 
conclusions as the different markers used in the respective studies may have targeted 
different subpopulations of macrophages. In contrast, Grosche et al. (2011) 
investigated CD163+ve populations in equine intestinal mucosal tissue, permitting 
more appropriate comparisons with the current study. Despite this, Grosche et al. 
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(2011) also reported a greater cell density (approx. 300 mucosal CD163+ve cells/mm2) 
than the current study (150-250 mucosal CD163+ve cells/mm2); the reasons for these 
differences are unclear although Groshe et al. used a different CD163 clone (AM-3k). 
Grosche reported that ischemia reperfusion injury failed to alter the number of 
CD163+ve cells, despite the apparent activation of the cells, based on their appearance 
characterised by large cytoplasmic vacuoles which contained cell debris and 
apoptotic bodies (Grosche et al., 2011).  
A limitation of this current equine study was the use of formalin-fixed tissues. The 
use of formalin to preserve tissues permitted the prompt collection of large numbers 
of samples following euthanasia. However, formalin can cause bond formation and 
conformational changes in the target antigens, compromising their recognition by 
antibodies. In addition, prolonged fixation can result in false negative results (Ramos-
Vara, 2005). Whilst antigen retrieval methods can reverse the formation of bonds, 
they can also cause further alterations to the target antigen. Therefore, in light of the 
fixation and antigen retrieval processes employed in the current study, it is possible 
that the reported CD163+ve cell densities may have underestimated the actual CD163+ve 
cell densities. Again, the use of RNAscope technology may have been beneficial 
whereby a specifically designed probe could have been used to locate a DNA or RNA 
section of the gene of interest within the tissue (Wang et al., 2012a), thus overcoming 
some of the issues associated with antibody recognition of altered protein targets. 
However, it was felt that despite these limitations, useful and novel information 
regarding the distribution and density of equine GIT macrophages was elicited.  
In conclusion, CD163+ve macrophages were identified and quantified within the equine 
GIT, and their morphology was analysed. Their distribution was found to be similar 
to that reported in rodents and humans and their close association with motility 
effector cells in the MP supports the proposed role of intestinal macrophages in the 
regulation of intestinal motility. Confirmation of the presence of macrophages in the 
mucosa and ME in the equine GIT was a necessary pre-requisite to subsequent studies 
reported in the thesis; most notably, the investigation of macrophage activation in 
the GIT of horses undergoing abdominal surgery (Chapter 5). 
  



















  Isolation and generation of Equine 
Bone Marrow-Derived Macrophages and their 
response to Lipopolysaccharide  
 




The initial aim of this chapter was to develop a protocol to isolate lamina propria 
macrophages (LpM) and muscularis macrophages (MM) from the horse 
gastrointestinal tract (GIT) and to compare the two populations. Protocols were 
adapted from Kalff et al., for MM (Kalff et al., 1998a) and Weigmann et al., for LpM 
(Weigmann et al., 2007). The isolation of viable MM from the intestine of horses 
proved unachievable due to problems with contamination, low cell yields and the 
relatively small number of horses from which it was possible to collect tissue to 
optimise the two techniques. As an alternative, in order to examine the gene 
expression profile of a relevant macrophage population, a protocol was developed to 
produce macrophages from bone marrow (BM) using macrophage colony-stimulating 
factor 1 (CSF-1) to differentiate isolated BM progenitor cells in culture. As discussed 
in Chapter 1, CSF-1 is essential for the proliferation, differentiation and survival of 
macrophages via signalling through a class III protein kinase receptor (CSF1R or 
CD115) which is expressed on all myeloid cells.  Based upon evidence supporting 
both a relatively rapid turnover of GI tract macrophages and their CSF-1-dependency 
(MacDonald et al., 2010, Bain et al., 2014), Baillie et al. argued that cultivation of 
human monocyte-derived macrophages (MDM) in CSF-1 is a de facto model for the 
differentiation of GI macrophages (Baillie et al., 2017). LpM are replenished by 
circulating monocytes (Bain et al., 2014) and are a comparatively ‘inert’ population, 
being relatively unresponsive to microbial, including LPS, challenge (Mowat and Bain, 
2011). Using data from the Functional Annotation of the Mammalian Genome 
(FANTOM) 5, Baillie et al. demonstrated that MDM grown in CSF-1, (conditions which 
replicate those of intestinal mucosal macrophages) down-regulated the normally high 
expression of pattern recognition molecules in monocytes and also suppressed CD14 
and the associated receptor molecules.  Although they still responded to bacterial 
LPS, in contrast to blood monocytes, they expressed low levels of pro-inflammatory 
cytokines such as IL-1, and high levels of anti-inflammatory IL-10.  
Previous studies from our group, involving the isolation of BM from other large 
animal species (pig and sheep) with subsequent culture in the presence of 
recombinant human CSF-1 (rhCSF-1), yielded large numbers of phagocytic cells that 
expressed macrophage markers (CD14, CD16) and produced tumour necrosis factor 
(TNF-α) in response to lipopolysaccharide (LPS) (pig) (Kapetanovic et al., 2012, Pridans 
et al., 2016).  In the horse, the generation of macrophages from BM has been described 
previously (Werners et al., 2004). However, these cells were cultured in granulocyte 
macrophage colony-stimulating factor (GM-CSF or CSF-2) which, in humans and mice, 
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generates macrophages with a distinct gene expression profile (Achuthan et al., 2016, 
Louis et al., 2015, Joshi et al., 2015).  Macrophages grown in GM-CSF have been 
referred to as dendritic cells, but may be more akin to lung macrophages, which 
depend upon GM-CSF for their development (Guilliams et al., 2013). In addition, these 
cells were maintained as an equine macrophage cell line (e-CAS). Potential problems 
associated with cell lines include contamination by other cells or microorganisms 
(Lorsch et al., 2014) which can result in molecular and cellular changes in the cell line 
(Oh et al., 2007). These problems have very recently been highlighted by Evans et al. 
who sequenced the eCAS cell line and found the cells to resemble mouse 
macrophages and not horse macrophages (Evans et al., 2018). 
This chapter describes the protocol used for the isolation of equine bone marrow 
derived macrophages (eqBMDMs) and how the cells were characterised (see Figure 
4-1 for overview). Following this, the response of eqBMDMs to LPS was investigated. 
In rodents, the translocation of endogenous LPS from the lumen to the muscularis, is 
proposed to activate muscularis macrophages in a model of post-operative ileus 
(Turler et al., 2007, Eskandari et al., 1997). By extension, gene expression data derived 
from the challenge of eqBMDMs with LPS might facilitate future efforts to identify 
appropriate markers of macrophage activation in equine intestinal tissue harvested 
from horses undergoing colic surgery. Other members of our laboratory have 
conducted parallel studies to optimise BMDM production from sheep, pig, goat, water 
buffalo and cattle and therefore a secondary objective of the study was to compare 
the macrophage gene expression profiles of the different species.   





4.2.1 Cell yield from ribs of adult horses  
Cell yield from two ribs varied from 5 x108 to 1 x 109 cells per adult horse (2.5 x 108 
to 5 x 108 per rib).  Following cryopreservation in medium containing 10% DMSO in 
horse serum (Sigma-Aldrich) at -155oC the percentage of viable cells on recovery (from 
1 month – to 12 months following cryopreservation), as evaluated by Trypan Blue 
staining, was between 60-80%.   
4.2.2 Optimisation of culture conditions 
Optimum culture conditions for eqBMDMs were assessed by performing a cell 
viability assay (MTT assay).  The MTT assay is a quantitative colorimetric assay used 
for measuring cell survival and proliferation using the dye 3-(4,5-dimethylthiazol-
2yl)-2,5-diphenyltetrazolium bromide (MTT) (Mosmann, 1983). NAD(P)H-dependent 
reductase enzymes in the mitochondria convert soluble tetrazolium into insoluble 
purple formazan crystals. Signal generated is dependent on viability of cells.  The 
formazan product is solubilised, and absorbance (570 nm) of the coloured solution 
is measured and quantified using a spectrophotometer. Conditions tested are 
summarised in Table 4-1. 
 
Figure 4-1 Workflow for isolation and characterisation of eqBMDMs 
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Table 4-1 Culture conditions tested for differentiation of eqBMDMs 
 
Condition Variables    
Serum 10% horse  20% horse 10% fetal calf 20% fetal calf 
rhCSF-1 concentration (U/ml) No rhCSF1 104   
Seeding density (cells) 5 x 104 1 x 105 2 x 105 4 x 105 
Addition of rhCSF-1 in culture accentuates development of macrophages 
Cells cultured at 4 x 105 cells/well in the presence of rhCSF-1 for up to 14 days showed 
greater metabolic activity, as measured by MTT assay than cells cultured without 
rhCSF-1. (Figure 4-2). In all wells, the presence of rhCSF-1 resulted in greater 
metabolic activity. The presence of rhCSF-1 in culture media resulted in a significant 
increase in cell metabolic activity, as measured by absorbance (apart from in 10% FCS) 
(Two-way ANOVA analysis. 20% HS p=0.001; 10% HS p=0.03; 20% FCS p=0.13 (not 
significant (ns)); 10%FCS p=0.03).  
Analysis by light microscopy (Figure 4-3) showed that cells cultured in rhCSF-1 and 
20% HS resembled macrophages and, compared with the other conditions, were the 
most confluent and had low numbers of dead cells. Although culture in 20% FCS 
generated large numbers of cells, this condition did not appear to generate 
macrophages; cells were small and round. In the absence of added rhCSF-1 no visible 
macrophage population was observed by day 14.  
 




Figure 4-2  Effect of the addition of rhCSF-1 on eqBMDMs in culture in various media 
eqBMDMs (n=3) were cultured in either 10% or 20% horse serum (HS) (A and C) or 10% or 
20% fetal calf serum (FCS) (B and D) at 2.5 x106 cells/ml for up to 14 days with or without 
rhCSF-1 (+/- rhCSF-1). E is combined data of both HS and FCS. An MTT assay was 
performed on Days 7, 10 and 14 to assess cell metabolic activity. Results are average of 
triplicates. Values are median with 95% CI. Significance between +rhCSF-1 and -rhCSF-1 
was performed using a paired t-test. *p<0.05, **p<0.001 




EqBMDMs differentiation is enhanced in horse serum compared to fetal 
calf serum 
The addition of serum to cell culture media is a critical component providing sources 
of nutrients, growth factors, hormones and proteins. Serum is usually obtained from 
either an autologous (e.g. HS for equine studies (Werners et al., 2004, Karagianni et 
al., 2013, Karagianni et al., 2017)) or a heterologous source (e.g. FCS for equine studies 
(Okano et al., 2006)) and is usually heat-inactivated (HI) to inactivate serum 
complement. Two components of serum are particularly relevant to this work, namely 
CSF-1 and lipopolysaccharide binding protein (LBP). CSF-1 is present in adult serum 
but not in FCS. LBP transfers LPS to CD14 on macrophages and monocytes, triggering 
the formation of the TLR4-MD2 complex. This in turn activates the NF-κB pathway 
Figure 4-3 Light microscopy images of eqBMDMs in different culture conditions 
Cells were imaged on Day 14 by light microscopy to assess morphology in various 
conditions. Cells in 20% horse serum (HS) and rhCSF-1 at the highest density (4 x 105/well) 
(A) were stellate and had good adherence with little evidence of cell death. Cells in 20% HS 
and rhCSF-1 at a lower density (2 x 105/well) (B) still adhered and showed the expected 
stellate morphology; however, there was increased cell death and clumping of cells visible. 
In addition, some cells were becoming excessively elongated (black arrows). Cells in 20% 
fetal calf serum (FCS) and rhCSF-1 (C) although mostly viable, did not differentiate into 
macrophages and were smaller and more circular. The absence of rhCSF-1 in 20% HS 
resulted in no visible macrophages (D). Bar = 50µm 
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resulting in cytokine production (e.g. IL-6, IL-8) (Miyake, 2004, Steinemann et al., 
1994). 
In equine monocytes, responses to LPS vary depending on the serum type used in 
culture. Figueiredo et al. (Figueiredo et al., 2008) compared HI FCS, commercial HS, 
HI commercial HS, autologous HS and HI autologous HS by measuring procoagulant 
activity of cultured monocytes.  They concluded that FCS is not an optimal source of 
LBP for equine monocytes stimulated with LPS and that FCS resulted in the activation 
of equine monocytes. Commercial and autologous HS did not directly activate 
monocytes and gave more consistent results when compared to FCS  
In this study, cells in HS and FCS did not show significant differences in the MTT 
assay (Figure 4-4) but did show significant morphological differences when viewed 
using light microscopy (Figure 4-3). Those cultured in HS in the presence of rhCSF-1 
differentiated into macrophages, whereas cell populations in FCS did not differentiate 
and remained small, circular and not very adherent. In contrast, previous work on 
equine alveolar macrophages by our group found that there were no visible 
morphological differences between cells cultured in HS and FCS. Alveolar 
macrophages cultured in HS produced significantly higher levels of TNF-α following 
stimulation with LPS (Karagianni, 2015). Cells cultured in 20% HS had greater survival 
and viability compared to cells cultured in 10% HS (Figure 4-5). 
 
Figure 4-4 Comparison of cell survival and proliferation in culture media containing 
either 20% fetal calf (FCS) or 20% horse serum (HS) 
eqBMDMs (n=3) were cultured in either 20% FCS or HS at 2.5 x106 cells/ml for up to 14 
days with or without rhCSF-1(+/- rhCSF-1). An MTT assay was performed on Days 7, 10 
and 14 to assess cell metabolic activity. Results are average of triplicates. Values are 
median with 95% CI.  




EqBMDMs differentiate better at higher seeding densities 
Cells were examined by light microscopy and cells at 4 x 105/well (2.5 x 106/ml) were 
the most confluent and looked the healthiest. At decreasing densities, as cells were 
sparser, there was increased cell death and areas of clumping (Figure 4-3).  
For all further analyses on eqBMDMs, cells were cultured in media containing 
20% HS with rhCSF-1 (104 U/ml) at an approximate cell density of 2.5 x 106 
cells/ml for up to 14 days. 
4.2.3 Differentiated cells resemble macrophages  
After culture on bacteriological plastic in rhCSF-1 for 10 days, cells had the expected 
morphology of macrophages; they were stellate and had an increased granularity and 
were adherent to bacteriological plastic (Figure 4-6). 
A key function of macrophages is phagocytosis. Phagocytic activity was evaluated 
using two methods: (a) Zymosan A Saccharomyces cerevisiae BioParticle assay 
followed by cell fixation, staining with DAPI and phalloidin and confocal microscopy 
(Figure 4-7); (b) pHrodo Red Escherichia coli BioParticle assay followed by flow 
cytometric analysis (Figure 4-8). Phagocytic activity was seen in 80% of eqBMDMs 
(median 80%; range 77-84%).  
Figure 4-5 Comparison of cell survival and proliferation in culture media containing 
either 10% or 20% horse serum 
eqBMDMs (n=3) were cultured in either 10% or 20% horse serum (HS) at 2.5 x106 cells/ml 
for up to 14 days with or without rhCSF-1(+/- rhCSF-1). An MTT assay was performed on 
Days 7, 10 and 14 to assess cell metabolic activity. Results are average of triplicates. Values 
are median with 95% CI.  






Figure 4-6 Analysis of cell morphology by light and confocal microscopy.  
After culture of cryopreserved eqBMDMs in rhCSF-1 for 10 days the supernatant was 
removed, and cells were examined using light microscopy (A). For confocal microscopy, 
adhered cells were carefully removed from bacteriological plastic culture dishes and 
transferred to glass coverslips and cultured for a further 24hrs in rhCSF1, until cells had 
adhered to the coverslip. Cells were then fixed and stained with DAPI and Phalloidin before 
being transferred onto microscope slides and examined using a confocal microscope (B). 
Cell populations showed the expected granular stellate morphology of macrophages and 
were adherent to bacteriological plastic. Image representative of 3 horses. 
Figure 4-7 Zymosan phagocytosis assay. 
Cells from 3 horses were cultured on bacteriological plastic for 10 days in rhCSF-1. On Day 
10 media was replaced with media containing Zymosan particles and cells were incubated 
with the Zymosan particles for 1 hour at 370C. Control cells had Zymosan particles added but 
were kept at 4oC. More than 70% of cells had phagocytosed Zymosan bioparticles (A).  (B) is 
a confocal image of macrophages with phagocytosed Zymosan particles. Bar = 20µm 





There are a limited number of antibodies against cell surface markers available for 
the horse. CD14, a co-receptor of the LPS receptor TLR4, is used as a marker for 
monocyte identification in several species, (Chamorro et al., 2005, Pridans et al., 2016, 
Wong et al., 2011b) including the horse (Kabithe et al., 2010). CD163, the haemoglobin 
scavenger receptor used as a marker in the previous chapter, is highly expressed in 
tissue macrophages in several species, such as pigs, humans and rodents (Van Gorp 
et al., 2010). It has been detected in some populations of human monocytes (Buechler 
et al., 2000).  In pigs, CD163 is regulated inversely with CD14, defining 
subpopulations of monocytes (Fairbairn et al., 2011). Equine monocytes also express 
CD163 (Ibrahim et al., 2007) as do equine alveolar macrophages (Karagianni et al., 
Figure 4-8 pHrodo BioParticle phagocytosis assay. 
Cells from 6 horses were cultured with rhCSF-1 on bacteriological plastic for 7 days. On day 
10 adhered cells were gently removed and cells combined before adding pHrodo Red 
Escherichia coli BioParticle for 1 hour at 370C before being analysed by flow cytometry. 
Control cells were kept at 40C for 1hr. See Figure 4-9 for gating strategy.  
Figure 4-9 Gating strategy for eqBMDMs 
Differentiated eqBMDMs were analysed for the expression of CD15 and CD163 by flow 
cytometry (Figure 4-10). SSC-Area (SSC-A) versus FSC-Height (FSC-H) was used to 
choose largest and most granular cells and excluding debris (A). Sytox blue was used to 
exclude dead cells (B). (C) identifies single cells and excludes doublets. Results are 
representative of at least 5 different experiments.  
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2013) although equine peritoneal macrophages lack this marker (Karagianni et al., 
2013). 
To test if eqBMDMs expressed the markers CD14 and CD163, adherent differentiated 
cells were detached and stained for flow cytometry. Forward scatter (FCS) and side 
scatter (SSC) were used to identify macrophages based on their size (FCS) and 
granularity (SSC). Dead cells were excluded, and analysis was performed on single 
cells as described in Figure 4-9. The majority (84.2%) of differentiated eqBMDMs 
expressed CD14 (Figure 4-10), as has been previously reported on the eCAS cell line 
(Werners et al., 2004). By contrast, CD163 was very weakly expressed in eqBMDMs, as 
previously reported in pig BMDMs (Kapetanovic et al., 2012).  
4.2.4 LPS stimulation of eqBMDMs 
Lipopolysaccharide (LPS), a structural component of all gram-negative bacterial cell 
walls, is a pathogen associated molecular pattern (PAMP). TLR4 is the pattern 
recognition receptor (PRR) for the lipid A component of LPS, and myeloid cells or 
mice lacking Tlr4 do not respond to pure LPS (Deng et al., 2013, Hoshino et al., 1999). 
Humans and horses are sensitive to the actions of LPS, with high mortality and 
morbidity in both species. In comparison, mice are less sensitive to LPS than humans 
and horses (Brade, 1999, Dinges and Schlievert, 2001); therefore, the use of rodent 
models to study sepsis in the horse or human is not optimal and indeed, may not be 
appropriate (Fink, 2014). A ‘humanised’ mouse model was considered to be more 
suitable for studying human sepsis (Warren, 2009, Unsinger et al., 2009) although 
given potential similarities in the LPS response of horses and humans (Parkinson et 
al., 2017, Karagianni et al., 2017) it may be more appropriate to use the horse as a 
model for human sepsis. 
Gene expression changes in response to LPS have previously been studied in equine 
peripheral blood mononuclear cells (PBMCs) (Parkinson et al., 2017, Pacholewska et 
al., 2017) and alveolar macrophages (Karagianni et al., 2017). To examine the specific 
macrophage response of eqBMDMs to LPS, adhered differentiated cells were 
harvested and plated at a concentration of 106 cells/ml and left overnight before 
being stimulated with LPS for 7 and 24 hours. The LPS used was Salmonella enterica 
Serotype Minnesota Re595; a rough mutant which is a pure TLR4 agonist, involving 
only the TLR4-MD2-CD14 complex, and no other TLRs (Hume et al., 2001). RNA was 
extracted from control (n=3) and LPS treated (n=3) cells and samples were used for 
qRT-PCR and total RNA-Sequencing (RNA-Seq).  
 




Validating the LPS response with qRT-PCR 
Macrophages stimulated with LPS produce the pro-inflammatory cytokine TNF-α in 
response to LPS binding to the CD14-TLR4-MD2 receptor complex (Palsson-
McDermott and O'Neill, 2004). TNF-α is an early response gene, and in other species, 
it peaks around 2 hours but is still elevated after 7 hours (Karagianni et al., 2013, 
Karagianni et al., 2017, Kapetanovic et al., 2012). Here it was used as a positive 
indicator of eqBMDM LPS-responsiveness. GAPDH was used as a reference gene.  
EqBMDMs showed around 25-fold upregulation of TNF-α mRNA after 7 hours in 
response to LPS (Figure 4-11).  
Figure 4-10 Flow cytometry of equine alveolar macrophages and eqBMDMs 
EqBMDMS were cultured for 7 – 10 days in rhCSF-1 (n=6). When confluent, adhered cells 
were stained for flow cytometry. Alveolar macrophages were thawed and cultured overnight 
in rhCSF-1 and adherent cells harvested for flow cytometry. Size (forward light scatter (FSC)) 
and granularity (side scatter (SSC)) were used for cell discrimination (data not shown. See  
Figure 4-9 for gating strategy). Equine alveolar macrophages were used as a positive control 
(A). eqBMDMs expressed CD14 (B) but only a small population of eqBMDMs (12%) 
expressed CD163 (C).  
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LPS induced IDO but not NOS2 expression in eqBMDMs 
Nitric oxide (NO) is a product of inducible nitric oxide synthase (NOS2) and is 
synthesized from arginine. It is an important component of the innate immune 
response of rodent macrophages to various pathogens (MacMicking et al., 1997). As 
discussed in Chapter 1, differences exist between species in the activation of arginine 
metabolism and release of NO.  Mouse macrophages produce NO (Stuehr and 
Marletta, 1985) but human and porcine macrophages do not (Kapetanovic et al., 
2012). There are conflicting data relating to equine macrophages; some studies report 
NO production from equine alveolar macrophages (Hammond et al., 1999) and the 
macrophage cell line, e-CAS, (Werners et al., 2004) and NOS2 induction in response 
to LPS.  However, these studies did not directly compare the magnitude of release 
with that of rodent-derived macrophages.  In contrast, Karagianni et al., (Karagianni 
et al., 2013). using murine-derived cells as a comparison, found no evidence of NOS2 
induction or NO production by LPS stimulated equine alveolar macrophages  Murine 
macrophages take up arginine via the cationic arginine transporter (CAT) 2, encoded 
by the  Cat2/Slc7a2 gene (Kakuda et al., 1999) and metabolise arginine to produce 
NO, via the induction of Nos2 (MacMicking et al., 1997). Neither human macrophages 
(Schroder et al., 2012) nor activated pig macrophages (Kapetanovic et al., 2012) 
express CAT2/SLC7A2. Instead, pig, human and equine alveolar macrophages 
metabolise tryptophan through the induction of indoleamine dioxygenase (IDO) 
(Karagianni et al., 2013, Kapetanovic et al., 2012, Schneemann et al., 1993).  This 
species-specific regulation was attributed to divergence of the NOS2 promoter 
sequences between species, with good conservation between human, pig and horse 
promoters, but little sequence alignment with mouse promoters   (Kapetanovic et al., 
2012, Karagianni et al., 2013).  
To address this question in eqBMDMs, the production of nitrite by differentiated 
eqBMDMs was measured following LPS stimulation for 7 and 24 hours. Chicken 
BMDMs, which produce large amounts of NO in response to LPS, were used as a 
positive control (Wu et al., 2016). There was no detectable nitrite production in 
eqBMDMs (Figure 4-12). In addition, no increase in NOS2 expression was detected by 
qRT-PCR following LPS stimulation. In comparison, and consistent with the findings 
derived from pig BMDMs and human MDMs (Kapetanovic et al., 2012), IDO1 mRNA 
was induced >100-fold at 7 hours (Figure 4-11).  





Figure 4-11 Relative quantification (RQ) of TNF-α, IDO and NOS2 in eqBMDMs after 
being in culture with LPS for 7hrs 
Cryopreserved eqBMDMs from 3 horses were cultured until confluent and adherent (Day 10). 
Cells were plated at 2 x 106 cells/well and left to rest overnight, in optimal conditions 
described in   Section 4.2.2. The media was replaced and LPS (100ng/ml) added for 7 hours. 
Control samples had culture media changed only. RNA was extracted and RQ relative to the 
housekeeping gene GAPDH for TNF-α, IDO and NOS2 was measured by qPCR. Graphs 
show median + 95 CI. Significance was determined using a paired t-test. *p<0.05, **p<0.001. 
Figure 4-12 Nitrite production of eqBMDMs following stimulation with LPS (100ng/ml) 
at 7 and 24 hours 
Cryopreserved eqBMDMs from horse (n=6) and chicken (n=1) were cultured until confluent 
and adherent (Day 10). Cells were plated in duplicate at 2 x 106 cells/well and left to rest 
overnight, in optimal conditions described in Section 4.2.2. The media was replaced and 
LPS (100ng/ml) added for 7 hours. Control samples had culture media changed only. Nitrite 
(µm/mL) was measured in supernatant. Results shown are median ± 95% CI.  
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4.2.5 RNA-seq analysis of eqBMDMs and their response to 
LPS 
Both earlier studies of LPS stimulated equine PBMCs used E. coli-derived LPS and 
analysis was performed at 24 hours. In this study, Salmonella-derived LPS was used 
and analysis performed at 7 hours. As mentioned earlier (Section 4.2.4), our group 
routinely uses Salmonella enterica Serotype Minnesota Re595, a pure TLR4 agonist 
(Hume et al., 2001) and its use in this study permitted direct comparisons with data 
derived from other species within our group.  
Having determined that the eqBMDMs treated for 7 hours with LPS responded with 
large alterations in expression of positive control genes, TNF-α and IDO1, the same 
mRNA was subjected to RNA-Seq analysis to provide a global overview of the LPS 
response. Parallel studies on the same cellular system (CSF1-stimulated BMDM) in 
other species (sheep, goat, pig, cattle, water buffalo and rat) provided the opportunity 
for comparative analysis to identify possible equine-specific responses that could 
contribute to extreme LPS sensitivity. As discussed in (Chapter 1), RNA-Seq has the 
advantage, compared to microarrays, of permitting the investigation of known and 
new transcripts; microarrays are limited to existing genomic information. By 
improving our understanding of the transcriptome, we can improve the functional 
annotation of the equine (Equus caballus) genome (EquCab2.0.). The horse genome is 
currently a relatively poor assembly. Comparing it to the pig (Sus scrofa) genome, 
Sscrofa11, coverage of the horse is 6.0x compared to 65x in the pig (Chapter 1). 
Contig N50 is also 400x greater in pig compared to horse in part through the use of 
newer long read technologies such as PacBio (www.pacb.com) in the assembly of the 
pig genome compared to the shorter read technologies used to assemble the horse 
genome. There are two studies in horses using RNA-seq to study the response of 
peripheral blood mononuclear cells (PBMCs) to LPS (Pacholewska et al., 2017, 
Parkinson et al., 2017). Several equine studies have used human and mouse 
microarrays (Barrey et al., 2006, Mucher et al., 2006, Smith et al., 2006, Ramery et al., 
2008), as well as equine microarrays (Gu and Bertone, 2004, Santangelo et al., 2007, 
Noschka et al., 2009, Mienaltowski et al., 2008). Studies using equine microarrays 
were limited by the poor annotation of the arrays, but whilst some probes on mouse 
and human arrays would fail to hybridise, the overall annotation when using these 
arrays was superior to the equine microarrays. To date, there are no RNA-Seq studies 
looking at the specific response of eqBMDMs to LPS in the horse although Werners et 
al. measured TNF-α and NO production in e-CAS cells (Werners et al., 2004).  
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Analysis of differential expression in eqBMDMs stimulated with LPS 
Transcripts were quantified, giving expression estimates as transcripts per million 
(TPM) using Kallisto (Bray et al., 2016) and annotated to the Equus caballus reference 
genome (via Ensembl BioMart v90) (Kinsella et al., 2011).  By this method, 21,906 
transcripts were found in total. Of these transcripts, 18% (3886) were identified as 
pseudogenes, 82% (18018) were protein coding and 0.8% (184) were identified as 
potential novel genes (Table 4-2). A PCA plot (Figure 4-13) showed separation of 
samples depending on condition (LPS stimulated vs unstimulated).  






Protein coding genes 18018 
Pseudogenes 3886 
Unknown 2 
Novel transcripts 184 
Total Transcripts 21906 
Network cluster analysis was performed using Miru (Kajeka Ltd, Edinburgh, UK) to 
analyse gene expression in LPS-stimulated eqBMDMs (Freeman et al., 2007, 
Theocharidis et al., 2009). Using a Pearson correlation threshold (r) of 0.97, a markov 
clustering algorithm (MCL) inflation value of 2.2 and a minimum cluster size of 8, a 
network graph was generated that consisted of 11446 nodes connected with 547614 
edges within a total of 295 clusters (Figure 4-14-A). Using the animation feature in 
Miru where closely correlated genes are highlighted, a series of cluster graphs was 
generated that distinguished two groups of clusters; one group at 0 hours and one 
group at 7 hours (Figure 4-14-B). Whilst 2 horses had similar graphs, H11 appeared 
to have a distinct group of co-expressed genes at 7 hours.  
Read counts were calculated using Kallisto and summarised to genes using the 
R/Bioconductor package tximport v1.0.3. This output was used in the R/Bioconductor 
package, edgeR v3.14.0  (Robinson et al., 2010), to normalise gene counts and to 
identify genes differentially expressed between control and LPS-treated eqBMDMs 
(Benjamini and Hochberg, 1995). From this list, using Log2 fold change (log2 fc) 
values of ≥ 1.5 or ≤ 1.5 with p < 0.02 a list of upregulated and down regulated genes 
was generated. Only genes with a minimum read count value of 10 at 7 hours for 
upregulated genes and a minimum read count of 10 at 0 hours for down regulated 
genes were included in the analysis. In total, 1070 genes were either induced (733) or 
repressed (237) by LPS in eqBMDMs. Using this list, the top 100 most differentially 
expressed genes were identified (Figure 4-15 and Figure 4-16). To compare functional 
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differences between the groups, gene function analysis was performed using the Gene 
Ontology (GO) tool in GATHER (Gene Annotation Tool to Help Explain Relationships) 
(Chang and Nevins, 2006). A total of 182 genes upregulated, and 38 genes 
downregulated, by LPS in eqBMDMs were not annotated to the horse genome 
(displayed as Ensembl IDs in Figure 4-15 and Figure 4-16) and did not have any 
orthologues available in Ensembl. Further analysis of the differential expression 
would include the identification of these potentially novel genes to further our 
understanding of the equine specific response to LPS 
 
Figure 4-13 Principal component analysis (PCA) of LPS treated eqBMDMs and 
untreated eqBMDMs plotted in two dimensions 
This is a PCA of LPS stimulated (blue) and control (red) eqBMDMs showing a distinct 
separation between LPS treated and control eqBMDMs. The proportions in each axis 
represent the percentage variance by each component. The ellipses indicate 95% confidence 
intervals. 




Figure 4-14 Network analysis of differentially expressed transcripts between 
eqBMDMs stimulated with LPS and control (unstimulated) eqBMDMs 
A network analysis graph of all samples (0 and 7 hours) generated in Miru for eqBMDMs (n=3) 
stimulated with 100ng/ml LPS for 7 hours and for control cells from the same animal (A). 
Transcript to transcript Pearson correlation was set at r>0.99. The graph contains 11446 
nodes (node = transcript) connected by 547614 edges (Pearson correlation relationships). 
The graph was clustered using MCL algorithm set at an inflation of 2.2 giving 295 clusters. 
Nodes with clusters of co-expressed transcripts will be closely connected. Using the animation 
feature, (B) shows nodes that are co-expressed together (expanded red nodes) at 0 and 7 
hours for each horse (H8, H9 & H11).   




Figure 4-15 Top 100 genes in eqBMDMs induced by LPS 
RNA-Seq data of genes induced by LPS in eqBMDMs as identified by Log2 fc and p<0.02. 
Genes with Ensembl IDs are genes not annotated to the horse genome and with no 
orthologues.  




Figure 4-16 Top 100 genes supressed by LPS in eqBMDMs 
RNA-Seq data of genes suppressed by LPS in eqBMDMs as identified by Log2 fc and 
p<0.02. Genes with Ensembl IDs are genes not annotated to the horse genome and with no 
identifiable orthologues.  




The top 100 (Figure 4-15) upregulated genes included genes associated with the 
initiation and maintenance of inflammation and with LPS stimulation of macrophages 
(Il1B, IL6, TNF-α, CXCL8). GO term analyses using GATHER showed genes associated 
with cell communication and signal transduction (e.g. SOCS1, SOCS3, MAP2K6, STAT1 
STAT2 STAT3 and STAT4), response to stimulus (e.g. CXCL2, CXCL3, CXCL6, IL10, 
IL12B and TNF-α) and immune response as the main groups of genes upregulated, 
consistent with LPS stimulation of macrophages (Figure 4-17-A). Genes associated 
with apoptosis (BCL2, CFLAR, APAF1, CASP3, CASP7, CASP10, NFKB1A, TNF-α, BIRC3, 
HSPA6, TNFSF10) were also a component of the second main functional pathway 
identified based upon GO term enrichment. Apoptosis is a feature of septic shock 
and is reported in models of sepsis (Joshi et al., 2003) and in LPS-induced apoptosis 
in murine BMDMs (Xaus et al., 2000). An increase in expression of genes involved in 
apoptosis has been previously detected in equine alveolar macrophages stimulated 
with LPS (Karagianni et al., 2017). In this dataset, genes associated with cell apoptosis 
were also LPS inducible (e.g. PDCD1LG1/CD274, PDCD1LG2, BCL2, CFLAR and APAF1) 
as were transcription factors (e.g. STAT4 and BATF3) (Table 4-3). 
Table 4-3 TPM values for LPS inducible genes and transcription factors associated 







PDCD1LG1/CD274 26.217 236.204 
PDCD1LG2 4.887 30.256 
BCL2 4.718 13.469 
CFLAR 81.318 410.644 
APAF1 25.176 77.053 
STAT4 6.551 106.317 
BATF3 13.806 153.497 
 
Downregulated genes (Figure 4-16) include DOK2 a negative regulator of 
macrophages stimulated with LPS (Shinohara et al., 2005). The largest biological 
processes involved are cell communication/signal transduction e.g. DOK2, TLR1 and 
CCR2 and cell cycle genes e.g. FBX043, ID3, RAPGEF4 and MYC (Figure 4-17-B). This 
supports the literature in which it is well documented that LPS inhibits genes 
associated with proliferation as LPS blocks the action of CSF-1 (Sester et al., 2005, 
Sweet et al., 2002). Murine BMDMs differentiated in CSF-1 have an elevated response 
 






Figure 4-17 Main functional groups of induced and repressed genes of eqBMDMs 
stimulated with LPS 
Histograms show main GO terms either induced (A) or suppressed (B) by LPS in eqBMDMs. 
Data was analysed using the GO term analysis tool in GATHER. All genes with Log2 fc of 
≥1.5 or ≤ -1.5 with p<0.02 were included. Results are for all GO terms with p<0.05 and Bayes 
Factor >6 (Chang and Nevins, 2006).  
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to LPS, a likely result of its activity as a macrophage growth factor but LPS down-
regulates expression of Csf-1r in BMDMs (Sweet et al., 2002, Sester et al., 1999). The 
implication of this is that macrophages at the site of infection have potentially been 
in contact with LPS and are therefore unlikely to be CSF-1 responsive, but they may 
be hypersensitive to the effects of bacterial DNA (Sweet et al., 2002). Additionally, the 
down regulation of the Csf-1r is caused by LPS mimicking the action of CSF-1 and 
resulting in the Csf-1r being removed from the cell surface and moved to the 
perinuclear region (Sester et al., 1999). This results in disruption to the macrophage 
cell cycle regulation (as CSF-1 can no longer bind to the CSF-1R) by blocking the G1-S 
phase. An example of genes involved in the cell cycle are cyclin-dependent kinases 
(CDK) (Morgan, 1997). In the horse CDK1, CDK2 CDK3 and CDK6 were all 
downregulated by LPS suggesting LPS inhibits the cell cycle as reported in murine 
BMDMs (Table 4-4).  
Table 4-4 Effect of LPS stimulation on cyclin-dependent kinases (CDK) involved in the 







CDK1 M, G2 23.305 11.789 
CDk2 G1, S 7.185 4.687 
CDK3 G0, G1 0.318 0.193 
CDK4 G1 62.497 30.474 
CDK6 G1 49.128 47.689 
Induction of early response genes in eqBMDMs at 7 hours post LPS 
stimulation  
A detailed time-course analysis of the horse response to LPS was beyond the scope 
of this project – the main function being to study the acute response of eqBMDMs to 
LPS and to apply this to intestinal surgical colic cases, to identify if macrophage 
activation occurs within the mucosa and muscularis at the time of abdominal surgery. 
Additionally, the study of the acute inflammatory response will help in the 
understanding of the innate immune response of the horse, particularly relevant in 
light of the high sensitivity of the horse to LPS. As well as genes induced by LPS, it is 
also important to study genes repressed by LPS. Inflammation suppressor genes are 
also activated by pathogens e.g. LPS and act to provide an ‘off switch’ to inflammatory 
mechanisms (Wells et al., 2005, Baillie et al., 2017). Without suppressors, there would 
be no effective resolution of inflammation. Monocytes entering the lamina propria 
(LP) of the gut must modulate their phenotype, to down regulate their response to 
bacteria within the intestinal lumen, thus preventing continuous and detrimental 
inflammation within the intestine (Bain and Mowat, 2014). This phenotypic 
modulation requires the presence of the macrophage growth factor, CSF-1. The 
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differentiation of monocytes to macrophages in the presence of CSF-1 therefore 
provides a good in vitro model of the process of differentiation of intestinal 
macrophages, as suggested by Baillie et al. 2017.  
LPS stimulation of macrophages triggers a sequence of waves of gene expression 
extending up to 48 hours, which has been studied in detail in mice (Sweet and Hume, 
1996, Takeuchi and Akira, 2010) and in humans (Baillie et al., 2017, Rossol et al., 
2011). In humans, early (immediate response genes) induced by LPS included EGR1, 
EGR2, EGR3, FOS, FOSB and NFKBIZ with their promotors showing an increase in 
detectable expression as early as 15 minutes post stimulation (Baillie et al., 2017). At 
7 hours in eqBMDMs the majority of these genes had the same TPM at 0 and 7 hours 
(ERG1, ERG2, ERG3 and FOSB) indicating that by 7 hours this early response “wave” 
had passed and that these genes had peaked and had returned to normal levels (Table 
4-5). NFKBIZ was upregulated and FOS was downregulated. NFKBIZ is a 
transcriptional regulator of Iκßζ induced in response to IL-1 or LPS (Yamazaki et al., 
2001) but not TNF-α (Yamamoto et al., 2004). Iκßζ, in conjunction with another gene, 
AKIRIN2, is required for IL-6 and IL-12B production. In mouse macrophages, AKIRIN2 
interacts with BAF60 proteins and Iκßζ, which as a complex are recruited to the IL-6 
and IL-12B promotors to induce chromatin remodelling. These then recruit the 
SW1/SNF complex to the promotors of the target genes (Tartey et al., 2014). From the 
eqBMDMs results, both IL-6 and IL-12B are significantly upregulated at 7 hours with 
Log2 fc of 8.6 and 9 respectively (p<0.001) (Figure 4-15). Table 4-5 shows TPM values 
for these genes. As with the early response genes, AKIRIN2 is unchanged between 0 
and 7 hours, likely consistent with a return to normal expression following an earlier 
peak.  







ERG1 3.656 3.294 
ERG2 25.784 16.051 
ERG3 1.022 0.938 
FOS 157.665 57.445 
FOSB 0.631 0.746 
NFKBIZ 3.198 11.164 
IL6 0.370 117.52 
IL-12B 0.055 24.49 
AKIRIN2 49.259 43.410 
Cytokine and chemokine signalling in response to LPS in eqBMDMs 
Chemokines are secreted by cells at the site of inflammation to recruit leukocytes to 
the site of inflammation. Chemokines associated with LPS activation of macrophages 
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or monocytes in mice include CXCL1, CXCL2, CXCL3, CXCL5, CXCL8, CXCL9, CCL2, 
CCL3, CCL4, CCL5, CCL11, CCL17 and CCL22 (Mantovani et al., 2004). The expression 
of genes encoding cytokines and chemokines associated with LPS stimulation of 
macrophages were all significantly upregulated (p<0.02) and contained within the list 
of DE genes in eqBMDMs. These included the inflammatory cytokines TNF-α, IL12B, 
IL6, IL1B and IL10 and chemokines CXCL2, CXCL3, CXCL8, CCL3, CCL4, CCL5 and 
CCL22.  
In eqBMDMs CXCL6 is one of the most upregulated genes (Figure 4-15), a finding also 
reported in a study of LPS stimulated equine PBMCs (Pacholewska et al., 2017). In LPS 
stimulated human PBMCs, CXCL6 was also upregulated (Pu and Wang, 2014).  There 
is no Cxcl6 gene in the mouse genome in Ensembl. CXCL6 is also expressed in alveolar 
macrophages stimulated with LPS (Figure 4-18). CXCL6, also known as granulocyte 
chemotactic protein 2 (GCP-2), signals the recruitment of neutrophils, via their 
surface expression of CXCR1 and CXCR2 receptors (Wuyts et al., 1997). In humans, 
pulmonary macrophages from patients undergoing lung resection of carcinoma 
produced GCP-2, as did human MDMs cultured for 5 days when stimulated with LPS, 
but not polyIC or IL1B (Wuyts et al., 2003). In the FANTOM5 dataset, CXCL6 is also 
upregulated in response to human MDMs in response to LPS 
(fantom.gsc.riken.jp/zenbu). However, LPS stimulation of freshly isolated PBMCs 
failed to produce GCP-2, suggesting that differentiation of unstimulated cells (e.g. in 
culture) influences the capacity for GCP-2 production (Wuyts et al., 2003). Neutrophils 
have two contrasting roles in sepsis. Impaired neutrophil recruitment and migration 
results in the inability to successfully fight infection. Conversely the neutrophilic 
antibacterial inflammatory response is thought to contribute to tissue ischemia, 
organ damage and even multiple organ dysfunction (Sônego et al., 2016). Other 
chemokines mediating the recruitment of neutrophils in mice include CXCL1, LFA-1, 
CD11b/Mac-1, ICAM-1, VCAM-1 ICAM-2 PECAM-1, CXCL2 and (Reichel et al., 2012). In 
eqBMDMs CXCL2, ICAM-1, VCAM-1, PECAM-1 and CCL3 were upregulated (Table 4-6), 
suggesting that the horse may be biased towards a strong neutrophilic response; 




















CXCL6 9.063 978.278 
CXCL2 51.594 164.963 
ICAM-1 67.395 399.324 
ICAM-2 35.219 21.477 
VCAM-1 17.361 193.913 
PECAM-1 0.295 0.528 
CCL3 1394.299 7608.37 
LFA-1 7.166 7.314 
Figure 4-18 Venn diagram of genes differentially expressed in eqBMDMs and equine 
alveolar macrophages stimulated with LPS 
Differentially expressed (DE) genes from eqBMDMs stimulated with LPS for 7 hours and 
alveolar macrophages (AMs) stimulated with LPS for 6 hours were compared. AMs DE was 
analysed using microarray and eqBMDMs DE was acquired from RNA-Seq analysis. 
Diagram showing genes in eqBMDMs and AMs that are significantly (p<0.05) upregulated 
following LPS stimulation. Genes included are with a fold change >2. In total 128 genes were 
commonly DE between the two datasets. 
Common differentially expressed genes: ADAR AIM2 AKAP7 ALCAM AMPD3 APAF1 
ARHGEF3 BATF3 BIRC2 CASP7 CCDC50 CCL22 CCNG2 CD38 CD40 CDS1 CERK 
CLIC5 CSF3 CXCL6 DDX60L  DENND5A DHX58 DTX3L EDN1 EHD4 ENPP4 ETV7 
EXT1 FAM129A FAM186B FAM3C FBXO39 FCHSD2 FMNL3 FOXS1 GBP5 GLCCI1 
GNB4 GNGT2 GSDMD HELB HERC5 HIVEP2 HSPA4L ICAM1 IDO1 IFIH1 IFNB1 IFT74 
IL10 IL1A IL1B IL27 IL2RA IL6   ISG15 ISG20 ITGB8 ITPR1 ITSN1 JAK2 KLF12 LIMCH1 
MARCKSL1 MASTL MBNL2 MCF2L MIP-2BETA MLKL MOV10 MX2 MYO1G NEK7 NUB1 
OAS1 OAS2 OAS3 OASL OBFC1 OTUD4 P2RY10 PARP15 PHF7 PIM1 PLEKHA4 PML 
PNPT1 PPM1K PRR5L PRRG4 PTGER2 PTGES PXK RAPGEF2 RASGEF1B RFX2 
RILPL2 RIN2 SAMD9 SDC4  SERPINB2 SLAMF7 SLC16A9 SLC9A7 SLFN5 SMARCE1 
SOCS3 SPRY1 STARD13 STAT4 STRIP2 STX11 TLR3 TMEM47 TNF-α TNFSF13B 
TNIP3 TRAF3IP2 TREX1 TRIM26 TRPM2 TSG-6 TSPAN33 TTC21A UBE2L6 USP15 
ZC3H12A 
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LPS-induced feedback  
An important feature of the macrophage response to LPS is the mechanisms by which 
induced transcripts and proteins are ‘switched off’, such as IL-10 for example.  IL-10 
is an anti-inflammatory cytokine and the production of IL-10 acts as an inhibitory 
signalling cascade in macrophages stimulated with LPS (Bogdan et al., 1992). 
Additionally, IL-10 also forms a group of regulatory cytokines in the gut contributing 
to intestinal homeostasis and immune function (Manzanillo et al., 2015) EqBMDMs 
upregulate IL-10 in response to LPS (Figure 4-15). Previous work by our group found 
that equine alveolar macrophages did not, but monocytes did, produce the protein 
(as measured by ELISA) in response to LPS.  Despite the lack of detectable IL-10 
protein secretion, equine alveolar macrophages did upregulate the gene in response 
to LPS (Karagianni, 2015). It would be beneficial in eqBMDMs to perform an ELISA on 
eqBMDMs culture supernatant also, to demonstrate protein secretion as well as the 
increased mRNA expression as reflected in the RNA-Seq data.  
IL-10, is just one example of several feedback loops that occur in response to LPS. In 
human monocytes, repressors of transcription included PRDM1, which is an early 
repressor of cytokine production; NR4A1 a repressor of NF-β and DUSP1 and DUSP2 
which regulate MAP kinase signalling (Baillie et al., 2017). In eqBMDMs, only NR4A1 
did not have an increase in TPM at 7 hours (Table 4-7). This may be due to 7 hours 
being too late to detect upregulation or may reflect a species difference between 
mouse and human. In humans, the cluster which NR4A1 was in, showed most 
upregulation at 30 minutes to 2 hours post LPS stimulation, with a decrease from 
baseline from 2 to 20 hours post LPS (Baillie et al., 2017); therefore, it is possible that 
a similar process occurs in the horse. NR4A1 is an inhibitor of NFB, a protein 
controlling cytokine production in myeloid cells (McEvoy et al., 2017). Other early 
inhibitors in humans of NF-β include NFKBIA, NFKBIB, NFKBIE, NFKBIZ and BCL3 
(Baillie et al., 2017). Apart from BCL3, all the other inhibitors of NFB were 
upregulated at 7 hours (Table 4-7) demonstrating that eqBMDMs do have an inducible 
inhibitory feedback pathway acting on NFB, activated in response to LPS. In human 
monocytes, later inhibitors of NF-β include PARP7, PARP10 and PARP12 (Baillie et 
al., 2017). In eqBMDMs at 7 hours PARP7 was unchanged, PARP10 is not annotated 
and PARP12 was upregulated in response to LPS (Table 4-7).  
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PRDM1 32.908  62.634 
NR4A1 1.144 1.031 
DUSP1 60.55  64.003 
DUSP2 0.776  4.409 
NFKBIE 51.296  123.129 
NFKBIB 19.945  28.167 
NFKBIA 150.359  511.619 
BCL3 2.464  3.736 
Baillie et al. (2017) published a table of mouse knockouts (n=188) that influence the 
LPS response. The resulting mutant phenotype exhibited either a reduced or 
increased responsiveness to LPS. Using this gene list, genes were segregated into 
those that suppress the LPS response (n=76) (i.e. where mutant mice showed 
increased sensitivity to LPS) and those that increased responsiveness to LPS (n=111) 
(i.e. where mutant mice had a reduced sensitivity to LPS). Using these lists, the DE 
expressed genes upregulated and downregulated in eqBMDMs in response to LPS were 
analysed. Amongst genes that suppress the LPS response only 5 (BIRC3, IER3, IL27, 
ADORA7A and EBI3) are present in the top 100 genes DE in eqBMDMs. Twenty-two 
were present out of all the genes (n=808) significantly upregulated in eqBMDMs. Two 
genes were downregulated (Table 4-8). This lack of specific LPS-induced regulators 
could contribute to the LPS hypersensitivity of the horse (Jackson and Kropp, 1999). 
Conversely, 13 genes that increase sensitivity to the LPS response were in the most 
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Table 4-8 Genes associated with an increase in LPS sensitivity in mice present in 
eqBMDMs significantly DE gene list 
 
Knockout genes 
present in top 100 DE 
genes in eqBMDMs 
stimulated with LPS 
Knockout genes 
present in gene list of 
all significantly 
upregulated DE 
genes in eqBMDMs 
stimulated with LPS 
Knockout genes 
present in gene list of 
all significantly DE 
downregulated genes 
in eqBMDMs 
stimulated with LPS 
BIRC3 TGM2 APPL2 
IER3 TIMP3 CCR2 
IL27 NUPR1  
ADORA7A BIRC3  
EBI3 ZC3H12A  
 ABCA1  
 STEAP4  
 PARP14  
 IER3  
 LYN  
 STAT2  
 SOCS3  
 SOCS1  
 IL27  
 EBI3  
 PDCD1LG2  
 ADORA2A  
 SRC  
 STAT3  
 IL10RA  
 CD83  
 TRPM2  
Table 4-9 Genes associated with a decreased sensitivity to LPS in mice present in 
eqBMDMs significantly DE gene lists 
 
Knockout genes 
present in top 100 





present in gene list 
of all significantly 
upregulated DE 




present in gene list 
of all significantly 
DE downregulated 
genes in eqBMDMs 
stimulated with 
LPS 
STAT4 GPR84  
FPR1 P2RX7  
PDE4B NFKBIZ  
 IL23A  
 FPR1  
 PDE4B  
 STAT4  
 PELI1  
 NOD2  
 TREM1  
 CASP1  
 ABCA1  
 CFLAR  
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RNA-Seq analysis of arginine and tryptophan pathways in eqBMDMs 
stimulated with LPS 
The RNA-Seq dataset enabled analysis of the expression of transcripts associated with 
the arginine and tryptophan pathways. Expression levels (averaged TPM) of 
transcripts involved in both pathways are in Table 4-10. LPS stimulation of eqBMDMs 
did not induce any significant expression of transcripts associated with arginine 
metabolism (Figure 4-19). ARG2, OAT, ODC1, SLC3A2 were all highly expressed (TPM 
>100) at 0 hours but were downregulated by LPS. Conversely, genes associated with 
tryptophan metabolism were upregulated with a Log2fc >1; IDO1, KYNU and KMO 
(Figure 4-20). IDO1 catabolises tryptophan into kynurenine, which is then further 
catabolised into either anthranilic acid by kynureninase (KYNU) or 3-
Hydroxykynurenine by kynurenine 3-monooxygenase (KMO). These data support the 
hypothesis that in response to LPS eqBMDMs catabolise tryptophan and not arginine, 
as do equine alveolar macrophages (Karagianni, 2015), pig BMDMs and human MDMs 
(Kapetanovic et al., 2012).   
Table 4-10 TPM values for genes in eqBMDMs associated with arginine (Young et al., 
2018) and tryptophan metabolism 
 
Pathway Gene 0 hours 7 hours 
Arginine metabolism 
ARG1 0.098 0.048 
ARG2 119.226 59.716 
ASL 24.06 14.478 
ASS1 25.849 20.336 
GCH1 24.765 31.888 
NOS2 0.002 0.012 
OAT 103.564 68.811 
ODC1 98.475 39.732 
PTS 27.977 16.301 
SLC3A2 168.353 120.178 
SLC7A1 13.267 9.721 
SLC7A2 0.01 0.053 
SLC7A5 8.969 7.278 
SLC7A7 57.119 46.604 
SPR 10.199 3.549 
Tryptophan 
metabolism 
IDO1 0.920 18.103 
IDO2 0.033 0.972 
TDO2 1.255 2.005 
KYAT1 25.353 15.300 
KYAT3 45.824 35.836 
KYNU  25.337 58.783 
KMO 37.123 95.635 
QPRT 0.004 0.015 
AADAT 0.101 0.047 
SLC3A2 168.353 120.178 
SLC7A8 69.858 31.141 
SLC7A5 8.960 7.278 





Figure 4-19 TPM (A) and Log2 fc (B) values of transcripts involved in the arginine 
metabolism pathway in eqBMDMs, with and without exposure to LPS 
Using TPM values generated with Kallisto genes in the arginine/NO pathway were graphed 
for either TPM values (A) or for Log2 fc. Results shown are the mean for all 3 horses.  
 





Figure 4-20 TPM (A) and Log2 fc (B) values of transcripts involved in the tryptophan 
metabolism pathway in eqBMDMs, with and without exposure to LPS 
Using TPM values generated with Kallisto genes in the tryptophan pathway were graphed for 
either TPM values (A) or for Log2 fc (B). Results shown are the mean for all 3 horses.  
 




Previous studies on eqBMDMs (eCAS cell line) have harvested cells from sternal 
biopsies performed on live sedated animals (Werners et al., 2004). Using this method 
17 x 106 cells per horse were obtained. In the current study, horses were euthanased 
prior to collection, and 5 x108 to 1 x 109 cells were obtained from 2 ribs per adult 
horse thus resulting in a cell yield considerably greater than the sternal biopsy 
method. Following cryopreservation in medium containing 10% DMSO in horse serum 
at -155oC, the percentage of viable cells on recovery, as evaluated by Trypan Blue 
staining, was between 60-80%. By performing MTT assays the most suitable growing 
conditions for eqBMDMs were identified; in media supplemented with HS and rhCSF-
1 at a density of 2.5 x 106 cells/ml. Differentiated cells had characteristics of typical 
macrophages including CD14 expression (Figure 4-10), characteristically consistent 
morphology (Figure 4-6), phagocytic activity (Figure 4-8) and TNF-α production in 
response to LPS (Figure 4-11).  
With the exception of the anatomical site of BM collection, this study differed from 
that of Werners et al. in relation to the culture conditions under which the cells were 
differentiated; Werners et al. cultured their cells in the presence of GM-CSF, whilst 
cells were cultured in the present study in the presence of M-CSF (CSF-1). 
Haemopoietic stem cell (HSC) lineages differ between GM-CSF and CSF-1 induced 
populations. Culturing of HSCs in GM-CSF promotes proliferation and differentiation 
into macrophages, dendritic cells (DC) and granulocytes, whereas CSF-1 promotes 
proliferation and differentiation of monocytes and macrophages (Hamilton, 2008, 
Hamilton and Achuthan, 2013, Hamilton and Anderson, 2004). In addition, GM-CSF is 
a pro-inflammatory cytokine whereas CSF-1 is anti-inflammatory (Hamilton, 2008). In 
humans, morphology of GM-CSF and CSF-1 cultured MDMs was very different with 
CSF-1- induced macrophages being more spindle like and GM-CSF-induced 
macrophages more circular (Hashimoto et al., 1999). In contrast, eqBMDMs 
macrophages cultured in GM-CSF were a combination of rounded and spindle like 
cells (Werners et al., 2004). In this study, cells cultured in CSF-1 had a stellate 
morphology (Figure 4-6). The most significant difference between eCAS cells and the 
cells in the present study was the production of NO in response to LPS. The e-CAS 
equine cells apparently produced NO in response to LPS.  As in previous reports on 
equine alveolar, peritoneal and MDMs, eqBMDMs also did not produce NO in response 
to LPS (Karagianni, 2015, Karagianni et al., 2013, Karagianni et al., 2017). Rodent 
macrophages produce NO, but it is not produced by human or pigs (Kapetanovic et 
al., 2012). This functional difference in NO production between the e-CAS cells and 
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the eqBMDMs may be attributed to the difference in culture conditions (GM-CSF vs 
CSF-1) for two reasons; 1) GM-CSF-induced HSC differentiation can also generate DCs 
and neutrophils in addition to macrophages. Both DCs and neutrophils can produce 
NO in humans (Wilsmann-Theis et al., 2013, Dinakar et al., 1999) 2) GM-CSF is acting 
as a proinflammatory cytokine (Hamilton, 2008) resulting in NO production. 
Alternatively, as noted above, the amounts of NO produced by e-CAS cells were not 
quantified relative to mice, and Karagianni et al. argued that they were likely 
extremely low by comparison. Recently Evans et al. (2018)  published sequence data 
from the eCAS cell line showing that the cells were mouse and not horse (Evans et al., 
2018). This result provides an alternative explanation for the difference in NO 
production between the eCAS cell line and eqBMDMs. The data generated for the 
horse in this study have been used in a comparative analysis of species-specific 
regulation of arginine metabolism, alongside sheep, goat, cattle, buffalo, pig, human 
and rat (Young et al., 2018). The analysis indicated that the pathway is under 
extensive evolutionary selection associated with sequence variation in promoter 
regulation. The findings argue that the lack of activity in eqBMDMs, and other 
macrophage populations, is not simply associated with different culture conditions 
or cell populations and is actually an evolutionary variation. In POI, NO production 
by phagocytes in the muscularis inhibits gastrointestinal motility following intestinal 
manipulation in rodents  (Kalff et al., 2000, Turler et al., 2006). However, given the 
inability of eqBMDMs to produce NO in response to LPS (Figure 4-12) and with the 
absence of upregulation of genes involved in arginine metabolism (Table 4-10), these 
data suggest that NO production from macrophages does not contribute to the 
pathophysiology of equine POI.  
The main aim of this chapter was to evaluate the response of eqBMDMs differentiated 
in CSF-1 to LPS. LPS is an agonist of TLR4, which is expressed by muscularis 
macrophages (MM) but not lamina propria macrophages (LpM) in the intestine 
(Schenk and Mueller, 2007, Eskandari et al., 1997). This in turn activates MM, resulting 
in a series of events which ultimately leads to smooth muscle dysfunction. Previous 
transcriptional studies of the LPS response in horses include microarray analysis of 
alveolar macrophages cultured in CSF-1 (Karagianni et al., 2017), RNA-Seq analysis of 
PBMCs (Pacholewska et al., 2017) and next -generation sequencing of PBMCs 
(Parkinson et al., 2017). Therefore, this study provided the first dataset to analyse the 
transcriptional profile of eqBMDMs cultured in CSF-1 and stimulated with LPS for 7 
hours. This revealed a core group of upregulated genes in response to LPS which form 
the typical innate immune response to LPS (Figure 4-15). Several of these genes (IL1β, 
IL-6, TNF-α, IDO1) were also upregulated in AMs differentiated in CSF-1 (Figure 4-18). 
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This core set of genes were used in Chapter 5 to identify if macrophage activation 
occurs in the mucosa and muscularis of the jejunum in horses undergoing abdominal 
surgery. 
CD163 is the macrophage marker used in Chapter 3 to identify intestinal 
macrophages in the horse. However, when eqBMDMs were analysed by flow cytometry 
they expressed very low levels of CD163 (Figure 4-10). CD163 is expressed on mature 
resident tissue macrophages (Van den Heuvel et al., 1999, Fabriek et al., 2005). CD163 
is induced by LPS (Gordon, 2003) but in eqBMDMs this also was not observed (TPM in 
eqBMDMs decreased from 166 at 0 hours to 91 at 7 hours). Expression of receptors 
on macrophages is dependent on signals from regional tissues such as cytokines, 
chemokines and growth factors (Gordon et al., 1995) so perhaps in eqBMDMs in vitro 
culture conditions do not replicate the niche of cytokines, chemokines and growth 
factors that tissues provide for the expression of CD163 in eqBMDMs.  
In this chapter a protocol was optimised to produce populations of eqBMDMs by 
cultivation of bone marrow from the ribs of adult horses in rhCSF1. Morphological 
features, the ability to phagocytose particles and the ability to produce cytokines in 
response to LPS confirmed the cells were macrophages. The method described allows 
generation of a homogenous population of eqBMDMs to further study their role in 
the equine innate immune system. Transcriptomic analysis of these cells stimulated 
with LPS identified core genes involved innate immunity of the horse. Additionally, 
these data show species-specific variation in innate immune biology in the horse. The 
absence of NO production in response to LPS and the significant upregulation of 
CXCL6 which signals the recruitment of neutrophils, suggesting the horse may be 
biased towards a strong neutrophilic response. In the next chapter, intestine from 





 Inflammatory response in the 
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Colic, which refers to the syndrome of abdominal pain, is a common health and 
welfare concern in the horse (Mellor et al., 2001). Whist the majority of cases will 
resolve with medical treatment alone, a small percentage (1-10%) will require surgery 
to correct the underlying cause (Hillyer et al., 2001). Any horse undergoing abdominal 
surgery is at risk of developing post-operative ileus (POI). The development of POI in 
horses reduces the likelihood of survival following abdominal surgery (Morton and 
Blikslager, 2002, Mair and Smith, 2005c). POI can be defined as the functional 
inhibition of propulsive bowel motility following abdominal surgery (Livingston and 
Passaro, 1990). As discussed in Chapter 1¸several causes and mechanisms of POI 
have been described; these include anaesthetic agents, opioids, levels of intravenous 
fluid administration, electrolyte imbalances, disruption to gastrointestinal (GI) 
hormones and neuropeptides, disruption of neural continuity, autonomic 
dysfunction and inflammatory cell activation (Vather et al., 2014). The proposed 
neurogenic and inflammatory mechanisms have received most attention in the 
literature; however, these proposed mechanisms are not mutually exclusive.  
Different triggers may act independently or collectively to produce a common 
endpoint, namely, impaired contractility of the intestinal smooth muscle. This 
impairment results in distention of the intestines and stomach with GI contents, 
causing abdominal discomfort, post-operative reflux, reduced appetite and reduced 
faecal output (Figure 5-1).  
Manipulation of the intestines is generally unavoidable during colic surgery. In rodent 
models of POI, inflammation of the muscularis externa (ME) in response to 
manipulation is strongly implicated as a significant causative factor in the 
pathogenesis of POI (Kalff et al., 1998a, Behrendt et al., 2004, Kalff et al., 2000, Kalff 
et al., 2003, Farro et al., 2017, Kalff et al., 1999a, Kalff et al., 1999b). Activation of 
muscularis macrophages (MM) occurs within hours of surgery (Farro et al., 2017, Kalff 
et al., 1999b, Kalff et al., 1999a, Kalff et al., 1998a). Macrophage activation following 
surgical trauma has also been demonstrated in human patients (Kalff et al., 2003). 
Briefly, the activation of MM by Damage Associated Molecular Patters (DAMPs) (e.g. 
ATP (Ozaki et al., 2004)) and/or Pathogen Associated Molecular Patterns (PAMPs) (e.g. 
LPS (Eskandari et al., 1997)) results in cytokine and chemokine release, followed by 
infiltration of leukocytes into the muscularis. These infiltrating leukocytes inhibit 
smooth muscle function via the secretion of leukocytic products, such as nitric oxide 
(NO) and prostaglandins (PG). 




Whilst rodent models offer a convenient way to study the pathogenesis of POI, 
rodents are evidently not ‘small horses’. One clear species-related difference is the 
potential role of manipulation-induced nitric oxide (NO) release from infiltrating 
leukocytes, particularly macrophages.  Like macrophages from other large animal 
species such as pigs and humans (Kapetanovic et al., 2012, Young et al., 2018), horse 
alveolar and peritoneal macrophages did not produce NO in response to LPS 
(Karagianni et al., 2013) This difference was further corroborated in Chapter 4 
whereby LPS stimulation also failed to induce neither NO release nor NOS2 mRNA 
expression in equine bone marrow-derived macrophages (eqBMDMs). In collaboration 
with other laboratory group members at the University of Edinburgh, the species 
comparison was further extended to ruminants (Young et al., 2018); LPS stimulation 
induced NO release in cattle and water buffalo, but not in sheep BMDMs. Such 
differences have clear implications with regard to translational application of data 
from one species to another.  
Earlier studies on the margins of bowel loops surgically resected from horses have 
identified a generalised stress response in the smooth muscle, characterised by an 
increase in apoptotic neurons and smooth muscle and glial cells (Rowe et al., 2003). 
Figure 5-1 Proposed role of intra-operative factors in the neurogenic and inflammatory 
phases of POI  
Reproduced from: An update on equine post‐operative ileus: Definitions, pathophysiology and 
management, Z. M. Lisowski, R. S. Pirie, A. T. Blikslager, D. Lefebvre, D. A. Hume & N. P. H. 
Hudson, Equine Veterinary Journal 50 (3), © 2017 EVJ Ltd 
Chapter 5: Intestinal inflammatory response in colic cases 
134 
 
Intestinal surgery in the horse has also been shown to induce post-operative 
neutrophilic and eosinophilic infiltration of the jejunum (Hopster-Iversen et al., 2014, 
Little et al., 2005, Hopster-Iversen et al., 2011). To date, there have been no studies 
investigating macrophage activation in horses undergoing abdominal surgery. The 
work described in this current chapter addresses this issue. Intestinal tissue was 
harvested from horses undergoing colic surgery. Samples were collected from 
macroscopically ‘healthy’ proximal and distal margins of resected intestine. Control 
tissues were obtained immediately post mortem from horses with no recent history 
of gastrointestinal disease or abdominal surgery. The aim of this chapter was to 
investigate the intestinal inflammatory response in horses undergoing abdominal 
surgery by measuring differential gene expression in intestinal tissues harvested 
from the surgery group and the control group. Selected genes of interest included 
those identified in Chapter 4 as being associated with macrophage activation (IDO1, 
the cytokines IL-6, IL-1β, TNF-α and the chemokine CCL2/MCP-1) and those encoding 
mediators involved in smooth muscle dysfunction (NOS2 and COX-2/PTGS2). 
 Results 
5.2.1 Animals 
Samples of jejunum were collected from 6 control horses. The control animals were 
selected randomly and consisted of 3 geldings with a median age of 15 years (mean 
15.6 years, range 15-17 years) and 3 mares with a median age of 21 years (mean 19.6 
years, range 15-23 years).  
Samples of jejunum were also collected from the proximal and distal margins of a 
length of small intestine resected from 12 horses undergoing abdominal surgery for 
evaluation and treatment of colic. Tissues were collected as described in Section 2.1. 
The cases included 6 males (5 geldings and 1 stallion) and 6 mares with a median age 
of 20 years (mean 17.8 years, range 9-27 years). Although all cases had ischaemic 
small intestine that required resection, as the resection was followed by an 
anastomosis procedure, the margins of the resected intestine was assessed by the 
surgeon to be healthy and viable. Case details are summarised in Table 2-2. 
5.2.2 RNA extraction 
RNA extraction was performed on separated mucosa and muscularis for all colic and 
control cases. It was not possible to extract RNA of adequate quality (RNA Integrity 
Number (RIN) >7) from all the surgically acquired and control samples. As a result, a 
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total of 9 muscularis samples (5 proximal and 4 distal) and 24 mucosal samples (12 
proximal and 12 distal) from colic cases and 4 muscularis and 6 mucosal samples 
from control horses were used for Real – Time quantitative polymerase chain reaction 
(RT qPCR) analysis. 
5.2.3 Real – Time quantitative polymerase chain reaction of 
resection margins 
No difference in gene expression was observed between proximal and 
distal samples  
When investigating cases of small and large intestinal strangulation, Rowe et al. 
demonstrated an increase in apoptotic neurons, smooth muscle cells and glial cells 
at locations far from the site of strangulation (Rowe et al., 2003). If such markers of 
surgical stress are detectable at sites far from the surgical lesion, then inflammatory 
cell activation may also be evident at such distant locations. The relative expression 
of target gene mRNA relative to the housekeeping gene, Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), in proximal and distal resection margins of tissues from 
colic cases and control horses for both the mucosa (Figure 5-2) and muscularis 
(Figure 5-3) was measured. No significant differences were observed between 
proximal and distal resection margins for both the muscularis and mucosa. 
Consequently, the proximal and distal margins were combined for all further analyses 
to increase the numbers of muscularis samples (n=9). Such further analyses were not 
applied to proximal and distal margins obtained from the same horse. For the 
mucosa, distal samples were selected for all cases (n=12) (Appendix 9.1). NOS2 was 
removed from the set of target genes as no mRNA was detectable in any of the jejunal 
sections (control and colic cases). This finding was consistent with the lack of NOS2 
expression in stimulated equine BMDMs (Chapter 4).  




Figure 5-2 Relative gene expression of IL-1B, IL6, PTGS2, TNF-α, CCL2 and IDO1 in 
mucosa of horses undergoing intestinal surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in proximal and 
distal mucosa of resection margins from horses undergoing intestinal surgery (n=12). Control 
samples were obtained from horses being euthanased for reasons unrelated to the GIT 
(n=6). Results calculated using 2^−ΔΔCt method. Mean value represented by red line. ns = not 
significant (p>0.05) using Mann-Whitney U test. 




Figure 5-3 Relative gene expression of IL-1B, IL6, PTGS2, TNF-α, CCL2 and IDO1 in 
the muscularis of horses undergoing intestinal surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in proximal and 
distal muscularis of resection margins from horses undergoing intestinal surgery (n=12). 
Control samples were obtained from horses being euthanased for reasons unrelated to the 
GIT (n=4). Results calculated using 2^−ΔΔCt method. Mean value represented by red line. ns = 
not significant (p>0.05) using Mann-Whitney U test. 
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Evidence of macrophage activation in the mucosa and muscularis of 
horses undergoing abdominal surgery 
Next, relative expression of the target genes (IL-6, IL-1β, TNF-α, CCL2, PTGS2 and 
IDO1) was evaluated in the mucosa (n=12) and muscularis (n=9) of colic cases and 
compared to the mucosa and muscularis of control cases (mucosa n=6; muscularis 
n=4) (Figure 5-4). In the mucosa, the level of expression of IL-1β, IL-6, PTGS2, TNF-α 
and CCL2 was significantly (p<0.05) greater in colic cases compared with healthy 
horses. In the muscularis, the level of expression of IL-1β, IL-6, TNF-α and CCL2 was 
significantly (p<0.05) greater in colic cases compared with healthy horses. The 
relative expression of IL-1β was significantly greater in the muscularis compared to 
the mucosa in colic cases. Likewise, the relative expression of PTGS2 was significantly 
greater in the mucosa of colic cases, compared to the muscularis of colic cases, in 
which expression was negligible. With the exception of one horse, there was no 
increase in the relative expression of IDO1 in colic cases, compared with control 
horses. 
 




Figure 5-4 Relative gene expression of IL-1B, IL6, PTGS2, TNF-α, CCL2 and IDO1 in 
the mucosa and muscularis of horses undergoing intestinal surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH. Proximal and 
distal mucosa (n=12) and muscularis (n=9) samples were combined. Control samples were 
obtained from jejunum of horses being euthanased for reasons unrelated to the GIT (mucosa 
n=6, muscularis n=4). Results calculated using 2^−ΔΔCt method. Mean value represented 
by red line. Significance of relative mRNA expression between control and surgical samples 
and between mucosa and muscularis surgical samples were performed with a Mann-Whitney 
U test. ns =not significant, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
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Analysis of relative expression in relation to pre-, intra- and post-
operative factors 
The colic cases from which samples were derived differed with respect to several pre-
, intra- and post-operative factors. Although the small numbers of horses limits 
subset analysis, where the possible impact of different variables on the expression of 
various inflammatory genes is considered below.  
Pre-operative factors 
The expression of all genes in colic cases (relative to GAPDH) was considered relative 
to duration of colic prior to surgery, age of the animal and the presence of pre-
operative reflux. Duration of colic prior to surgery was evaluated as this was 
considered to potentially impact on the magnitude of the intestinal inflammatory 
response. Both increasing age (Roussel et al., 2001) and the presence of pre-operative 
reflux (Mair and Smith, 2005c, Torfs et al., 2009) have been associated with an 
increased risk of POI in horses.  
Age 
Median age of colic horses in the mucosa group (n=12) was 20.5 years (range 10-27 
years) and in the muscularis group (n=9) was 12 years (range 9-27years). In the 
muscularis, there was no significant relationship between age and relative gene 
expression, although there was a trend towards an age-related increase in the relative 
expression of IL-1β, IL-6, TNF-α and CCL2 (Figure 5-5). In the mucosa, there was a 
significant age-associated decrease in the relative expression of PTGS2 and CCL2 
(Figure 5-6). In contrast to the muscularis, there was also a trend towards an age-
related decrease in the relative expression of IL-1β and IL6 consistent with the 
muscularis derived data, there was a trend towards increased relative expression in 
TNF-α in the mucosa.   
 





Figure 5-5 Effect of age on relative gene expression of IL1B, IL6, PTGS2, TNF-α, CCL2 
and IDO1 in the muscularis of horses undergoing intestinal surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in muscularis from 
resection margins of horses undergoing intestinal surgery (n=9). Results calculated using 
2^−ΔΔCt method. Significance of age on relative mRNA expression performed by linear 
regression (represented by black line).  






Figure 5-6 Effect of age on relative gene expression of IL1B, IL6, PTGS2, TNF-α, 
CCL2 and IDO1 in the mucosa of horses undergoing intestinal surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in mucosa from 
resection margins of horses undergoing intestinal surgery (n=12). Results calculated using 
2^−ΔΔCt method. Significance of age on relative mRNA expression performed by linear 
regression (represented by black line). *p<0.05. 
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Duration of colic 
Median duration of colic in the mucosa group (n=12) was 6.5 hours (range 2-12 hours) 
and in the muscularis group (n=9) was 4 hours (range 2-5 hours). There were no 
significant associations between duration of colic and inflammatory gene expression 
in either the mucosa (Figure 5-7) or muscularis group (Figure 5-8). There was a trend 
towards a decrease in the relative expression of IL-1β, IL-6 and CCL2 in the mucosa 
and IL-6, CCL2 and TNF-α in the muscularis with increasing duration of colic prior to 
surgery.     
Presence of pre-operative reflux 
Four out of 12 of the mucosa group and 4 out of 9 of the muscularis group had pre-
operative reflux. The presence of pre-operative reflux was not associated with a 
greater level of expression of inflammatory genes (Figure 5-9 and Figure 5-10). 





Figure 5-7 Effect of colic duration on relative gene expression of IL1B, IL6, PTGS2, 
TNF-α, CCL2 and IDO1 in the mucosa of horses undergoing intestinal surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in mucosa from 
resection margins of horses undergoing intestinal surgery (n=12). Results calculated using 
2^−ΔΔCt method. Significance of colic duration on relative mRNA expression performed by linear 
regression (represented by black line). 





Figure 5-8 Effect of colic duration on relative gene expression of IL1B, IL6, PTGS2, 
TNF-α, CCL2 and IDO1 in the muscularis of horses undergoing intestinal surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in muscularis 
from resection margins of horses undergoing intestinal surgery (n=9). Results calculated 
using 2^−ΔΔCt method. Significance of colic duration on relative mRNA expression performed 
by linear regression (represented by black line). 





Figure 5-9 Relative gene expression of IL1B, IL6, PTGS2, TNF-α, CCL2 and IDO1 in 
the mucosa of horses presenting with and without pre-operative reflux. 
Scatter plots showing mRNA expression of target genes relative to GAPDH in mucosa from 
resection margins of horses undergoing intestinal surgery (n=12). Results calculated using 
2^−ΔΔCt method. Red line represents mean value. Significance of gene expression in horses 
with pre-operative reflux performed by Mann-Whitney U Test.  




Figure 5-10 Relative gene expression of IL1B, IL6, PTGS2, TNF-α, CCL2 and IDO1 in 
the muscularis of horses presenting with and without pre-operative reflux 
Scatter plots showing mRNA expression of target genes relative to GAPDH in muscularis 
from resection margins of horses undergoing intestinal surgery (n=9) in horses that presented 
with (n=4) or without (n=5) pre-operative reflux. Results calculated using 2^−ΔΔCt method. Red 
line represents mean value. Significance of gene expression in horses with pre-operative 
reflux performed by Mann-Whitney U Test.  





Resection of intestine has been identified as a risk factor for the development of POI 
(Roussel et al., 2001). All the horses in this study had resections. Horses in the mucosa 
group had a median resection length of 1.8 metres (range 0.5-15 metres).  Horses in 
the muscularis group had a median resection length of 0.5 metres (range 0.5-1.8 
metres). As shown in Figure 5-11 and Figure 5-12, there was no significant 
association between relative gene expression and length of resected intestine.  
Post-operative factors 
The development of post-operative reflux (POR) is a consequence of POI; namely that, 
due to the inhibition of smooth muscle function this results in the accumulation of 
fluid and ingesta within the GIT resulting in the presence of POR. Horses that develop 
POI are less likely to survive following surgery (Morton and Blikslager, 2002, Mair and 
Smith, 2005c). In this current study, short term survival refers to all horses that 
survived to discharge. In rodent models, a greater inflammatory response is 
associated with more ‘severe’ POI (van Bree et al., 2012). Consequently, the horses 
which did develop POR were compared with those that did not with respect to the 
relative expression of target genes. Due to the small number of cases, any horse that 
developed POR of more than 2 litres on more than 2 intubations in the post-operative 
period was included.  
Post-operative reflux 
In the mucosa group, there was a significantly greater expression of TNF-α in the 3 
horses which developed POR, compared with the 9 which did not (Figure 5-13). In the 
muscularis group, there was no significant difference in relative gene expression 
between the 3 horses which developed POR and the 6 which did not. (Figure 5-14). In 
both mucosa and muscularis samples, there was a trend towards greater mean 
expression of IL-1β, IL-6, PTGS2, TNF-α and CCL2 in horses that did develop POR 
compared to those that did not.  
Short term survival 
 Within the mucosa group, 4 horses did not survive to discharge. There were no 
significant differences in expression in horses that did not survive to discharge 
(Figure 5-15). In the muscularis group 2 horses did not survive to discharge. As with 
the mucosa, no differences in relative expression of target genes between horses that 
did and did not survive to discharge was observed (Figure 5-16). 




Figure 5-11 Association of resection length and relative gene expression of IL1B, IL6, 
PTGS2, TNF-α, CCL2 and IDO1 in the mucosa of horses undergoing intestinal 
surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in mucosa from 
resection margins of horses undergoing intestinal surgery (n=12). Results calculated using 
2^−ΔΔCt method. Significance of resection length on relative mRNA expression performed by 
linear regression (represented by black line).  




Figure 5-12 Association of resection length and relative gene expression of IL1B, IL6, 
PTGS2, TNF-α, CCL2 and IDO1 in the muscularis of horses undergoing intestinal 
surgery 
Scatter plots showing mRNA expression of target genes relative to GAPDH in muscularis from 
resection margins of horses undergoing intestinal surgery (n=9). Results calculated using 
2^−ΔΔCt method. Significance of resection length on relative mRNA expression performed by 
linear regression (represented by black line).  





Figure 5-13 Relative gene expression of IL1B, IL6, PTGS2, TNF-α, CCL2 and IDO1 in 
the mucosa of horses with and without post-operative reflux 
Scatter plots showing mRNA expression of target genes relative to GAPDH in mucosa from 
resection margins of horses undergoing intestinal surgery (n=9) in horses that developed 
(n=3) post-operative reflux. Results calculated using 2^−ΔΔCt method. Red line represents 
mean value. Significance of gene expression in horses with pre-operative reflux performed 
by Mann-Whitney U Test.*p<0.05 





Figure 5-14 Relative gene expression of IL1B, IL6, PTGS2, TNF-α, CCL2 and IDO1 in 
the muscularis of horses with and without post-operative reflux 
Scatter plots showing mRNA expression of target genes relative to GAPDH in muscularis 
from resection margins of horses undergoing intestinal surgery (n=7) in horses that 
developed (n=3) post-operative reflux. Results calculated using 2^−ΔΔCt method. Red line 
represents mean value. Significance of gene expression in horses with pre-operative reflux 
performed by Mann-Whitney U Test. 





Figure 5-15 Association of relative gene expression of IL1B, IL6, PTGS2, TNF-α, 
CCL2 and IDO1 and short-term survival 
Scatter plots showing mRNA expression of target genes relative to GAPDH in mucosa of 
resection margins (n=12) in horses surviving the immediate post-operative period (n=8) 
compared to horses requiring euthanasia in the immediate post-operative period (n=4). 
Results calculated using 2^−ΔΔCt method. Red line represents mean value. Significance of 
gene expression between groups performed by Mann-Whitney U Test. 






Figure 5-16 Association of relative gene expression of IL1B, IL6, PTGS2, TNF-α, 
CCL2 and IDO1 and short-term survival 
Scatter plots showing mRNA expression of target genes relative to GAPDH in muscularis 
of resection margins (n=12) in horses surviving the immediate post-operative period (n=7) 
compared to horses requiring euthanasia in the immediate post-operative period (n=2). 
Results calculated using 2^−ΔΔCt method. Red line represents mean value. Significance of 
gene expression between groups performed by Mann-Whitney U Test. 




The presence of MM in the horse was demonstrated in Chapter 3. CD163+ve 
macrophages were present within the circular and longitudinal muscle of the equine 
GIT. The aim of this chapter was to evaluate tissues from horses undergoing 
abdominal surgery and to investigate whether there was evidence of macrophage 
activation in these tissues. Whilst neural pathway disruption may result in reduced 
motility in the immediate post-operative period, rodent models have identified 
inflammation of the ME as a mechanism for the development of a more prolonged 
phase of POI (Kalff et al., 1999a, Kalff et al., 1999b, Kalff et al., 1998a, van Bree et al., 
2012, Wehner et al., 2007). Activation of resident MM triggers a sequence of events 
that ultimately ends in smooth muscle dysfunction. Activation of MM triggers the 
release of cytokines (e.g. IL-1β, TNF-α) which, along with LPS, induce ICAM-1 and P-
selectin expression in the vascular endothelium of the muscularis, an effect which 
can last at least 12 hours following intestinal manipulation. This results in the 
recruitment of leukocytes into the ME, and the release of leukocyte-derived factors 
(e.g. nitric oxide, prostaglandins) which cause smooth muscle dysfunction (Kalff et 
al., 1999a).  
In this study, mucosa and ME harvested from horses undergoing intestinal surgery 
was analysed for a specific group of genes; those encoding the cytokines IL-6, IL-1β, 
CCL2 and TNF-α and the mediators PTGS2 and IDO1. These genes are upregulated in 
the intestinal ME in mouse models of POI (Farro et al., 2017) and in the ME of humans 
undergoing laparotomy (Kalff et al., 2003).   
Firstly, a comparison of relative gene expression between proximal and distal 
resection margins of the mucosa and ME was performed (Figure 5-2 and Figure 5-3); 
no significant differences were identified. This may be considered unsurprising in 
light of the likely symmetrical relationship between marginally located healthy 
intestine (proximal and distal) relative to the centrally located devitalised intestine in 
the resected section. However, it does contrast with the reported increase in apoptotic 
neurons, smooth muscle cells and glial cells at sites distal to the surgical lesions in 
resected small and large intestine of horses (Rowe et al., 2003) The failure of the 
symmetric distribution pattern of inflammation observed in this study to follow the 
reported asymmetric pattern of apoptosis is perhaps not unsurprising, as apoptosis 
does not induce an inflammatory reaction, unlike necrotic cell death (Szondy et al., 
2017).  
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IL-6, IL-1β, CCL2 and TNF-α were all upregulated in the mucosa and ME in colic cases 
when compared to controls (Figure 5-4). PTGS2 was upregulated in the mucosa only. 
These data demonstrate an inflammatory response within grossly non-devitalised 
intestine in horses undergoing intestinal resection following small intestinal 
strangulations. This finding is similar to that reported in the ME of humans 
undergoing laparotomy (Kalff et al., 2003). In contrast to human derived data, these 
equine results demonstrate a cytokine and mediator response within the intestinal 
mucosa as well as the ME; this is not reported in human intestine (Kalff et al., 2003). 
Similarly, intestinal manipulation failed to induce an increase in mucosal IL-6 in rats 
(Wehner et al., 2005). Despite these apparent differences, it remains highly feasible 
that the increase in relative gene expression in the mucosa of the horses was, at least 
in part, attributable to the small intestinal strangulation and not solely intestinal 
manipulation during surgery.  
The cytokines IL-6, IL-1 and TNF-α all affect intestinal motility. TNF- induces motor 
dysfunction in mice by acting directly on the smooth muscle cells (Lodato et al., 1999) 
(Kinoshita et al., 2006) and in rats via suppression of noradrenaline release in the 
myenteric plexus (Hurst and Collins, 1994). TNF- (Ohama et al., 2003) and IL-1 
(Ohama et al., 2007) both decrease the activity of CPI-17, whose activation is required 
for inducing smooth muscle contraction, resulting in decreased smooth muscle 
contractility in the rat. Additionally, IL-1 suppresses acetylcholine (Main et al., 1993) 
and noradrenaline (Hurst and Collins, 1993) release in rats and acts synergistically 
with IL-6 to further supress noradrenaline release (Ruhl et al., 1994). IL-6 also 
suppresses motility, although the exact mechanism is not currently known (Nullens 
et al., 2016). Unlike IL-6, IL- and TNF-, CCL2 does not seem to directly affect 
neurotransmission or smooth muscle function. However, its upregulation indirectly 
affects motility via its role in monocyte and leukocyte recruitment. CCL2 (also 
referred to as monocyte chemoattractant protein-1 [MCP-1]) regulates the migration 
and infiltration of leukocytes via the CC chemokine receptor 2 (CCR2) and is 
upregulated in intestinal inflammation in rodents (Turler et al., 2002, Tsou et al., 
2007, Hori et al., 2008, Kurihara et al., 1997). When inflamed, both the mucosa (Khan 
et al., 2006) and ME (Turler et al., 2002) show an increase in CCL2 and MMs were 
shown to produce CCL2 in an endotoxaemic model of ileus in the rat (Turler et al., 
2002).  
Infiltrating neutrophils and monocytes impair smooth muscle contraction via 
secreted products such as reactive oxygen intermediates, proteases, NO and 
prostaglandins (Schwarz et al., 2001, Kalff et al., 2000) (Josephs et al., 1999). Of these, 
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prostaglandins and NO have a profound effect on intestinal motility.  In rodents 
PTGS2 inhibits smooth muscle function in both an IM (Schwarz et al., 2001) and sepsis 
(Hori et al.) model of POI. Consistent with such an inhibitory role inhibition of the 
PTGS2 pathway results in increased contractility of jejunal circular muscle in humans 
(Kalff et al., 2003). This somewhat contrasts with the failure to identify any increase 
in PTGS2 mRNA expression in the ME of horses undergoing abdominal surgery, 
despite a significant increase in the mucosa (Figure 5-4). This may be attributable to 
the time course of gene expression, related to the cell infiltrate at the time of the 
resection, whereby cells in the mucosa are activated sooner than cells within the ME. 
Gene expression may also vary with stage of disease at which the resection was 
performed, given that during intestinal inflammation a biphasic response has been 
reported (Nullens et al., 2018). The increased mucosal expression of PTGS2 could 
reflect stimulation of macrophages by inflammatory cytokines, damage associated 
molecular patterns (DAMPs) or translocated LPS from the intestinal lumen. Cellular 
origins of PTGS2 in the ME include endothelial cells, neurones and vascular smooth 
muscle cells (Dubois et al., 1998) and intestinal manipulation has been shown to 
induce PTGS2 release from both ME inflammatory cells and myenteric neurons 
(Josephs et al., 1999, Schwarz et al., 2001), both of which potentially contribute 
towards smooth muscle dysfunction.  
This observed collective increase in the relative expression of IL-6, IL-1, TNF-α, PTGS2 
and CCL2 in colic cases could potentially play a role in post-operative smooth muscle 
dysfunction in the horse and thus contribute to POI. The resultant reduction in 
smooth muscle contractions leads to reduced or arrested peristalsis and the 
subsequent build-up of ingesta within the GIT. The inability of the horse to vomit 
necessitates passage of a nasogastric tube to decompress the stomach of fluid. This 
procedure is often performed both before and regularly after intestinal surgery. 
Mechanical, as opposed to functional, obstructions will also result in the same main 
clinical findings; namely, sign of accumulation of gastric fluid. In this study, relative 
gene expression was evaluated in horses, some of which had pre-operative 
nasogastric reflux and some of which had POR. Horses with pre-operative reflux did 
not have any significant differences in relative gene expression compared to those 
that did not, with the mean expression in both groups being similar (Figure 5-9 and 
Figure 5-10). The reflux in horses with pre-operative reflux was most likely 
attributable to a mechanical obstruction of the small intestine resulting in failure of 
aboral flow of ingesta. This is in contrast to a functional ileus and may explain why 
no difference in relative gene expression was seen between those with pre-operative 
reflux and those without. In contrast, relative gene expression of TNF-α was 
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significantly greater (p<0.05) in the mucosa of horses with POR than those without. 
Although not statistically significant,  the mean relative expression of IL-6, IL-1, 
CCL2 and TNF- was greater in horses with POR compared to those without (Figure 
5-13 and Figure 5-14).  
In contrast to other inflammatory markers (with the exception of one horse) there 
was no detectable difference in IDO1 expression between colic cases and healthy 
horses, in either mucosa or ME (Figure 5-4). This was surprising considering the 
increase in IDO1 expression observed in eqBMDMs in response to LPS stimulation 
(Chapter 4); although, in comparison to IL-1 , its level of expression was low (Table 
5-1). IDO is expressed (both mRNA and protein) throughout the whole murine GIT, 
particularly in the jejunum and ileum, and is largely associated with CD11c+ve 
dendritic cells (Matteoli et al., 2010). IDO1 expression also increases in inflammation, 
via infiltration of CD123+ mononuclear cells in human inflammatory bowel disease 
(Wolf et al., 2004).  
Table 5-1 TPM values of IDO and IL1B in eqBMDMs stimulated with LPS (Data from 
Chapter 4) 
 
Gene TPM 0 hours 
(resting) 
TPM 7 hours post LPS 
stimulation 
IDO1 0.920 18.103 
IL-1β 10.59 1097.029 
IDO1 induction can be mediated through IFN- dependent and independent pathways 
and its LPS-mediated induction can be further potentiated via inflammatory cytokines 
such as TNF-, IL-6 and IL-1 (Fujigaki et al., 2006, Fujigaki et al., 2001). However, the 
most potent inducer of IDO is thought to be IFN-, which induces both gene 
expression and enzyme activity of IDO1 (Dai and Gupta, 1990). The lack of IDO1 
induction in the current study may have been attributable to either a failure of 
abdominal surgery to activate the IFN- pathway or insufficient time to have lapsed 
for the induction of IDO1 via IFN- independent pathways (LPS/TNF-).  
NO is an inhibitor of intestinal motility and is produced by NOS2 derived from 
infiltrating leukocytes in the ME in rodents; this is reversed by inhibition of NOS2 
(Kalff et al., 2000). No NOS2 mRNA was detectable in any equine jejunal sections 
(control and colic cases); consequently, NOS2 was removed from the set of target 
genes. These findings were consistent with the lack of NOS2 expression in stimulated 
equine BMDMs and highlights the interspecies variation in NO production and the 
importance of studying species specific pathophysiology of POI (Young et al., 2018). 
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NO may still play a role in POI via NOS1, which relates to the neuronal control of 
intestinal motility (Stark et al., 1991). 
Several factors such as age and the presence of pre-operative nasogastric reflux have 
been associated with an increased incidence of POI in horses (Mair and Smith, 2005b). 
Subset analysis was performed to determine if any association with clinical variables 
was present.  In the mucosa, all genes apart from TNF-α reduced with age (Figure 5-6). 
In the ME the converse was true (Figure 5-5), where all genes showed an increase in 
relative gene expression with age. A confounding factor in these data is age; 6 out of 
the 12 colic cases were diagnosed with pedunculated lipomas at surgery (Table 2-2).  
Pedunculated lipomas have a higher incidence in older horses (Edwards and 
Proudman, 1994). The effect of aging on the intestinal barrier is unknown. In a study 
of healthy human of varying ages (7-77 years) no changes in TNF-α, IFN-γ and IL-1β 
expression occurred in older patients but IL-6 was significantly increased in the aging 
group (Man et al., 2015). However, an increase in intestinal permeability as a result of 
age-associated changes in intestinal epithelial tight junctions has been reported (Tran 
and Greenwood-Van Meerveld, 2013, Man et al., 2015).  The association of an increase 
in gene expression in the muscularis with age in the colic cases may therefore be 
attributable to an increase in intestinal permeability with age in the colic cases. The 
increased intestinal permeability could result in a greater translocation of PAMPs and 
DAMPs from the gut lumen, causing greater activation of the resident muscularis 
macrophages which is reflected by the higher relative changes in gene expression. 
Relative gene expression was lower in horses that had a longer duration of colic prior 
to surgery in both the mucosa (Figure 5-7) and ME (Figure 5-8). Neither intestinal 
resection length (Figure 5-11) (Figure 5-12) nor short-term survival (Figure 5-16) 
showed any association with relative gene expression in both mucosa and ME.  The 
small group sizes constitute a significant limitation of this analysis; therefore, it is 
difficult to make definitive conclusions from these data. The gene expression data 
for resection length had 1 outlier (1 horse that required 15m of intestine to be 
resected). On removing this outlier, no significant difference in relative gene 
expression was associated with resection length although PTGS2 and TNF-α in the 
mucosa had an increasing trend with resection length, whilst in the ME IL-1β and IL-
6 decreased with resection length. 
In conclusion, these data demonstrate an inflammatory response within the GIT of 
horses undergoing abdominal surgery. The data suggest an upregulation of genes 
associated with activation of macrophages (IL-6, TNF-α, IL1B). These, along with 
PTGS2 and CCL2 are all capable of inhibiting smooth muscle contractility, therefore 
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disrupting normal intestinal motility and resulting in functional POI. The absence of 
NOS2 upregulation highlights inter-species variation in this inflammatory pathway, 
thus emphasising the importance of considering the target species when developing 
potential therapeutic targets. Further work could include targeted analysis of the 
resident macrophage population. Furthermore, whilst the intestinal recruitment of 
neutrophils in equine abdominal surgery has been studied (Little et al., 2005), to date 
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The gastrointestinal (GI) muscularis macrophages (MM), which are distributed 
throughout the length of the muscularis externa (ME), respond to alterations in 
intestinal luminal contents and regulate gastrointestinal motility by interactions with 
enteric neurons by secreting bone morphogenetic protein 2 (BMP2) (Muller et al., 
2014). In turn, enteric neurons were believed to be a major source of the growth factor 
CSF-1, required for macrophage proliferation, differentiation and survival.  
As discussed in Chapter 1, the activation of MM is a component of the inflammatory 
cascade following abdominal surgery which leads to the development of post-
operative ileus (POI). Activation of the MM results in an influx of leukocytes within 
hours of the commencement of abdominal surgery, ultimately resulting in smooth 
muscle dysfunction and impaired GI motility (De Jonge et al., 2003).  
The majority of POI studies focus on the depletion of MM or blocking the leukocytic 
infiltrate (Wehner et al., 2007, Kalff et al., 1999b, The et al., 2005). The function of 
macrophages in the resolution of inflammation and POI has received less interest. 
With every tissue injury, immune cells and their products will also contribute to the 
resolution of inflammation. In mouse models of POI, Il-10 knockout mice are unable 
to resolve their muscularis inflammatory response compared to wild type (WT) mice 
which results in higher mortality rates (Stoffels et al., 2009). The administration of 
exogenous IL-10 improved post-operative GI transit and reduced inflammatory 
cytokines, chemokine and nitric oxide (NO). Until recently, the role of monocytes and 
macrophages in the resolution of POI had not been studied. In mouse models of other 
disease such as liver disease, stroke and spinal disease, infiltrating monocyte-derived 
macrophages (MDM) are needed for recovery (Shechter et al., 2009, Wattananit et al., 
2016, Zigmond et al., 2014). Using C-C motif chemokine receptor 2 (CCR2) deficient 
mice (Ccr2-/-), Farro et al. (2017) reached a similar conclusion in a model of intestinal 
manipulation-induced POI (Farro et al., 2017). The receptor encoded by the Ccr2 gene 
mediates monocyte chemotaxis in tissues and Ccr2-/- mice have defective monocyte 
recruitment to sites of inflammation (Kurihara et al., 1997). Following intestinal 
manipulation (IM), Ccr2-/- mice still develop POI to the same extent as WT mice 24 
hours post-operatively. They also have similar expression of pro-inflammatory 
cytokines (tnf, il6 and il1a) and chemokines (ccl2, cxcl1 and cxcl2) as WT mice. This 
supports previously published data that resident MM are responsible for the initiation 
of the inflammatory response rather than recruited leukocytes, such as MDMs and 
neutrophils. However, WT and Ccr2-/- mice differ in their recovery from the challenge. 
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Ccr2-/- mice had a more persistent inflammatory response with higher expression of 
pro-inflammatory cytokines and chemokines, increased neutrophil-mediated 
pathology, increased neuronal and smooth muscle dysfunction, increased fibrosis of 
the muscularis and a delay in return of normal GI transit when compared to WT mice. 
WT mice had higher mRNA levels of pro-resolving genes such as Arg1, Mrc1 and Ym1, 
when compared to Ccr2-/- mice. The impaired monocyte recruitment in Ccr2-/- mice 
therefore appeared to prevent resolution of the inflammatory process in POI, 
implying that recruited cells are pro -resolving and therefore required to restore 
normal intestinal homeostasis (Farro et al., 2017).  
The macrophage growth factor, CSF-1, promotes monocyte production, recruitment, 
maturation and local macrophage proliferation (Hume et al., 1988). Administration 
of CSF-1 promotes regeneration and repair in several murine disease models such as 
those involving the kidney (Alikhan et al., 2011), liver (Stutchfield et al., 2015) and 
brain (Boissonneault et al., 2009). The development of CSF1-Fc, a fusion of pig CSF-1 
and the Fc region of pig IgG1a, addressed the initial limitations of CSF-1 therapy by 
generating a protein with an increased half-life at lower doses than the native protein 
(Gow et al., 2014). The administration of CSF1-Fc to WT mice and pigs increases 
circulating monocyte and tissue macrophage numbers (Gow et al., 2014, Sauter et al., 
2016, Stutchfield et al., 2015, Sauter et al., 2014). It was previously thought that 
release of Ly6Chi monocytes from the bone marrow depended upon  CCR2 signalling 
(Shi and Pamer, 2011). but CSF-1-Fc was able to override the CCR2 requirement for 
the release of monocytes from the bone marrow (Stutchfield et al., 2015).  
Muller et al. (2014) showed previously that the MM express Csf1r, and CSF-1 is 
required for their development and maintenance.  MM were absent from juvenile 
Csf1r (-/-) or Csf1(op/op) mice, and rapidly became depleted following treatment with anti-
CSF-1R antibody, as shown previously by Macdonald et al. (2010) using a different 
antibody.  Muller et al. favoured a model in which regulated production of CSF-1 by 
neurons controls the function of MM, which in turn regulated neuronal function 
through production of BMP2.   However, their analysis did not directly demonstrate 
that increased availability of CSF-1 can regulate MM function or gene expression, nor 
did they show that CSF-1 can modulate gastrointestinal motility.  A more recent study 
in neonatal mice without enteric neurons and in intestine from humans with 
Hirschsprung’s disease, which also lack enteric neurons, found that normal 
colonisation by MM occurs (Avetisyan et al., 2018). This suggests that enteric neurons 
are not required for colonisation by MM, and that neuronal-macrophage interactions 
develop postnatally. Many aspects of gene expression in MM resemble microglia. In 
the brain, increased CSF-1 is strongly-associated with microgliosis seen in many 
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neurodegenerative diseases (Askew et al., 2017) and increased neuronal CSF-1 has 
also been implicated in neuropathic pain (Tang et al., 2018, Guan et al., 2016). 
Most of the work of Muller et al. utilised a widely-used Cx3cr1-EGFP reporter gene to 
locate MM.  In this chapter, Csf1r reporter genes (Hawley et al., 2018, Sasmono et al., 
2003) are used to image macrophages in the layers of the ME. In combination with 
the novel CSF1-Fc agent, the direct impact of CSF-1 in regulating MM numbers and 
the impact of CSF1-Fc on the phenotype of intestinal macrophages is examined. Based 
upon these data, in a collaboration with Professor Gianluca Matteoli (Translational 
Research in Gastrointestinal Disorders [TARGID], KU Leuven, Belgium) who was 
investigating the role of MDMs in POI, we administered CSF1-Fc to WT and CCr2-/- mice 
in a mouse model of IM-induced POI. Some of the data presented in this chapter were 
published in collaboration with Professor Gianluca Matteoli (Farro et al., 2017). 
 Results 
6.2.1 Administration of CSF1-Fc to mice does not affect 
gastrointestinal transit time 
Mice (12-week-old males and females, n=3 per group) were injected daily with 
0.75mg/kg of CSF1-Fc for either 3 days or 5 days. The control group received an equal 
volume of PBS.  
As has been reported previously, CSF1-Fc administration resulted in increased spleen 
weight (Farro et al., 2017, Gow et al., 2014, Stutchfield et al., 2015). No difference was 
observed in liver weights between the 2 groups following 3 days of treatment but was 
present after 5 days of treatment with CSF1-Fc (Figure 6-1). The removal of MM is 
thought to result in intestinal dysmotility (Muller et al., 2014). Currently no data exist 
regarding the of effect of increased intestinal macrophage populations on motility. 
Mice were treated with CSF1-Fc which has previously been shown to increase LpM 
(Sauter et al., 2014). Alterations in MM populations have not been studied to date. In 
the present study, there was no difference in GI motility between CSF1-Fc and saline 
treated mice (Figure 6-2). In all but one mouse, fluorescent dextran material had 
reached the caecum after 90 minutes, which is equivalent to section 11 on the scale 
used to measure geometric centre (GC). To evaluate if this result was due to a failure 
of CSF1-Fc to act on MM, imaging was performed on intestinal whole mounts to 
evaluate the MM.  






Figure 6-1 Effect of CSF1-Fc on spleen and liver weights in mice 
Bar graphs showing spleen and liver weight to bodyweight ratio in mice administered CSF-
Fc daily for 3 days (A) and 5 days (B). Graphs show mean ± 95% CI. **p<0.001, ***p<0.001, 
****p<0.001 by unpaired t-test. 




6.2.2 Administration of CSF1-Fc alters morphology of 
resident muscularis macrophages  
Distribution of resident gastrointestinal macrophages is identical in 
MacGreen and mApple macrophage reporter mice 
Prior to analysis of tissues from mice treated with CSF1-Fc, imaging was optimised 
for a new macrophage reporter mouse; the Csf1r-mApple (Hawley et al., 2018). The 
MacGreen mouse is an EGFP reporter mouse driven by regulatory elements of Csf1r 
(Sasmono et al., 2003) that allows the imaging of Csf1r-expressing cells to be 
visualised in situ. The mApple transgenic mouse is also a Csf1r fluorescent reporter, 
using the red reporter gene, mApple (Hawley et al., 2018). Muller et al. used the 
Cx3cr1 fluorescent reporter mouse, a gene which is highly expressed in microglia and 
mast cells of mice and expressed at lower levels in BMDMs (Figure 6-3). Cx3cr1 is 
commonly used as a microglial marker but is not expressed on all microglia detected 
with the Csf1r-ECFP transgene and is not expressed by all resident macrophage 
populations, particularly those derived recently from Cx3cr1-negative monocytes 
(D.A. Hume, personal communication). 
 
Figure 6-2 Effect of 3 and 5 days of CSF1-Fc administration on gastrointestinal 
transit times in wildtype mice 
Wildtype mice were treated for 3 or 5 days with 0.75mg/kg of CSF1-Fc once daily 
subcutaneously. Control mice were treated with PBS. Dots represent geometric centre (GC) 
values from individual mice. Mean is also shown. No significant differences between CSF1-
Fc and saline treated data sets as determined via unpaired t-test.  




Figure 6-3 Gene expression chart for Cx3cr1 in mouse 
Gene expression chart for Cx3cr1 gene in mice from a variety of tissues, organs and cell lines. 
Microglia (Blue); RAW_264 cells (Dark Green); Bone marrow-derived macrophages (ochre); 
Mast cells (light green); brain regions (Grey). Gene expression data from Mouse MOE430 
Gene Atlas (GEO: GSE10246) (Su et al., 2002) 
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Firstly, confocal images from MacGreen mice were obtained from ex situ intestinal 
whole mounts (Figure 6-4). The distribution of the transgene in tissues of the 
MacGreen mouse has been well documented (Sasmono et al., 2003, Sauter et al., 2014) 
but no studies have imaged MM. Expression of the transgene was visible in the lamina 
propria and ME of the small and large intestine (Figure 6-5). The transgene 
emphasised the base of each villus in the lamina propria whilst in the ME of both the 
small and large intestine, a dense network of microglial-like macrophages was visible. 
This is consistent with other studies, which have used Cx3cr1GFP/+ reporter mice to 
image intestinal macrophages (Gabanyi et al., 2016). As discussed in Chapter 3, 
immunohistochemical studies have demonstrated that MM within the muscle layers 
are elongated, bipolar with MM between the muscle layers being more stellate with 
multiple dendrites (Kalff et al., 1998b, Mikkelsen, 2010). In the MacGreen mouse, 
amongst the MM population within the ME there were two distinct morphological sub 
populations; bipolar cells within the muscle layer and stellate cells in the 
intermuscular layer (at the level of the myenteric plexus) (Figure 6-5). Imaging of 
mApple ex-situ intestinal whole mounts revealed identical transgene expression in 
the GIT to the MacGreen (Figure 6-6 and Figure 6-7). Morphology of macrophages in 
the ME was also alike in mApple and MacGreen mice (Figure 6-7). This is consistent 
with imaging of other mApple tissues, where expression patterns are the same 
between the two transgenes (Hawley et al., 2018). 
 




Figure 6-4 Intestinal whole mount images of the lamina propria (A) and muscularis 
(B) of the jejunum and muscularis of the colon (C) 
Confocal microscopy images of intestinal whole mounts of the small (A and B) and large (C) 
intestine. (A) is a single slice. (B) and (C) are image stacks of whole muscularis. Magnification 
X10. Bar=100µm. Images representative of 3 experiments, n=3 per experiment 
 




Figure 6-5 Intestinal whole mount imaging of the colon of MacGreen mice 
Whole mount images of colon showing image stack of muscularis externa (A). (B) represents 
single slices of the inner (circular) muscle (LEFT) and myenteric plexus and outer muscle 
region, (RIGHT). Insets show magnified individual macrophage morphology. Magnification 
(A) X10, (B) X20. Bar =100µm. Images representative of 3 experiments, n=3 per experiment 




Figure 6-6 Whole mount fluorescence microscopy of the intestines of mApple mice  
Ex-situ fresh intestinal whole mounts of mApple mice (A,C,D,E,F) and wild type mice (B) 
were imaged by fluorescence microscopy. Sections imaged are jejunum (A and B), villi of 
jejunum (C and D) and muscularis of jejunum (E) and colon (F). Magnification (A) and (B) 
X5. (C) X10. (D), (E) and (F) X20. A – D Bar=200µm. (E) and (F) Bar=50µm.  
  




Figure 6-7 Intestinal whole mount fluorescent imaging of the muscularis externa in 
MacGreen and mApple mice 
Whole mount images of colon showing image stack of muscularis externa in MacGreen (A) 
and mApple (C) mice. (B) and (D) represent single slices of the inner (circular) muscle (LEFT) 
and myenteric plexus and outer muscle region, (RIGHT).  
Magnification: (A) and (C) X10 Bar=100µm, (B) X20. Bar =50µm. (D) X40 Bar=10µm.  
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A striking feature observed in the whole mounts is the regularity of the distribution 
of the MM throughout the GIT (Figure 6-7). This distribution and regularity resembles 
that seen in other resident macrophage populations particularly those in the skin 
(Langerhans cells) and brain (microglia). A feature of Langerhans cells and microglia 
is that they occupy an area within the tissue, with no overlapping of dendrites 
(Tremblay et al., 2011), although contact between microglia cell components has been 
observed (Hanisch and Kettenmann, 2007). MM also occupy a specific area with no 
overlapping of dendrites (Figure 6-8). Some dendrites were in very close proximity to 
each other but did not overlap (Figure 6-9). This close proximity suggests that, as 
microglia do, MM dendrites do come into contact with each other, although live 
imaging of whole mounts would need to be performed to demonstrate this. 
 
Figure 6-8 Intestinal whole mount fluorescent imaging of the muscularis externa in 
MacGreen mouse 
Whole mount image of colon in a MacGreen mouse with the regional space occupied by 
each  muscularis mapped out (red line).  
Magnification X20. Bar =50µm 





Figure 6-9 Intestinal whole mount fluorescent imaging of the muscularis externa in 
MacGreen mouse 
Whole mount image of colon in a MacGreen mouse showing the proximity of dendrities to 
each other. 
Magnification X20. Bar =100µm 
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Administration of CSF1-Fc alters cell size but not number in the 
muscularis externa 
Previous studies, using a Csf1r-ECFP reporter that labels monocytes, but only a subset 
of tissue macrophages and DC, demonstrated that CSF1-Fc elicited an influx of 
monocyte-derived cells into the lamina propria (Sauter et al., 2014).  CSF1-Fc also 
greatly increased macrophage numbers in the liver, spleen and lung (Gow et al., 2014). 
This change was due to both monocyte infiltration and proliferation of resident tissue 
macrophages (Stutchfield et al., 2015).   To test the ability of CSF-1 to modulate MM 
numbers or function, WT mApple mice were administered either CSF1-Fc (n=3) or PBS 
(n=3) daily for 5 days. Following sacrifice, whole-mount fluorescence microscopy of 
the intestines was performed. Administration of CSF1-Fc resulted in an increase in 
cell size (measured as total area of fluorescence) in both the small and large intestine 
(Figure 6-10). The regular distribution of the MM remained unchanged and there was 
no significant difference in cell numbers, neither from infiltration of monocyte-like 
cells nor from regional proliferation. This differs from the effect on LpM, whereby 
administration of CSF1-Fc resulted in an influx of cells into the lamina propria (Sauter 
et al., 2014). Despite there being no effect on MM in number, there was a dramatic 
morphological change in response to CSF1-Fc administration, whereby MM in 










Figure 6-10 Effect of CSF1-Fc on muscularis externa macrophages 
Whole mount image stack (A) and slices (B and C) of jejunum (B) and colon (C) showing 
morphology of muscularis externa macrophages after 5 days of CSF1-Fc treatment. (D) Bar 
plot showing area of fluorescence in jejunum and colon. Data shown mean ± 95% CI. 
Significance determined via unpaired t-test. *p<0.05 Magnification: (A) X10 Bar=50µm. 
Magnification: (B) and (C) X40 Bar=10µm 
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6.2.3 Administration of CSF1-Fc in a mouse model of POI 
drives the differentiation of pro resolving macrophages 
This section of work has been previously published in Gut entitled ‘CCR2-dependent 
monocyte-derived macrophages resolve inflammation and restore gut motility in 
postoperative ileus’ and was performed in collaboration with Professor Gianluca 
Matteoli. The aim for this study was to evaluate the effect of CSF1-Fc in a murine 
model of IM-induced POI in WT mice. Professor Matteoli’s group was interested in the 
effect of CSF1-Fc administration to CCr2-/- mice. The work on both WT and CCr2-/- 
mice was performed concurrently at TARGID, Leuven, Belgium. Full results are in 
published in Farro et al. 2017 and are summarised below. 
CSF1-Fc was administered to WT mice for 5 days, commencing 24 hours prior to IM 
and then daily until sacrifice (Day 3 post manipulation). CSF1-Fc treatment increased 
spleen and liver weight compared to mice receiving saline alone (Figure 6-11) as seen 
in previous studies (Gow et al., 2014, Sauter et al., 2016, Stutchfield et al., 2015). No 
significant difference in GI motility was observed between the two groups (Figure 
6-12-C). CSF1-Fc administration increased the number of monocytes in the muscularis 
3 days following IM, as well as the number of Ly6ChiMHCII+ immature macrophages 
and Ly6CloMHCIIlo macrophages (Figure 6-12-A). CSF1-Fc administration failed to 
increase cell numbers in WT gut which had not undergone manipulation (see section 
above). This would imply that manipulation induced infiltration occurred, which was 
increased with CSF1-Fc treatment. The two data sets are not entirely comparable as, 
measurement between the two are different; manipulated ME cell numbers were 
measured by flow cytometry following digestion of the ME whereas non-manipulated 
WT muscularis was analysed by imaging alone. Nevertheless, the results are 
consistent with the finding that CSF1-Fc acts on monocyte-derived cell populations 
and not resident cell populations (Stutchfield et al., 2015). In contrast however, Sauter 
et al. demonstrated local resident cell proliferation (namely, Kupffer cells in the liver) 
in response to CSF1-Fc by (Sauter et al., 2016).  
The main impact of CSF1-Fc treatment on WT mice was to inhibit neutrophil 
infiltration into the ME (Figure 6-13) suggesting monocytes and/or macrophages limit 
neutrophil migration into the ME. As a result, CSF1-Fc treated mice had significantly 
lower numbers of reactive oxygen species (ROS)-producing neutrophils (Figure 6-12-
B). Expression of anti-inflammatory and pro-resolving genes was also increased with 
CSF1-Fc treatment. Expression of the anti-inflammatory genes Arg1 and Il10 were 
increased (although Arg1 not significantly) with CSF1-Fc treatment as were pro-
resolving genes such as Stab1, Lyve1, Mrc1 and Cd163 (Figure 6-14). 















































































Figure 6-11 CSF1-Fc treatment increases spleen and liver weight (Supplementary 
Figure 10 Farro et al. 2017).  
Spleen (A) and liver (B) weight ratio over body weight of WT and Ccr2-/- mice treated with 
(0.75 µg/g) CSF1 Fc or saline for 4 consecutive days. Statistical significance between CSF1-
Fc and saline-treated data sets was determined via unpaired t-test (*** P < 0.0001) 
 
Reproduced from: CCR2-dependent monocyte-derived macrophages resolve inflammation 
and restore gut motility in post-operative ileus, Farro, G., Stakenborg, M., Gomez-Pinilla, P. 
J., Labeeuw, E., Goverse, G., Di Giovangiulio, M., Stakenborg, N., Meroni, E., D'Errico, F., 
Elkrim, Y. Laoui, D., Lisowski, Z. M., Sauter, K. A., Hume, D. A., Van Ginderachter, J. A., 
Boeckxstaens, G. E., Matteoli, G. 66:20982109, © Article authors 2017 with permission from 
BMJ Publishing Group Ltd. 
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Figure 6-12 Colony-stimulating factor (CSF) 1 drives pro-resolving macrophage 
differentiation and favours recovery of GI motility (Figure 8 Farro et al. 2017)  
WT and Ccr2−/− mice undergoing intestinal manipulation (IM) were treated with either 0.75 
µg/g CSF1-Fc or saline. Functional and inflammatory parameters were assessed 3 days 
after IM. (A) Absolute numbers of Ly6ChiMHCII− monocytes, Ly6C+MHCII+ immature MΦs, 
Ly6C−MHCIIlo and Ly6C−MHCIIhi MΦs in WT and Ccr2−/− mice. Statistical significance 
between CSF1-Fc and saline-treated data sets was determined via unpaired t-test (*p<0.05, 
**p<0.001, ***p<0.0001; ns, not significant). (B) Absolute numbers of ROS+ neutrophils. 
Statistical significance between CSF1-Fc and saline-treated data sets was determined via 
unpaired t-test (**p<0.001). (C) Dots represent GC values from individual mice; mean is 
also shown. Statistical significance between CSF1-Fc and saline-treated data sets was 
determined via unpaired t-test (*p<0.05).  
 
Reproduced from: CCR2-dependent monocyte-derived macrophages resolve inflammation 
and restore gut motility in post-operative ileus, Farro, G., Stakenborg, M., Gomez-Pinilla, P. 
J., Labeeuw, E., Goverse, G., Di Giovangiulio, M., Stakenborg, N., Meroni, E., D'Errico, F., 
Elkrim, Y. Laoui, D., Lisowski, Z. M., Sauter, K. A., Hume, D. A., Van Ginderachter, J. A., 
Boeckxstaens, G. E., Matteoli, G. 66:20982109, © Article authors 2017 with permission from 
BMJ Publishing Group Ltd. 










































































































































Figure 6-13 CSF1 reduces influx of neutrophils and drives accumulation of 
macrophages into the muscularis externa during recovery after IM (Supplementary 
Figure 11 Farro et al. 2017)  
WT and Ccr2-/- mice undergoing IM were treated with either CSF1-Fc or saline. Percentages 
of CD11b+Ly6G+ neutrophils (A), Ly6ChiMHCII- monocytes (B), Ly6C+MHCII+ immature MΦ 
(C), Ly6C-MHCIIlo (D) Ly6C-MHCIIhi MΦ (E) in the ME and Ly6ChiMHCII- blood monocytes 
(F) in WT and Ccr2-/- mice 3 days after IM. Statistical significance between CSF1-Fc and 
saline-treated data sets was determined via unpaired t-test (* P < 0.05, ** P < 0.001, *** P < 
0.0001 and ns= not significant). 
 
Reproduced from: CCR2-dependent monocyte-derived macrophages resolve inflammation 
and restore gut motility in post-operative ileus, Farro, G., Stakenborg, M., Gomez-Pinilla, P. 
J., Labeeuw, E., Goverse, G., Di Giovangiulio, M., Stakenborg, N., Meroni, E., D'Errico, F., 
Elkrim, Y. Laoui, D., Lisowski, Z. M., Sauter, K. A., Hume, D. A., Van Ginderachter, J. A., 
Boeckxstaens, G. E., Matteoli, G. 66:20982109, © Article authors 2017 with permission from 
BMJ Publishing Group Ltd. 
 


























































































































































































































Figure 6-14 CSF1-Fc treatment drives expression of anti-inflammatory genes in the 
muscularis externa during recovery (Supplementary Figure 12 Farro et al. 2017) 
Gene expression levels of anti-inflammatory gens were measured in homogenates of ME from 
WT and Ccr2-/- mice treated with either CSF1-Fc or saline 3 days after IM. (A) mRNA levels 
are expressed as fold change mean values ± SEM versus naïve. Statistical significance 
between CSF1-Fc and saline-treated data sets was determined via unpaired t-test (* P < 0.05, 
** P < 0.001 and ns= not significant). 
 
Reproduced from: CCR2-dependent monocyte-derived macrophages resolve inflammation 
and restore gut motility in post-operative ileus, Farro, G., Stakenborg, M., Gomez-Pinilla, P. 
J., Labeeuw, E., Goverse, G., Di Giovangiulio, M., Stakenborg, N., Meroni, E., D'Errico, F., 
Elkrim, Y. Laoui, D., Lisowski, Z. M., Sauter, K. A., Hume, D. A., Van Ginderachter, J. A., 
Boeckxstaens, G. E., Matteoli, G. 66:20982109, © Article authors 2017 with permission from 
BMJ Publishing Group Ltd. 
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6.2.4 Microarray analysis of muscularis externa treated with 
CSF1-Fc 
Based upon the morphological impacts detected with the Csf1r-mApple transgene, it 
appeared that MM were responsive to exogenous CSF-1. To analyse gene expression 
changes in non-manipulated muscularis in response to CSF1-Fc administration, gene 
expression arrays were performed to further determine the potential pro-resolving 
benefit of CSF1-Fc. RNA was extracted from the muscularis of PBS-treated (n=3) and 
CSF1-Fc treated (n=3) mice that had undergone IM. RNA extractions were performed 
by Michelle Stakenbourg, TARGID, KU Leuven. RNA quality was analysed using 
TapeStation and samples with a RIN >7 were used. This was performed at The Roslin 
Institute, University of Edinburgh.  
Expression data were Robust Multi-array Average (RMA) normalised prior to analysis. 
Differential expression analysis was performed to identify genes most differentially 
expressed between PBS and CSF1-Fc treated ME in WT mice. Of 22,407 genes 716 
showed significant differential expression with only 15 upregulated with a log2 fold 
change (fc) of >1 and 38 downregulated <-1 log2 fc (Figure 6-15). Figure 6-15 shows 
a reduction in the detection of neutrophil markers (S100a8 and S100a9) which agrees 
with the findings in the previous section showing reduced neutrophil numbers in 
CSF1-Fc-treated mice in manipulate intestine, and with previous published studies 
(Stutchfield et al., 2015). There is no evidence of a substantially increased detection 
of monocyte-macrophage markers such as Csf1r and Cd14, although Cx3cr1 
expression was increased (Table 6-1). 










Cx3cr1 7.39 8.44 1.05 0.01 
Csf1r 10.26 10.90 0.64 0.02 
CD14 7.90 8.26 0.36 0.35 
 
 




Figure 6-15 Top genes induced and suppressed following CSF1-Fc administration in 
manipulated muscularis externa 
Microarray data of genes induced (Log2fc >1) or suppressed (log2fc<-1) by CSF1-Fc in the 
muscularis externa of mice following intestinal manipulation. 




The aim of this chapter was to evaluate the effect of CSF1-Fc, a novel agent that 
promotes monocyte production and recruitment and macrophage maturation and 
local proliferation, as a potential therapeutic approach in a mouse model of POI. POI 
occurs following abdominal surgery.  IM during surgery is thought to trigger DAMPs 
and PAMPs, triggering an inflammatory reaction of the MMs which results in 
infiltration of the ME with leukocytes (De Jonge et al., 2003, Kalff et al., 1999b). The 
administration of CSF-1 has been tested in several diseases with multiple effects 
(Hume and MacDonald, 2012). In some circumstances, such as in disseminated 
candidiasis, CSF-1 treatment exacerbated the disease; whereas, pre-treatment with 
CSF-1 was found to be protective from the disease (Cenci et al., 1991). This is not 
unsurprising given that some pathologies are macrophage-mediated, but also due to 
CSF-1 driving a pro-inflammatory macrophage phenotype in some scenarios (Abd et 
al., 1991). In models of ischaemic kidney disease (Alikhan et al., 2011) and partial 
hepatectomy (Stutchfield et al., 2015), the increase in pro-resolving macrophages 
improved recovery. In this preliminary study, it was decided to initially evaluate the 
effect of CSF1-Fc administration to mice undergoing IM-induced POI model as a pre-
treatment.  
Prior to use in association with the mouse model of POI, the effect of CSF1-Fc on 
normal intestine was evaluated using the Csf1r-EGFP and Csf1r-mApple mouse 
(Sasmono et al., 2003, Hawley et al., 2018). Firstly, the MM populations were evaluated 
in both transgenes (Figure 6-4,Figure 6-5,Figure 6-6 and Figure 6-7). This confirmed 
that the Csf1r-mApple transgene (a newer strain of mouse) had identical expression 
in the ME in both the small and large intestine. The MM formed a regular network 
throughout the whole GIT, with either a stellate or bipolar morphology (Figure 6-5 
and Figure 6-7). This difference in morphology represents two subsets of MMs with 
different phenotypes, with stellate macrophages associated with the myenteric 
plexus and bipolar macrophages associated with the muscle layers (Gabanyi et al., 
2016). Other macrophage populations with a stellate morphology are microglia 
(Tremblay et al., 2011, Nimmerjahn et al., 2005) and Langerhans cells (Mulholland et 
al., 2006). MM occupy an area in the ME and there is no overlapping of dendrites 
(Figure 6-8 and Figure 6-9) although some do come into close proximity (Figure 6-9) 
suggesting that, as observed in microglia (Nimmerjahn et al., 2005, Hanisch and 
Kettenmann, 2007), cell contact and communication does occur. These data suggest 
that MM occupy a specific niche, a feature also seen with other intestinal 
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macrophages; for example, LpM are closely associated with the intestinal crypt 
epithelium (Sehgal et al., 2018).  
Intestinal transit time (Figure 6-2) and the morphology of the MM population (Figure 
6-10) was evaluated following administration of CSF1-Fc to normal WT mice. 
Administration of CSF1-Fc did not alter transit time, and therefore does not appear 
to regulate intestinal motility. Neurons secrete CSF-1 to maintain MM populations 
(Muller et al., 2014) although enteric neurons are not required for MM colonisation of 
the intestine (Avetisyan et al., 2018). In return, MM, via secretion of BMP2, maintain 
intestinal motility (Muller et al., 2014). The data in the resent study suggest that an 
increase in CSF1-Fc does not result in an alteration of intestinal motility. To determine 
whether this was due to a failure of CSF1-Fc acting on MM, whole mount imaging of 
ME was performed. In response to CSF1-Fc, MMs became more amoeboid, with a 
greater area occupied by each cell, thus demonstrating that MM do indeed respond 
to CSF1-Fc administration (Figure 6-10). Although CSF1-Fc administration results in 
an increase in monocyte-derived macrophages in the lamina propria (Sauter et al., 
2014) and increased local proliferation of macrophages in the liver (Stutchfield et al., 
2015, Sauter et al., 2016), there was no evidence of this cellular expansion with 
respect to the MMs. This may reflect the fact that LpMs and Kupffer cells are 
replenished by monocytes (Bain et al., 2014, Sauter et al., 2016). To date very few fate 
mapping data of MMs exist, but some early work does show that MMs expressing 
MHCII are present in the ME and myenteric plexus in embryos and new-born mice 
(Mikkelsen et al., 2004).  
Next, CSF1-Fc was administrated to mice prior to undergoing IM. Again, mice showed 
the expected increase in liver and spleen weight (Figure 6-11) as reported previously 
(Gow et al., 2014, Sauter et al., 2016). CSF1-Fc treatment increased circulating 
monocytes and pro-tissue repair macrophages (Figure 6-12 and Figure 6-13). CSF1-
Fc drives macrophages towards a pro-tissue repair phenotype (Martinez et al., 2006) 
and as such has been shown to be beneficial in recovery of kidney and liver disease 
models. In this model of POI, CSF1-Fc increased macrophages in the ME (Figure 6-13) 
and reduced ROS-producing neutrophils (Figure 6-12). Secondly, as reported in other 
disease models, there was an increase in anti-inflammatory gene expression of Arg1, 
Ym1, Il10, Stab1, lyve1, Mrc1 and Cd163 (Figure 6-14). Preliminary analysis of 
differential gene expression of manipulated ME corroborates these findings with a 
reduction in neutrophil (e.g. S100a8, S100a9) associated genes and an upregulation 
in anti-inflammatory genes (e.g. Lyve1, Ccl24).  
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These data show that CSF1-Fc does act on MM in non-manipulated mouse intestine, 
although this doesn’t result in an alteration of intestinal motility. Furthermore, in a 
mouse model of IM-induced POI, CSF1-Fc administration reduces neutrophilic 
infiltration in the ME and promotes tissue recovery by increasing monocytes and 
macrophages in the muscularis. In addition, CSF1-Fc promotes further tissue repair 
by increasing anti-inflammatory gene expression in the ME. These data suggest that 
CSF1-Fc may be beneficial in POI to promote tissue repair and recovery. Together with 
the data by Professor Matteoli’s group using Ccr2-/- mice demonstrating a requirement 
for monocytes in tissue repair in POI, these findings support a potential need for 
future therapeutic discovery initiatives to focus on the promotion of tissue repair by 
monocytes and macrophages and not solely on anti-inflammatory treatments aimed 
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 General Discussion 
The aims of this thesis were to further our knowledge of equine macrophage biology 
with a focus on intestinal macrophages and their role in post-operative ileus (POI). 
Few studies have been conducted on the pathophysiology of POI in the horse. No 
studies have been conducted on the contributory role of equine resident intestinal 
macrophages, cells which have been shown to be pivotal in both rodent (Kalff et al., 
1998a, Farro et al., 2017) and human (Kalff et al., 2003) POI studies via their role in 
triggering the inflammatory response that ultimately results in smooth muscle 
dysfunction.  
In Chapter 3, the distribution of macrophages in the equine GIT was analysed. The 
first aim of the chapter was to identify a suitable macrophage marker. A significant 
limiting factor in the study of equine immunology is the lack of available antibodies. 
CD163, a macrophage scavenger receptor, is expressed on most macrophage tissue 
populations (Fabriek et al., 2005) and in rats this marker is present on the most 
abundant macrophage population in the muscularis externa (ME) (Kalff et al., 1998b). 
CD163 (Clone AM-3K) has previously been used in equine intestinal tissue (Yamate et 
al., 2000, Grosche et al., 2011). Following antibody optimisation, intestinal tissue from 
the stomach to the small colon from 10 non-colic horses was stained for CD163 
(Clone KT-103 as Clone AM-3K did not work). CD163+ve cells were present in all tissue 
layers of the equine intestine: mucosa, submucosa, ME and the serosa. CD163+ve cells 
were regularly distributed within the ME, with accumulations adjacent to the 
myenteric plexus, and therefore to intestinal motility effector cells such as neurons 
and the Interstitial Cells of Cajal (ICC), supporting a potential influential role of 
macrophages on intestinal motility, as reported in mice (Muller et al., 2014).  
Building upon the work in Chapter 3, Chapter 4 describes the attempt to optimise 
protocols aimed at isolating intestinal macrophages from the horse GIT to 
characterise the function and phenotype of the 2 subpopulations (lamina propria and 
MM). Due to several methodological problems, an alternative project strategy was 
formulated and equine bone marrow derived macrophages (eqBMDMs) were instead 
isolated, differentiated with CSF-1 and characterised and stimulated with LPS. Bone 
marrow-derived macrophages (BMDMs) are primary macrophages cells. They are 
derived from progenitor cells and in the presence of the macrophage lineage specific 
growth factor CSF-1 they differentiate and proliferate into macrophages (Hume and 
Gordon, 1983). This techniques has been used extensively in the Hume laboratory in 
other large animal species such as pig (Kapetanovic et al., 2012), sheep (Clark et al., 
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2017, Pridans et al., 2016), goat, cow and buffalo (Young et al., 2018). Previous work 
in the group demonstrated that equine cells do respond to recombinant human CSF-
1 (rhCSF1) (Karagianni et al., 2013, Karagianni, 2015, Karagianni et al., 2017). In this 
present study, progenitor cells from adult equine bone marrow were successfully 
differentiated into macrophages in the presence of rhCSF-1. EqBMDMs morphology 
and functionality was assessed using microscopy, flow cytometry and phagocytosis 
assays, thus confirming their identity as macrophages.  
Flow cytometry analysis of eqBMDMs failed to show expression of CD163 on 
eqBMDMs, a similar finding to that observed with pig bone-marrow derived 
macrophages (Kapetanovic et al., 2012). Alveolar macrophages did express CD163 
(Karagianni et al., 2013) as did intestinal macrophages in the equine GIT in this 
present study (Chapter 3) and in prior studies (Yamate et al., 2000). CD163 is 
expressed on mature resident tissue macrophages (Fabriek et al., 2005). Bone marrow-
derived macrophages are primary cells, and alveolar macrophages are resident tissue 
macrophages. Therefore, a possible explanation of the difference in expression could 
be the lack of regional signals in bone marrow derived macrophages that are needed 
for the expression of certain receptors such as CD163. Alveolar macrophages may 
have ‘received’ these signals from the lung, prior to collection and culture.  
LPS translocation from the gut lumen is an activator of ME macrophages in POI 
(Eskandari et al., 1997). The response of eqBMDMs to LPS stimulation included 
increased expression of positive control genes, TNF-α and IDO1. Extracted mRNA was 
also subjected to transcriptomic (RNA-Seq) analysis. Differential gene expression and 
network cluster analysis demonstrated an inflammatory response, indicated by the 
production of pro-inflammatory cytokines such as interleukin 1 beta (IL-1β) and 
interleukin 6 (IL-6). However, in contrast to rodent macrophages, eqBMDMs failed to 
produce nitric oxide in response to LPS, indicating species-specific variation in innate 
immune biology. This corroborates earlier findings by our group that equine alveolar 
macrophages do not produce NO in response to LPS (Karagianni et al., 2013, 
Karagianni et al., 2017). This difference between rodents and horse is not surprising 
given the species divergence in arginine metabolism demonstrated in a recent study 
looking at transcriptional regulation of genes associated with the arginine pathway 
in several species (Young et al., 2018).  Rats produce NO in response to LPS, a response 
shared with mice. Goat macrophages produce detectable NO, but sheep do not 
although both species showed an induction in NOS2 mRNA. Horse and pig do not 
produce NO nor is there an induction in mRNA. Cattle produce NO and induce the 
mRNA; buffalo produced lower levels of NO production and mRNA induction when 
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compared to cattle. These differing response to LPS were attributed to divergence in 
the iNOS (NOS2) promoter sequences between all the species (Young et al., 2018). The 
NO pathway is important in innate immune response to pathogens therefore these 
differences in the metabolism of arginine imply species-specific responses to 
pathogens.  
A feature of the equine LPS response was the number of negative feedback regulators 
identified in mouse and human macrophage responses that were apparently absent 
in the equine DE genes. This may explain why the horse is more susceptible to 
LPS/endotoxaemia compared to other species, such as mouse (Brade, 1999, Dinges 
and Schlievert, 2001).  
Utilising the data generated in Chapter 4, Chapter 5 compared gene expression in 
intestinal samples from horses undergoing abdominal surgery for colic (abdominal 
pain) with non-colic control horses. The colic group had evidence of induction IL-1β, 
IL-6, CCL2 and TNF-α mRNA expression in the mucosa and ME when compared to the 
control group, consistent with activation of the resident macrophages. This 
corroborates findings in humans undergoing laparotomy (Kalff et al., 2003) and mice 
undergoing IM (Farro et al., 2017). Whilst some similarities between species exist, the 
absence of NOS2 upregulation highlights inter-species variation stressing the 
importance of considering the target species when using alternative species models 
to develop potential therapeutic targets. Horses that developed post-operative reflux 
(POR), a clinical indicator of POI, had increased gene expression of IL-1β, IL-6 and 
TNF-α compared to horses that did not develop POR. These preliminary data are 
consistent with activation of macrophages within the ME of horses undergoing 
abdominal surgery for colic and support a potential association with the subsequent 
development of POI. IL-6, TNF-α, IL1B and PTGS2 can all inhibit smooth muscle 
contractility, which results in a functional inhibition of intestinal motility. These data 
do not however permit any definitive conclusions regarding the mechanism of 
macrophage activation; this may be attributable to either intestinal manipulation or 
the nature of the pre-existing condition which warranted surgical intervention.  
The final part of this project investigated the potential value of Fc fusion protein 
(CSF1-Fc), a long-acting form of CSF-1, as a treatment for POI using a mouse model 
(Chapter 6). Firstly, the effect of CSF1-Fc on the mouse muscularis was evaluated by 
measuring intestinal transit and confocal microscopy of the muscularis. Due to the 
close spatial relationship of resident MM with the myenteric plexus in the intestine, 
communication between MMs and the motility effector cells within the myenteric 
plexus has long been hypothesised. This was recently demonstrated in mice, whereby 
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MM communicate with enteric neurons via signalling with BMP2. In return, enteric 
neurons produce CSF-1, a factor required for macrophage survival, suggesting a 
synergistic relationship between the enteric nervous system and MMS. In this study, 
administration of exogenous CSF-1 did not alter intestinal motility, although 
morphological changes in the MM were observed. In contrast to LpM, CSF-1 
administration failed to result in an influx of macrophages into the ME of the intestine 
(Bain et al., 2014). In comparison, in a murine manipulation-induced POI model, 
administration of CSF1-Fc resulted in a reduction in neutrophil infiltration into the 
ME and an increase in the number of macrophages in the ME. RT-qPCR and network 
cluster analysis of the ME revealed clusters of genes induced and downregulated in 
association with CSF1-Fc administration prior to IM in WT mice. This revealed 
increased expression of both anti-inflammatory and pro-resolving genes. These data, 
when considered in conjunction with the data confirming the role of monocytes in 
the resolution of POI, suggest that future efforts to identify potential therapeutic 
targets should focus on the mechanisms which underpin the resolution of 
inflammation as well as mechanisms which reduce inflammation.   
In this study cohort, mice were pre-treated with CSF1-Fc prior to IM. This differs from 
the clinical situation with respect to colic surgery in the horse, whereby surgical 
intervention is generally required immediately upon clinical presentation to a surgical 
facility. Furthermore, such cases will generally have pre-existing 
inflammatory/ischaemic intestinal lesions. These factors would require 
consideration prior to any attempts to evaluate CSF1-Fc as a potential therapeutic 
approach in equine POI.  In the majority of equine colic cases, pre-treatment with 
CSF1-Fc would not be possible; this would only be applicable in cases undergoing an 
elective exploratory procedure (e.g. for the investigation of recurrent colic episodes). 
Furthermore, it should also be considered that CSF-1 administration has resulted in 
a worsening of clinical signs in relation to certain diseases, such as disseminated 
candidiasis, (Cenci et al., 1991). 
 Limitations of the study 
Horses used in this study were of varying ages, breeds and backgrounds. Despite 
appearing ‘clinically normal’ the full clinical histories of horses used, either as non-
colic or colic cases was unknown. The heterogenous nature of these equine subjects 
is an unavoidable limitation in these large animal studies involving clinical patients, 
but should not preclude clinical studies such as this, owing to the species differences 
observed between the horse and small laboratory mammals. 
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In Chapter 3, CD163 was the sole marker used for the identification of macrophages. 
The use of only one macrophage marker limits these results to only particular subset 
of intestinal macrophages in the horse. Given the heterogeneity in macrophage 
populations, ideally other markers should be used e.g. CD14, CD68, MHCII to further 
identify and characterise the macrophage populations in the equine GIT. The lack of 
available reagents (e.g. antibodies) represents a significant limiting factor in studies 
of the equine innate immune system. Whilst cross reactivity of reagents does occur 
(as in this study with CD163), the required optimisation exercise for each antibody 
and/or reagent used can be time consuming, costly and is not always successful. 
Therefore, the development of reagents specific for horse would be of great benefit.  
In Chapter 4, due to financial and time constraints only one time point following LPS 
stimulation was studied (7 hours). The transcriptomic response to LPS is a succession 
of waves of induction and repression of genes over 48 hours. Therefore, by studying 
one time point, this limits the evaluation of the horse’s full response to LPS. A full-
time course analysis (including sequential time points from 0 hours up to 24-48 
hours) would greatly expand on our knowledge of regulatory loops in the equine LPS 
response. Furthermore, the equine genome is poorly annotated meaning some genes 
may have been annotated incorrectly, or important pieces of information may be 
missing.  
A significant limitation of Chapter 5 was the small numbers used in the analysis of 
colic cases. On this basis, the recruitment of more colic cases would improve this 
preliminary data set. In addition, significant variation existed within the cohort of 
horses undergoing colic surgery, in relation to the following factors: intestinal lesion, 
duration of colic prior to surgery, age and breed of the horse. Although unavoidable 
in such a clinical-based study, this variation may have influenced the relative gene 
expression data generated and therefore the ability to draw definitive conclusions 
from the study.  This contrasts with the mouse model of POI, where each mouse 
underwent the same procedure, thus reducing the likelihood of the results being 
confounded by variability within the model.  
 
 Future Directions 
Each of the chapters in this thesis have provided usable preliminary data which can 
be further developed and researched.  
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To expand the work in Chapter 3, the use of dual labelling techniques could be 
implemented to label both the enteric nervous system and macrophages and analyse 
if any close spatial relationships exist, as has been observed in mice. The further 
development and optimisation of antibodies for use in horses would facilitate this 
work. Enteric neurons produce CSF-1 which helps maintain the MM population in 
mouse ME (Muller et al., 2014). Equine dysautonomia (also referred to as equine grass 
sickness) is a polyneuropathy affecting horses (Pirie et al., 2014). A feature of equine 
dysautonomia is neuronal degeneration of the neurons in the myenteric plexus which 
ultimately results in intestinal dysmotility (Cottrell et al., 1999). Therefore, MM in 
equine dysautonomia cases could be evaluated for evidence of any macrophage 
population alterations in the absence of CSF-1 signalling from enteric neurons. 
The potential for future work with the RNA-Seq dataset generated in this project 
(Chapter 4) is vast. Firstly, expanding the dataset to other time points (0-48 hours) 
would improve our understanding of the full genetic regulation of the equine 
macrophage’s response to LPS. The approach to quantification used in this study does 
not use the full information content of the RNA-Seq data, for example to identify 
examples of alternative splicing.  Two emerging interests in the lab relate to the 
expression by macrophages of the adhesion receptor, Adgre1, widely used as a 
macrophage marker in mice (Austyn and Gordon, 1981, Hume et al., 2002) and of the 
growth factor CSF-1. Both have alternative splice isoforms and Sashimi plots revealed 
exon skipping which was highly variable between species (Waddell et al., 2018). The 
epidermal growth factor (EGF)-like calcium binding domain of ADRGE1 showed 
sequence variation between species. Pig, human and rat have 7 EGF-like 
transmembrane domains whereas the ruminants (sheep, goat, cow and buffalo) and 
the horse had longer sequences, which probably encode 14 EGF-like domains, likely 
arising from a duplication of the 7-domain structure in rat, pig and human.  
RNA-Seq analysis pipelines (such as StringTie (Pertea et al., 2016, Pertea et al., 2015)), 
used in other projects in our laboratory (Clark et al., 2017)), depend upon the 
availability of a quality genome to identify splice junctions.  In this thesis, many 
unannotated genes identified by RNA-Seq and expressed or induced in macrophages 
were not further studied. In many instances, detailed annotation awaits an improved 
horse genome. However, in many cases the likely identity can be inferred from cross-
species mapping, with further confidence derived from the pattern of expression. 
Consequently, further functional annotation of the horse macrophage transcriptome 
will help improve our understanding and knowledge of the equine innate immune 
response to LPS. Furthermore, the data generated can be used to help further 
Chapter 7: General discussion and conclusion 
194 
 
annotate the next release of the equine genome. The availability of new technologies 
such as long-read sequencing is rapidly expanding the set of high quality contiguous 
mammalian genomes, with recent release of the goat  (Bickhart et al., 2017)  and 
upcoming release of pig and water buffalo (involving members of our laboratory) 
rivalling human and mouse genomes.  Another class of transcripts that remains 
currently unannotated in the horse is the long non-coding RNAs (LncRNA).  These are 
a significant component of the LPS-inducible transcriptome in mice and human 
macrophages (Akcora et al., 2013, Ilott et al., 2014, Mao et al., 2015, Pefanis et al., 
2015, Mumtaz et al., 2017). Because of their low expression, these are difficult to 
assemble from short-read RNA-Seq, but additional evidence can be derived from 
cross-species comparison (Bush et al., 2018)).  
The failure of eqBMDMs to induce LPS suppressor genes warrants further 
investigation. The horse BMDM system optimised here offers the possibility of 
generating clustered, regularly interspaced, short palindromic repeats (CRISPR)-
associated nuclease Cas9 system mediated mutations (Shalem et al., 2014) in horse 
macrophages. A specific focus could be on the response to LPS. For example, targeting 
of cellular signalling pathways (Sharma and Petsalaki, 2018) in normal and LPS 
stimulated macrophages could help identify potential therapeutic targets.  
Development of the work in Chapter 5 in colic cases, could involve evaluation of 
macrophage populations (and other immune cell populations) by 
immunohistochemistry. By using monocyte markers this may help identify if 
monocytes are recruited to the intestine during abdominal surgery as reported in 
mice. Further study to look at risk factors or associations with the development of 
POI may then be evaluated.  An increase in numbers for further qPCR analysis would 
also be beneficial.  
In Chapter 6 pre-treatment of mice with CSF1-Fc in a model of POI was beneficial by 
increasing monocyte-derived macrophages required for tissue repair, reducing 
neutrophils and inducing anti-inflammatory genes in the muscularis. The next stage 
would be to evaluate the effect of CSF1-Fc when administered at the time of surgery, 
which would better reflect the clinical scenario of equine abdominal surgery, where 
pre-treatment is unlikely to be an option, due to the nature of the clinical presentation 
of colic. Furthermore, further analysis of microarray data of non-manipulated and 
manipulated muscularis treated with CSF1-Fc, and with the blocking antibody to the 
CSF-1 receptor will help our understanding of the effect of CSF-1 in the intestine. 




This thesis has explored several aspects of macrophage biology in the horse with a 
focus on the relevance to post-operative ileus. The work has generated a protocol to 
produce populations of equine primary macrophages (eqBMDMs) by culturing bone 
marrow in rhCSF-1 and thus providing a tissue macrophage surrogate to study LPS-
induced gene expression. RNA-Seq analysis of eqBMDMs stimulated with LPS clearly 
demonstrated a species-specific variation in innate immune biology and highlighted 
the potential caveats when translating data derived from other species to the horse 
(including data relating to the pathophysiology of POI). Macrophages were identified 
in all layers of the equine gastrointestinal tract of normal horse. Compared to 
controls, horses undergoing abdominal surgery had increased expression of IL-1β, IL-
6 and TNF-α in the mucosa and muscularis. These preliminary data support the 
hypothesis that intestinal surgery in the horse results in the activation of the 
intestinal macrophage population. Finally, the beneficial effect of CSF1-Fc on 
resolution of inflammation in a mouse model of POI warrants further investigation 
and research into its use as a potential therapeutic agent. 
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 Csf1r-mApple transgene expression and ligand 
binding in vivo reveal dynamics of CSF1R expression 
within the mononuclear phagocyte system 
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 Macrophage colony-stimulating factor (CSF1) 
controls monocyte production and maturation and 
the steady-state size of the liver in pigs 
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 Activation of macrophages in the mucosa and 
muscularis of jejunum in horses undergoing 
abdominal surgery for strangulating small intestinal 
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marrow-derived macrophages       
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 Transcriptomic response of equine bone 
marrow-derived macrophages cultured in 
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 Distribution of Macrophages in the 
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 Isolation and characterisation of the equine bone 
marrow derived macrophage. 
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 Distribution of macrophages in the 
gastrointestinal tract of normal horses 
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 Targeting the macrophage in equine post-
operative ileus 
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 Appendix 8: Table of 2^-ddCt values used in 




Tissue Description Animal ID ddCt IL1B ddCt IL6 ddCt PTGS2 ddCt TNF ddCt CCL2 ddCt IDO1
Mucosa Control 1 1.12 0.17 0.19 0.59 0.58 0.90
Mucosa Control 2 0.44 0.46 0.69 1.22 0.66 0.32
Mucosa Control 3 0.90 0.97 1.59 1.11 0.94 2.21
Mucosa Control 4 1.72 2.49 1.59 2.01 1.02 2.72
Mucosa Control 5 2.01 8.39 1.74 0.94 2.75 0.45
Mucosa Control 6 0.65 0.63 1.71 0.65 0.98 1.27
Mucosa distal Case B 3.37 3.46 14.13 0.86 5.26 2.31
Mucosa distal Case C 3.67 468.03 115.97 2.13 97.43 3.01
Mucosa distal Case D 13.66 67.59 6.30 6.28 4.65 0.68
Mucosa distal Case E 5.82 7.66 7.18 6.63 3.87 2.73
Mucosa distal Case F 9.82 73.46 6.25 2.87 8.74 2.89
Mucosa distal Case A 52.12 352.74 17.41 3.02 25.91 0.11
Mucosa distal Case H 8.40 23.19 6.53 2.33 7.09 0.20
Mucosa distal Case L 6.92 25.29 7.64 12.59 3.27 1.09
Mucosa proximal Case B 2.29 2.85 10.30 0.91 2.91 3.03
Mucosa proximal Case C 3.15 111.47 51.64 2.21 26.50 242.48
Mucosa proximal Case E 1.71 1.11 4.05 3.58 1.69 0.55
Mucosa proximal Case G 6.01 23.53 5.01 5.12 3.90 0.01
Mucosa proximal Case H 15.59 70.50 7.59 4.43 14.35 1.20
Mucosa proximal Case I 0.29 3.08 3.29 0.91 2.14 1.82
Mucosa proximal Case J 31.83 432.27 27.29 9.32 27.04 1.38
Mucosa proximal Case L 1.47 2.13 2.39 4.92 2.06 0.32
Muscularis Control 1 1.11 1.42 1.67 1.00 0.79 0.84
Muscularis Control 2 0.56 0.74 1.13 1.37 0.77 1.58
Muscularis Control 3 1.37 1.18 0.60 0.73 1.07 0.64
Muscularis Control 4 1.17 0.81 0.89 1.00 1.54 1.18
Muscularis distal Case A 18.68 1.97 0.31 8.83 2.51 1.70
Muscularis distal Case B 15.66 48.67 1.03 1.27 10.85 0.93
Muscularis distal Case F 110.25 19.45 0.39 11.11 6.47 0.14
Muscularis distal Case I 17.39 2.41 0.55 17.48 3.31 0.18
Muscularis distal Case J 85.42 23.17 0.63 56.75 7.41 0.13
Muscularis proximal Case C 22.73 5.20 0.30 10.96 2.84 1.90
Muscularis proximal Case K 29.49 35.11 1.54 1.36 10.68 0.06
Muscularis proximal Case D 143.76 58.21 0.95 41.82 13.53 2.25
Muscularis proximal Case H 67.02 21.67 0.64 9.77 4.51 0.64
Figure 9-1 2^-ddCt values of target genes from colic and control cases  
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Mucosa Control 1 1.12 0.17 0.19 0.59 0.58 0.90
Mucosa Control 2 0.44 0.46 0.69 1.22 0.66 0.32
Mucosa Control 3 0.90 0.97 1.59 1.11 0.94 2.21
Mucosa Control 4 1.72 2.49 1.59 2.01 1.02 2.72
Mucosa Control 5 2.01 8.39 1.74 0.94 2.75 0.45
Mucosa Control 6 0.65 0.63 1.71 0.65 0.98 1.27
Mucosa distal Case A 52.12 352.74 17.41 3.02 25.91 0.11
Mucosa proximal Case B 2.29 2.85 10.30 0.91 2.91 3.03
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Mucosa proximal Case E 1.71 1.11 4.05 3.58 1.69 0.55
Mucosa distal Case F 9.82 73.46 6.25 2.87 8.74 2.89
Mucosa proximal Case G 6.01 23.53 5.01 5.12 3.90 0.01
Mucosa proximal Case H 15.59 70.50 7.59 4.43 14.35 1.20
Mucosa proximal Case I 0.29 3.08 3.29 0.91 2.14 1.82
Mucosa proximal Case J 31.83 432.27 27.29 9.32 27.04 1.38
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Figure 9-2 2^-ddCt values of target genes in colic cases and non-colic control horses 
